A DNA-Encoded Chemical Library Incorporating Elements of Natural Macrocycles by Stress, Cedric J. et al.
doi.org/10.26434/chemrxiv.7679984.v1
A DNA-Encoded Macrocycle Library that Resembles Natural
Macrocycles
Cedric Stress, Basilius Sauter, Lukas A. Schneider, Timothy Sharpe, Dennis G. Gillingham
Submitted date: 06/02/2019 • Posted date: 06/02/2019
Licence: CC BY-NC-ND 4.0
Citation information: Stress, Cedric; Sauter, Basilius; Schneider, Lukas A.; Sharpe, Timothy; Gillingham,
Dennis G. (2019): A DNA-Encoded Macrocycle Library that Resembles Natural Macrocycles. ChemRxiv.
Preprint.
Herein we perform a seven-step chemical synthesis of a DNA-encoded macrocycle library (DEML) on DNA.
Inspired by polyketide and mixed peptide-polyketide natural products, the library was designed to incorporate
rich backbone diversity. Achieving this diversity, however, comes at the cost of custom synthesis of
bifunctional building block libraries. Our work outlines the importance of careful retrosynthetic design in
DNA-encoded libraries, while revealing areas where new DNA synthetic methods are needed.
File list (2)
download fileview on ChemRxivDNA-Encoded Macrocycle Library_ChemRxiv.pdf (691.94 KiB)
download fileview on ChemRxivSupporting Info DNA-Encoded Macrocycle Library Chem... (24.31 MiB)
          
 
 
 
 
A DNA-encoded macrocycle library that resembles natural 
macrocycles 
Cedric J. Stress,[a] Basilius Sauter, Lukas A. Schneider, Timothy Sharpe and Dennis Gillingham*[a]
Abstract: Herein we perform a seven-step chemical synthesis of a 
DNA-encoded macrocycle library (DEML) on DNA. Inspired by 
polyketide and mixed peptide-polyketide natural products, the library 
was designed to incorporate rich backbone diversity. Achieving this 
diversity, however, comes at the cost of custom synthesis of 
bifunctional building block libraries. Our work outlines the importance 
of careful retrosynthetic design in DNA-encoded libraries, while 
revealing areas where new DNA synthetic methods are needed. 
Nearly all approved macrocyclic drugs are natural products or 
close derivatives.[1] Developing novel man-made macrocycle 
drugs is challenging and unpredictable because they violate all 
or some of Lipinski's rules for oral bioavailability.[2] A second 
problem is that non-peptidic macrocycles are not amenable to 
chemical optimization the way that small molecule drugs are. 
Macrocyclic ‘hits’ are often highly optimized and synthetically 
cumbersome (because they are large and derived from natural 
products), with little opportunity for chemical tuning. Macrocycle 
libraries to date have largely focused on side-chain diversity, but 
recent work suggests that the backbone is intimately involved in 
binding of macrocycles to their targets.[3] In fact natural 
macrocycles as a class are characterized by highly diverse 
backbones rather than side-chains.[1, 4] Some great strides have 
been made in understanding the properties of macrocycles that 
improve their prospects as drugs, despite their seemingly 
unfavorable physicochemical properties. The Whitty[3, 5] and 
Kihlberg[6] groups have independently examined large 
collections of macrocycles to try and identify a set of actionable 
rules for predicting oral bioavailability beyond the rule-of-five. A 
key feature seems to be a macrocycle’s ability to minimize polar 
surface area when exposed to non-polar solvents. This 
‘chameleonic’ property is likely the source of many macrocycle’s 
ability to maintain cell permeability despite their large size. But 
these datasets are based on approved drugs from Nature’s 
bounty of macrocycles. A bigger collection of macrocycles to 
screen and study would allow us to determine whether they are 
truly unusual in terms of cell permeability and protein binding; or 
whether our current thinking is biased by the compound set we 
have been given by natural evolution. In this vein, a number of 
exciting methods, both biological[7] and chemical,[8] have recently 
been developed to create large collections of encoded 
macrocycles. In particular, the Liu lab has created a backbone 
diverse DNA-encoded macrocycle library (DEML),[8a-c] while the 
Neri lab[8d] has reported a highly side-chain diverse DEML built 
on a constant peptide scaffold (see Fig. 1a & B). Missing from 
the current set is a library that includes more hydrophobic 
components in the backbone. Given this background, we 
focused on the construction of an encoded natural product-like 
DEML with diverse ring scaffolds. Scaffold diversity, however, 
comes at a high synthetic cost since commercial libraries of 
bifunctional hydrocarbon precursors are not available. Here we 
report the synthesis and preliminary evaluation of a DEML 
where the backbone is inspired by the polyketide and mixed 
peptide-polyketide macrocyclic natural products. The DEML 
contains over two thousand distinct scaffolds, which, along with 
its side-chain diversity, gives a total library size of over a million 
members. 
Modern drug discovery typically begins with screening diverse 
compound libraries to find ‘hits’ against a given target, which are 
then further optimized into lead structures for in vivo testing. 
However, high throughput screening (HTS) of compound 
collections has a large infrastructure cost and throughput scales 
increase linearly with the size of the compound collection since 
each compound must be spatially separated. Technologies that 
allow screening of pooled compound libraries offer an alternative, 
but comes with the problem of accurate hit deconvolution after 
selection.[9] Biological and biochemical selection techniques offer 
an elegant solution because the genotype (DNA) and the 
phenotype (aptamer, protein) are physically connected. Thus, 
after a functional or binding selection, the structure of best 
performers can be determined by standard DNA sequencing. 
The advent of next generation sequencing has further 
revolutionized the field because now information on entire pools 
of selected molecules can be gleaned, offering a more nuanced 
interpretation of selection datasets. Selection approaches were 
restricted to natural systems until Brenner and Lerner, inspired 
by the success of monoclonal antibody development with phage 
display libraries,[9] proposed in the early nineties that sequential 
synthesis and encoding on a chimeric bead might allow 
selection of wholly artificial molecules.[10] It took several years for 
this concept to be become practical,[9, 11] but today several library 
construction technologies have been demonstrated.[12] A 
challenge in DECL synthesis is the compatibility of the chemical 
synthesis with the DNA itself and the biochemical steps 
(encoding and amplification). Here we push the limits of current 
chemical synthesis on DNA by performing a seven step 
synthesis of a DNA-encoded macrocycle library (DEML) that is 
inspired by polyketide and mixed peptide-polyketide natural 
products (see Fig. 1C & D).    
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Figure 1. A The macrocycle library produced by the Liu lab is peptide derived, 
and rich in scaffold diversity. [13] B The macrocycle library from the Neri lab 
looks at deep side-chain diversity derived from a single scaffold. C The library 
described here uses a DE-1 comprised exclusively of carbon or ether chains 
and a DE-2 that is a mix of carbon frameworks and amino acids. D 
Representative diversity element members. 
The macrocycle synthesis on DNA. The building blocks of the 
two ring scaffold diversity elements (DE-1 & DE-2) were 
designed to cover a broad swath of ring structures with different 
sizes, shapes, strain and polarities (see the Electronic 
Supporting Information [ESI] for building blocks) Fig. 1C shows 
the general design of the DEML as well as a few representative 
examples of the building blocks (Fig. 1D). The synthetic starting 
point of the macrocycle ring was a readily available 2-
iodoterephthalic acid derivative (1 in Fig. 2A). In four chemical 
steps this precursor could be elaborated into the BBs for DE-1. 
Before embarking on the DEML synthesis we next carried out a 
full macrocycle synthesis of a single library member on a short 
single-stranded DNA so that we could optimize the chemistry at 
each step (Fig. 2B&C). 
  
Figure 2. A The DE-1 library is created in four chemical steps from a readily 
available precursor. B A representative library member was synthesized 
completely on ssDNA to probe the compatibility with DNA. C The DNA 
remains pure throughout all seven steps of the macrocycle synthesis. Nos = 2-
nitrophenylsulfonyl. 
The synthesis began with a Cu-catalyzed azide-alkyne 
cycloaddition (CuAAC) to connect the DNA with the DE-1 library 
member 2 (step 1, Fig. 2B). The next step was to introduce the 
key trifunctional lynchpin 3 (step 2). This proved challenging 
because an α-azido-β-amino acid proved unstable, and azido-
alanine led to elimination of the azide to create dehydroalanine 
under basic conditions. These two compact molecules were our 
preferred lynchpins because the aim was to keep the out-of-the-
ring diversity element as close to the macrocyclic core as 
possible, since it would then have the greatest effect on the 
macrocycle’s conformational space. In the end we had to settle 
for compound 3, which contained an additional methylene 
spacer. Saponification of the methyl ester (step 3) then opened 
the necessary coupling site to install the DE-2 library. In the test 
synthesis we used alanine as a coupling partner and its coupling 
efficiency was highest with DMTMM (step 4). Given how critical 
this step was to the library we carried out a comprehensive 
screen across 126 amino acids and evaluated the reactions by 
LC-MS analysis. We scored the reactions by coupling efficiency 
and purity, applying thresholds of >80% conversion and ≥50% 
product purity for inclusion in the DEML itself. Most amino acids 
exceeded these limitations, although we could identify trends in 
the poorly reacting members. In general, other than 1-
aminocyclopropanecarboxylic acid and sarcosine, α,α-
disubstituted and N-methylated amino acids were poorly coupled. 
Also problematic were homoprolines as well as compounds with 
leaving groups in the sidechain (chloroalanine, azidoalanine). 
The full list of the coupling results are shown in the ESI. The 
choice of the coupling reagent had a big impact on coupling 
efficiencies for the different building blocks. While 
EDC/HOAt/DIPEA is often the system of choice[14] we found that 
coupling with DMTMM-BF4/NMM was better in most cases, 
resulting in higher conversions and cleaner products. 
EDC/HOAt/DIPEA was only superior for strained cyclic 
secondary amino acids and tyrosine derivatives, a problem that 
likely stems from reaction of the tyrosine hydroxy group with 
DMTMM-BF4/NMM. Informed by this reaction screening, in the 
library synthesis itself we coupled each DE-2 according to the 
optimal conditions identified in this screen. In total, after 
screening and applying the quality filters, a set of 102 different 
amino acids were selected for DE-2. 
Prior to macrocyclization the ester and the 2-
nitrophenylsulfonyl (Nos) group needed to be removed from 6 
(step 5). This could be done in a one-pot operation using 2-
mercaptoethanol (BME) in combination with DBU (step 5) to 
deliver the fully deprotected version of 6. This seemingly simple 
step turned out to be tricky and dependent on the nature of the 
DE-2 moiety. In the ESI we describe a detailed optimization 
study across 20 representative macrocycle precursors with 
constant DE-1 and varying DE-2 (Figure Sxx). Most of the test 
compounds showed good deprotection efficiencies and low 
sideproduct formation. The best substrates were members with 
cyclic (proline derived) DE-2 elements. In contrast, amino acids 
with sterically hindered sidechains like adamantyl and 
dicyclohexyl were poorly deprotected. An unusual side-product 
was observed in certain cases, seemingly derived from cleavage 
of the trifunctional linker and the DE-2 moiety to leave the 
terminal amide of, for example, compound 2. The azide is 
responsible for this side-reaction since if we synthesize a variant 
          
 
 
 
 
of 4 with an alkyne instead of an azide, it does not occur. The 
Asn was also a poor performer in the Nos deprotection because 
the side-chain amide seemed to back-bite onto the backbone 
under the deprotection conditions. Nevertheless these undesired 
reactions affected only a small subset of the DE-2 members 
(particularly methylhistidine, serine) and hence we continued 
without further optimization. Macrocyclization (step 6) and the 
CuAAC (step 7) both occurred in high chemical yield and 
delivered pure product 7, according to LC-MS analysis. As 
shown in the PAGE gel (Fig. 2C) the DNA shows no detectable 
degradation over all seven synthetic steps. 
Split-and-pool synthesis of the library. With the synthetic 
route to the DEML established, the next task was to elaborate 
this into the full library. In DE-1 we included alkyl, aromatic, 
heteroaromatic and polyene moieties as well as combinations 
thereof. Since the DE-1 building blocks (BBs) needed to be 
synthesized individually we limited the number of members in 
this group to 21 (synthetic procedures and analytical data are 
found in the Supp. Info). As iterative cross-coupling strategies 
continue to evolve,[15]  we expect that DE-1 diversity in our 
scaffold could be expanded further. The DE-1 members were 
directly encoded by clicking each individual DE-1 with a unique 
5'-hexynyl modified oligonucleotide (Figure Sxxx for complete 
library assembling procedure). The DE-1 library was pooled and 
split in 102 vessels and coupled with the DE-2s. The reactions 
were encoded by annealing with a partially complementary DNA 
strand, bearing the coding sequence for the introduced (second) 
diversity element in the 5’-overhang. After Klenow fill-in the 
vessels were pooled and purified to yield the DEML precursor 
library with 2142 encoded macrocycle precursors. These were 
deprotected with BME/DBU and macrocyclized with DMTMM at 
dilute concentration (10µM). Test macrocyclizations proposed at 
least 60% conversion and in most test cases we even found 
>80% conversion. 
In preparation for introduction of the last diversity element the 
coding double-stranded DNA was restricted by BamHI, yielding 
a 5'-overhang of four bases on the non-macrocycle bearing 
strand. Despite extensive optimization, restriction yield could not 
be improved beyond 80% (see the ESI for further details). The 
restricted DEML was split into 663 vessels and coupled with an 
alkyne library. The CuAAC was performed at 2.5 µM 
concentration and so we used large excesses of alkyne (100 
eq.), copper catalyst (200 eq.) and ascorbate (200 eq.) to obtain 
full conversion. The individual reactions were subsequently 
encoded by T4 ligation and Klenow fill-in with a pre-annealed 
partially double-stranded DNA strand, showing a 5'- 
phosphorylated GATC overhang and the six-bases codon for the 
DE-3 (see SuppInfo for detailed coding strategy). Purification of 
the DEML was performed by reversed phase column 
chromatography. 
 
Figure 3. Complete library synthesis and encoding strategy. The detailed 
chemical steps are outlined in Figure 2. 
Prior to protein binding assays all theoretical members of our 
library were analyzed for their physicochemical properties with 
the RDKit (www.rdkit.org) package, which included a custom 
script to interface with our library tables (described in the ESI). 
We compared the results with the published guidelines for oral 
macrocyclic drugs recently defined by the Whitty[32] and 
Kihlberg[6, 16] groups (Figure 4). Our library falls largely within the 
reported guidelines since the majority of the members showed a 
molecular weight below 1000 Da, a total polar surface area 
(TPSA) between 150 and 250 Å2 and an estimated partition 
coefficient (AlogP) between 0 and 6. Furthermore the diversity of 
our macrocycle scaffolds can be seen by the ring-size 
distribution. While the majority of the members consists of 17 - 
23 ring atoms, the range is from 16 up to 33 ring atoms. Further 
property analyses and comparison to the published guidelines 
are shown in the ESI. 
Figure 4. Molecular property distribution across the entire 1.4 x 106-membered 
DEML library. Blue/orange indicate the region found favorable for oral 
bioavailability of known macrocyclic drugs according to published guidelines. 
After these evaluations of the DEML we used it for selections 
against two human blood serum proteins, human serum albumin 
(HSA) and α-1-acid glycoprotein (AGP). HSA is the most 
abundant protein in human blood serum and carries mostly 
acidic ligands.[17] AGP is a second, less abundant transport 
protein in human blood serum, and it carries mainly neutral and 
          
 
 
 
 
basic molecules such as the macrocyclic polymyxins (e. g. 
Colistin).[18] Protein binding assays were performed on 
hydrophilic streptavidin-coated magnetic beads, which were 
pretreated with biotinylated HSA and AGP respectively.[19] The 
DNA of the eluted binders from the treatments was amplified by 
PCR and analyzed by next generation high throughput 
sequencing in comparison with library fingerprint and bead only 
(dummy) selections. The resynthesized hits from HSA selections 
delivered mid-high micromolar binding and were not pursued 
further (full discussion in the ESI). In the case of AGP binding 
several hits were selected for resynthesis (see ESI for detailed 
synthetic procedures). The top two hits, which appeared as 
singleton hits, gave low or poor binding in differential scanning 
fluorimetry (see the ESI) assays. The fourth highest hit 
contained the most highly represented DE-2 in the top 100 hits, 
and indeed showed a strong thermal denaturation shift in a 
differential scanning fluorimetry assay. Detailed characterization 
by isothermal titration calorimetry (ITC) revealed a low 
micromolar dissociation constant (KD = 7 µM, Figure 6c). 
Intriguingly, a similar binding constant (KD = 4 µM) was 
determined when we tested the azide precursor (Figure 6d), 
suggesting that the macrocyclic scaffold, and not the DE-3 side-
chain, was the key for good binding. This result reveals that the 
azide could be a starting point for further improvement of the 
binder. For example, starting from the macrocycle with only DE-
1 and DE-2 installed (see X in Fig. 3), a Staudinger reduction 
followed by reductive amination with aldehydes would provide 
an amine sub-library pre-enriched in strong binders. A great 
advantage of the modular synthetic design means such a 
strategy could be done with library precursors that were already 
prepared.    
Figure 5. A The three top hits from AGP selection results were resynthesized. 
B The TCTT codon, corresponding to the 2-chlorophenyl side-chain, was the 
most strongly selected codon in the top 100 hits. C Isothermal titration 
calorimetry reports a KD = 7 µM. D The azide precursor to the selected 
macrocycle shows a similarly potent binding constant (KD = 4 µM), indicating 
that the macrocycle scaffold is the key binding feature.  
We have synthesized and characterized a macrocycle library 
bearing hydrophobic backbone elements reminiscent of 
macrocyclic polyketide natural products. The greatest challenge 
was the synthesis of the largely hydrocarbon DE-1 diversity 
elements. Although only 21 members, this sub-library 
preparation was the most time-consuming part of the synthesis, 
highlighting the need for continued development of carbon-
carbon bond-forming reactions compatible with DNA encoded 
library construction. Although over a million members, a better 
way to conceptualize this library is that it contains 2142 
macrocyclic scaffolds each with 663 side-chain variations. It is 
therefore encouraging that even with such a relatively small 
number of scaffolds, a low micromolar hit could be identified in a 
protein selection. Scaffold diversification is a great challenge in 
all types of library preparation and our results reveal this is no 
different for macrocycles. While the current state of synthesis 
will dictate that encoded libraries are dominated by a single core 
structure with diverse side-chains, iterative synthetic strategies[15, 
20] compatible with DNA would open new areas of chemical 
space to DECL. Our results with the DEML reported here 
suggest this to be a compelling pursuit for organic synthesis. 
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1. General Information 
1.1 General Experimental Information 
Reagents, Solvents, Oligonucleotides 
Reagents and solvents used were purchased from Sigma-Aldrich, Alfa Aesar, Apollo Scientific Ltd., Fluka, Fluorochem, Enamine, 
TCI, Bachem, Biosolve or Acros and used as received. Enzymes and their buffers were purchased from New England Biolabs. 
Oligonucleotides were purchased from Microsynth in desalted or HPLC purified form as lyophilized material or dissolved in H2O as 
100 µM stock solutions. MOPS buffer refers to a solution of 50 mM MOPS 500 mM NaCl in H2O, pH 8.2. 
Chromatographic Purification and Isolation 
Flash chromatography was performed on SilicaFlash® gel P60 40-63 µm (230-400 mesh) (SiliCycle, Quebec) according to Still[1] or 
on a Biotage Isolera four using SilicaFlash® gel packed cartridges. Reversed phase chromatographic separations were conducted on 
a Biotage Isolera four, using LiChroprep RP-18 (40-63 µM) silica from Merck. Preparative RP-HPLC was carried out on a Shimadzu 
Prominence UFLC Preparative Liquid Chromatograph.  
Method A: Gemini NX-C18, 5 µm, 110 Å, 21.2 x 250 mm from Phenomenex with a flow rate of 20 mL/min, gradient: 1% (3 min)-99% 
(25 min)-99% (3 min) (B), monitoring and collecting the products at 254 nm. Buffer (A): 0.1% TFA (v/v) in H2O, Buffer (B): 0.1% TFA 
(v/v) in MeCN.  
Method B: Gemini NX-C18, 5 µm, 110 Å, 21.2 x 250 mm from Phenomenex with a flow rate of 20 mL/min, gradient: 1% (3 min)-80% 
(25 min)-99% (0.1 min)-99% (3 min) (B), monitoring and collecting the products at 254 nm. Buffer (A): 50 mM TEAA in H2O, pH 7.2, 
Buffer (B): MeCN.  
Method C: Jupiter C4, 5 µm, 300 Å, 10 x 250 mm from Phenomenex with a flow rate of 10 mL/min, gradient: 0% (3 min)-30% 
(17 min)-30% (2 min) (B), monitoring and collecting the products at 254 nm. Buffer (A): 50 mM TEAA in H2O, pH 7.2, Buffer (B): 
MeCN.  
The crude compound mixtures were injected as H2O, MeCN, MeOH or DMSO solutions. Buffers and HPLC eluents were prepared 
with nanopure water (resistivity 18.2 MΩ). Concentration under reduced pressure was performed by rotatory evaporation at 40°C. 
Aqueous product fractions were frozen in liquid N2 and lyophilized on a Christ Alpha 2-4 LDplus flask lyophilizer at 0.3 mbar or below.  
Chromatographic Analysis 
Analytical TLC was performed on Silica gel 60 F254, 0.25 mm pre-coated glass plates (Merck) and visualized by fluorescence 
quenching under UV light at 254 nm and subsequent KMnO4 or ninhydrin staining.  
HPLC analysis was performed on an Agilent 1100 system equipped with Jupiter C4, 5 µm, 300 Å, 2 x 50 mm or 2 x 150 mm columns 
with a flow rate of 0.6 ml/min. Gradients: 0% (1.8 min)-30% (3.2 min)-90% (2.2 min)-90% (1.8 min) (B) or 0% (1.8 min)-30% 
(12.2 min)-90% (4 min)-90% (2 min) (B), Buffer (A): 50 mM NH4OAc in H2O, pH 7.2, Buffer (B): MeCN.  
ESI-MS and LC-MS 
ESI-MS spectra were recorded on a Bruker Esquire3000 spectrometer by direct injection in positive or negative polarity of the ion trap 
detector. Compounds were injected as MeOH, MeCN or H2O solutions. High-resolution mass spectra (HRMS) were recorded by the 
mass spectrometric service of the University of Basel on a Bruker maXis 4G QTOF ESI mass spectrometer.  
LC-MS spectra were recorded on a hyphenated system, consisting of the previously described Agilent 1100 HPLC and the Bruker 
Esquire3000 ESI-MS. Hyphenation software: HyStar 3.1.  
UPLC-MS was carried out on an Agilent 1290 Infinity system equipped with an Agilent 6130 Quadrupole ESI-MS using a C18 column 
(ZORBAX Eclipse Plus RRHD, 1.8 µm, 2.1 x 50 mm) from Agilent with a flow rate of 0.45 mL/min at 40°C. Buffer (A): 0.1% (v/v) 
formic acid in H2O/1% MeCN (v/v), Buffer (B): 0.1% (v/v) formic acid in MeCN/1% H2O (v/v) using the following gradient: 5-90% 
(3.5 min)-90% (1 min) (B), ESI-MS in positive ion mode of the ion trap.  
Nuclear Magnetic Resonance (NMR) 
1H, 13C and 2D-NMR spectra were acquired on a BrukerAvance (400, 500 or 600 MHz proton frequency) spectrometer at 298.15 K. 
Chemical shifts (δ values) are referenced to the solvent’s residual peak and reported in ppm. Multiplicities are reported as follows: s = 
singlet, sbr = broad singlet, d = doublet, t = triplet, dd = doublet of doublets, td = triplet of doublets, m = multiplet or unresolved and 
coupling constant J in Hz.  
DNA Purification/Handling 
0.2, 0.5, 1.5 and 2.0 ml tubes were centrifuged in an Eppendorf Centrifuge 5418R. 5, 14 and 45 ml tubes as well as 96-well plates 
were centrifuged in an Eppendorf Centrifuge 5804R. DNA and protein sample heating or cooling was performed with a BIOER Mixing 
Block MB-102. Vacuum centrifugation was performed with an Eppendorf Concentrator 5301. DNA and protein concentration 
measurements were performed on a Nanodrop 2000 from Thermo Scientific.  
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Gel Electrophoresis 
Gel electrophoresis was performed with a Bio-Rad PowerPac HV high-voltage power supply. Gels were prepared in 83 x 83 x 1.0 or 
1.5 mm format with 10 or 15 wells.  
Native DNA polyacrylamide gels were prepared from 40% acrylamide/bis-acrylamide 19:1 (Fisher Scientific) with TBE (TRIS-Borate-
EDTA) buffer with 0.1% (v/v) TEMED (N,N,N',N'-Tetramethylethylene-1,2-diamine) and 0.1% (v/v) APS (25% ammonium persulfate in 
H2O solution). Loading dye: Gel loading dye purple (6X), no SDS from NEB. To improve loading, the dye was used as 3X.  
For denaturing DNA polyacrylamide gels the same recipe was used with the addition of urea (final concentration: 7M). The DNA 
sample was treated with 2X formamide loading dye (95% formamide, 5 mM EDTA, pH 8, 0.025% (m/v) bromophenol blue) and 
denatured at 95°C for 2 min prior to loading onto the gel.  
DNA agarose gels were prepared by heat dissolving agarose (Fisher Scientific) in 1X TBE (50 ml per gel) and cooling to room 
temperature. Loading dye: 0.025% (m/v) bromophenol blue in 30% (v/v) glycerol in TE buffer, pH 8.  
Denaturing protein gels were prepared with a 5% stacking gel (approx. 2 cm high) and x% resolving gel. The stacking gel was 
prepared from 40% acrylamide/bis-acrylamide 37.5:1 (Fisher Scientific) with 0.1% (m/v) SDS, 0.2% (v/v) TEMED and 0.4% (v/v) APS 
(10% APS solution in H2O) in 125 mM TRIS, pH 6.8. The resolving gel was prepared from 40% acrylamide/bis-acrylamide 37.5:1 
(Fisher Scientific) with 0.1% (m/v) SDS, 0.1% (v/v) TEMED and 0.3% (v/v) APS (10% APS solution in H2O) in 375 mM TRIS, pH 8.8. 
Protein samples were treated with 2X loading dye (66 mM TRIS pH 6.8, 2% (m/v) SDS, 0.01% (m/v) bromophenol blue, 30% (v/v) 
glycerol) and denatured at 95°C for 5 min prior to gel loading. Running buffer for DNA gels: 1X TBE. Running buffer for protein gels: 
193 mM glycine, 25 mM TRIS, 0.1% (m/v) SDS.  
PCR and qPCR 
PCR was performed in 0.2 ml PCR tubes in a Bio-Rad T100 Thermal cycler. qPCR was performed in a StepOnePlus real-time PCR 
system from Applied Biosystems using StepOne v2.3 software. qPCR samples were set up in 96-well plates. 
Differential Scanning Fluorimetry (DSF) and Isothermal Calorimetry (ITC) 
Thermal denaturation experiments were performed with a Nanotemper Prometheus NT.48 instrument using standing capillaries. All 
samples were subjected to continuous ramping from 20-95°C at a rate of 1.5°C/min. The thermal denaturation was monitored by the 
intrinsic fluorescence emission at 330/350 nm after excitation at 285 nm. The data was processed using a beta-version of the 
Nanotemper PR.Analysis software and Graphpad Prism v7. 
ITC experiments were performed on an ITC200 instrument from Malvern Panalytic. Protein samples were degassed prior to ligand 
binding assays. The ligand solution in the syringe was added stepwise to the protein solution in the sample cell at 10 or 25°C. 300 s 
initial delay with stirring was followed by 17 syringe injections (1 x 0.5 µL, 16 x 2.3 µL). The baseline subtraction and integration of the 
differential power vs. time was performed using NITPIC[2] and data fitting was performed using Sedphat.[3] 
1.2 LC-MS Analysis of DNA-tagged Small Molecules 
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Figure 1. Example of an encoded macrocycle precursor LC-MS analysis with the found ion fragments 
Chemical modifications of DNA-tagged small molecules were analyzed with a hyphenated system consisting of an Agilent 1100 
HPLC and a Bruker Esquire3000 ESI-MS with a direct connection tube between the devices (no flow splitter). The ESI-MS was run at 
350°C with a N2 flow of 10.5 L/min and 35 psi pressure in positive ionization mode. Tuning ranges used were 500 - 1400 or 1000 - 
1800 Da. Control software for the ESI-MS was Esquire Control and for the hyphenated system HyStar 3.1 was used. With this setup 
DNA-encoded compounds could be analyzed due to the specific fragmentation of the molecule. Therefore, no multiply charged 
species needed to be deconvoluted, which made it possible to directly find 1 Da modifications of the attached small molecule. The 
accuracy of this method was determined to be ≤ 0.3 Da. In Figure 1 an example of an encoded macrocycle precursor is shown. The 
MS trace analysis clearly shows the proposed fragments. The major fragment consists of the small molecule with the phosphate and 
the ribose (now as furyl group) of the first nucleotide. The rest of the DNA strand was eliminated. A second less abundant fragment 
has the same structure but the elimination occurred at the second nucleotide whereby the first nucleotide (in our case G) stayed 
intact. Sodium (M + Na+) and potassium (M + K+) adducts were often found along with the protonated species. 
1.3 DNA Ethanol Precipitation 
DNA samples were treated with 3M NaOAc pH 5.2 buffer (10% of DNA sample volume) and mixed with 3-4 volumes EtOH. The 
mixture was kept on ice for 2 h (unless otherwise stated). The DNA suspension was centrifuged (4°C, 16900 g, 30 min) and the 
supernatant was discarded. The obtained pellet was washed twice with cold EtOH and centrifuged again (4°C, 16900 g, 2 x 15 min). 
The supernatants were discarded and the washed pellet was dried in the air for 30 min. Clean pellets were dissolved in H2O or buffer. 
1.4 10 mM Cu(II)-TBTA Stock Solution in 55% DMSO 
The Cu(II)-TBTA stock solution was prepared according to a published procedure for click modifications of oligonucleotides found on 
the Lumiprobe website (https://www.lumiprobe.com/protocols/click-chemistry-dna-labeling). 
A solution of copper(II) sulfate pentahydrate (50 mg, 200 µmol 1.0 eq.) in distilled H2O (10 mL) was mixed with a solution of TBTA 
(116 mg, 219 µmol, 1.1 eq.) in DMSO (11 mL). The dark blue solution was stored at room temperature for months without any 
observed loss of catalytic activity in copper-catalyzed click reactions. 
2. Test Synthesis of a DNA-Encoded Macrocycle 
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2.1 Synthesis of the Encoded Macrocycle Precursor XB by Click Reaction with Alkyne-Modified DNA 
 
In a 1.5 ml Eppendorf tube a 5'-alkyne-DNA strand (1 mM in H2O, 44.0 µL, 1.0 eq.) of the sequence 5'-hexyne-GGA GCT TGT GAA 
TTC TGG ATG GGA CGT GTG TGA ATT GTC-3’, DE-1 azide XA (10 mM in DMSO, 8.8 µL, 2.0 eq.), sodium ascorbate (5 mM in 
H2O, 44.0 µL, 5.0 eq.), TEAA buffer (1M, pH 7.2, 88 µL), DMSO (198 µL) and H2O (35 µL) were mixed. N2 was bubbled through the 
solution for 30 s. The Cu(II)-TBTA solution (10 mM in 55% DMSO, 22.0 µL, 5.0 eq.) was added and the solution was degassed again 
for 30 s. The mixture was agitated at RT for 20 h after which HPLC showed 88% conversion to the desired product. The mixture was 
purified by preparative HPLC (Method B). The product containing fractions were combined and lyophilized to yield the desired 
product XB as a white solid. The DNA was dissolved in MOPS buffer (161 µL) to yield a clear solution (140 µM, 51%). 
 
Figure 2. LC-MS chromatogram of the purified encoded compound XB. 
2.2 TFL2 Amide Coupling with XB 
 
In a 1.5 ml Eppendorf tube XB (140 µM in MOPS buffer, 21.4 µl, 1.0 eq.) was mixed with TFL2 (0.5 M in DMSO, 6.0 µL, 1000 eq.), 
DMTMM-BF4 (400 mM in DMSO, 7.5 µL, 1000 eq.) and NMM (400 mM in DMSO, 15.7 µL, 2100 eq.). The mixture was agitated at RT 
for 24 h. The reaction was purified by EtOH precipitation and the clean DNA pellet was dissolved in H2O (25 µL) to yield the desired 
product XC as a clear solution (130 µM, quant.). 
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Figure 3. LC-MS chromatogram of the purified encoded compound XC. 
2.3 Ester Hydrolysis of XC 
 
In a 1.5 ml Eppendorf tube XC (130 µM in H2O, 25.0 µL, 1.0 eq.), LiOH*H2O (100 mM in H2O, 4.9 µL, 150 eq.) and MeCN (15 µL) 
were mixed and agitated at RT for 3 h. The reaction was purified by EtOH precipitation and the clean DNA pellet was dissolved in 
MOPS buffer (28 µL) to yield the desired product XD as a clear solution (100 µM, 86%). 
 
Figure 4. LC-MS chromatogram of the purified encoded compound XD. 
2.4 Amide Coupling with AA001, Introduction of the 2nd Diversity Element 
 
In a 1.5 ml Eppendorf tube XD (90 µM in MOPS buffer, 29.0 µL, 1.0 eq.) was mixed with L-alanine methyl ester hydrochloride AA001 
(500 mM in DMSO, 5.2 µL, 1000 eq.), DMTMM-BF4 (150 mM in DMSO, 17.4 µL, 1000 eq.) and NMM (250 mM in DMSO, 36.5 µL, 
3500 eq.) and the solution was agitated at RT for 20 h. The mixture was purified by EtOH precipitation and the clean DNA-pellet was 
dissolved in H2O (135 µL) to yield the desired product XE as a clear solution (20 µM, quant.).  
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Figure 5. LC-MS chromatogram of the purified encoded compound XE. 
2.5 Ester Hydrolysis and NOSYL Deprotection of XE 
 
In a 0.5 ml Eppendorf tube XE (50 µM in 300 mM MOPS/500 mM NaCl pH 8.2 buffer, 15.0 µL, 1.0 eq.) was mixed with DBU (300 mM 
in DMSO, 15.0 µL, 6000 eq.) and BME (300 mM in DMSO, 15.0 µL, 6000 eq.). The mixture was degassed with N2 for 30 s and 
agitated at RT for 6 h. The reaction was purified by EtOH precipitation and the clean DNA pellet was dissolved in MOPS buffer (20 
µL) to yield the desired product XF as a clear solution (30 µM, 80%).  
 
Figure 6. LC-MS chromatogram of the purified encoded compound XF. 
2.6 Macrocyclization of XF 
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In a 0.5 ml Eppendorf tube XF (25 µM in MOPS buffer, 13.0 µL, 1.0 eq.) was mixed with MOPS buffer (2.0 µL), DMSO (4.6 µL), 
DMTMM-BF4 (25 mM in DMSO, 3.9 µL, 300 eq.) and NMM (50 mM in DMSO, 6.5 µL, 1000 eq.). The mixture was agitated at RT for 
18 h. The reaction was purified by EtOH precipitation. The reaction was set up again with above stated reagent amounts. After EtOH 
precipitation the clean DNA pellet was dissolved in H2O (15 µL) to yield the desired product XG as a clear solution (24 µM, quant.) 
Note: The macrocyclization was repeated once because LC-MS showed incomplete conversion. Increase of the coupling reagent 
amount (up to 500 eq.) and DMSO amount (>55%) should yield full macrocyclization in one step. 
 
Figure 7. LC-MS chromatogram of the purified encoded compound XG. 
2.7 Diversity Element 3 Introduction by Click Reaction 
 
In a 0.5 ml Eppendorf tube, XG (10 µM in 500 mM TEAA pH 7.2, 26.4 µL, 1.0 eq.) was mixed with ethyl propiolate TA641 (1 mM in 
DMSO, 26.4 µL, 100 eq.), sodium ascorbate (3 mM in H2O, 17.6 µL, 200 eq.) and DMSO (17.5 µL) and degassed with N2 for 30 s. 
Copper(II)-TBTA complex (3 mM in 55% DMSO, 17.6 µL, 200 eq.) was added and the solution was degassed with N2 again. The 
solution was agitated at RT for 16 h. The reaction was purified by EtOH precipitation and the clean DNA pellet was dissolved in H2O 
(15 µL) to yield the desired product XH as a clear solution (14 µM, 80%). 
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Figure 8. LC-MS chromatogram of the purified encoded compound XH. 
3. DNA-Encoded Macrocycle Library Synthesis 
 
Scheme 1. DEML synthesis overview. a) Cu-TBTA, NaOAsc, TEAA buffer pH 7.2, DMSO, RT, 20 h. b) DMTMM-BF4, NMM, MOPS buffer pH 8.2, DMSO, RT, 24 
h. c) LiOH, H2O/MeCN 3:1, RT, 2.5 h. d) DMTMM-BF4, NMM, MOPS buffer pH 8.2, DMSO, RT, 20 h or EDC*HCl, HOAt, DIPEA, MOPS buffer pH 8.2, DMSO, 
RT, 20 h. e) Klenow Polymerase, NEBuffer 2, dNTPs, 25°C, 30 min. f) 2-Mercaptoethanol, DBU, MOPS buffer pH 8.2, DMSO, RT, 6 h. g) DMTMM-BF4, NMM, 
MOPS buffer pH 8.2, DMSO, RT, 18 h. h) BamHI-HF, CutSmart buffer, 37°C, 30 min. i) Cu-TBTA, NaOAsc, TEAA buffer pH 7.2, DMSO, RT, 16 h. j) T4 DNA 
ligase, NEB ligase buffer, ATP, 16°C, 16 h. k) Klenow Polymerase, NEB ligase Buffer, dNTPs, 25°C, 30 min. 
3.1 Encoding of the Diversity Elements 1 (DE-1) with Alkyne-Modified DNA (21 elements) 
 
In a 1.5 ml Eppendorf tube an alkyne-DNA strand (1 mM in H2O, 1.0 eq.) of the sequence 5'-hexyne-GGA GCT TGT GAA TTC TGG 
XXX GGA CGT GTG TGA ATT GTC-3’, DE-1 azide (10 mM in DMSO, 2.0 eq.), sodium ascorbate (5 mM in H2O, 5.0 eq.), TEAA 
buffer (1M, pH 7.2), DMSO and H2O were mixed. N2 was bubbled through the solution for 30 s. Cu(II)-TBTA complex (10 mM in 55% 
DMSO, 5.0 eq.) was added, N2 was bubbled through the solution again and the mixture was shaken at RT overnight (20 h). The final 
concentrations of the reagents were as follows: 100 µM DNA, 200 µM DE-1 azide, 500 µM Cu(II)-TBTA complex, 500 µM sodium 
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ascorbate, 0.2 M TEAA, 50% DMSO. Typical DNA amounts: 30 nmol. Conversion and purity of the product was measured by HPLC. 
The mixture was directly purified by prep. HPLC Method B. Product-containing fractions were combined and lyophilized. The isolated 
product was dissolved in MOPS buffer to yield a 140 µM solution. Typical conversions: 80-90%. XXX represents the three-base 
codon for the diversity element 1. This procedure was repeated for all DE-1 (Table 1). 
Table 1. All 21 diversity element 1 building blocks. R indicates the constant scaffold. 
No. Structure No. Structure No. Structure 
NP01  NP08  
NP15  
NP02  NP09  NP16  
NP03  NP10  NP17  
NP04  NP11  NP18  
NP05  NP12  NP19  
NP06  NP13  NP20  
NP07  NP14  NP21  
3.2 Trifunctional Linker Coupling with DNA-DE-1 Pool  
 
20 encoded DE-1 DNA strands (NP1-6 and NP8-21; 21.5 µL, 3 nmol each, 50 mM MOPS buffer) were pooled in a LowBind 1.5 ml 
Eppendorf tube and NMM (315 µL, 0.4M in DMSO, 2100 eq.) was added. The trifunctional linker (120 µL, 0.5M in DMSO, 1000 eq.) 
was added, followed by DMTMM-BF4 (150 µL, 0.4M in DMSO, 1000 eq.). The solution was shaken at RT for 24 h. The mixture was 
purified by ethanol precipitation and the pool was dissolved in H2O (540 µL) to yield a 130 µM solution. Success of the coupling was 
checked by HPLC analysis. DE-1 element NP7 was coupled independently since 2 couplings were necessary to achieve full 
conversion to the desired product. The procedure was conducted at the same reagent concentrations as with the pooled elements. 
Element NP7 was pooled with the other 20 elements after successful modification. 
3.3 Ester Hydrolysis of the DNA-DE-1 Pool 
 
In a LowBind 1.5 ml Eppendorf tube the DNA-DE-1 pool (130 µM in H2O, 564 µL, 1.0 eq.) was mixed with MeCN (340 µL) and LiOH * 
H2O (100 mM in H2O, 110 µL, 150 eq.). The solution was shaken at RT for 2.5 h followed by ethanol precipitation. HPLC showed full 
conversion of the starting material (peak shift). The pool was dissolved in MOPS buffer (648 uL) to yield a 100 µM solution. 
3.4 Amino Acid Test Couplings for Usage in the DEML Synthesis 
 
In a PCR tube XX (74 µM, MOPS buffer, 2.0 µL 1.0 eq.), NMM (250 mM, DMSO, 2.0 µL, 3378 eq.), AAm (500 mM, DMSO, 0.3 µL, 
1014 eq.) and DMTMM-BF4 (75 mM, DMSO, 2.0 µL, 1014 eq.) were mixed. The reaction was left standing at RT for 19 h. The 
mixture was purified by EtOH precipitation The DNA was dissolved in H2O (6 uL) and analyzed by HPLC (2 uL) and LC-MS (4 uL). 
126 amino acids were tested with these conditions. Low yielding or non-converting building blocks were repeated with EDC/HOAt 
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conditions (NMM was replaced by DIPEA, DMTMM-BF4 was replaced by EDC*HCl (150 mM, 1.0 µL) and HOAt (150 mM, 1.0 eq.)). 
In the case of XX with n=1 the dehydroalanine sideproduct was found along with the desired products. These eliminated species 
were included in the conversion and purity yields of the amide coupling reaction. 
Table 2. DE-2 amino acids screening results. 126 building blocks were tested for their reactivity in amide coupling. Unless stated otherwise the screening was 
performed with XX (n = 1). Red coloring indicates the building blocks that were excluded from the final DEML assembly due to insufficient conversion and purity. 
Cutoff: >85% conversion and ≥50% purity. 
No. Structure 
Calc. Mass 
[m/z] 
Obs. Mass 
[m/z] 
Conversion  
(Purity) 
No. Structure 
Calc. Mass 
[m/z] 
Obs. Mass 
[m/z] 
Conversion 
(Purity) 
AA001  1077.3 1077.3 100% (70%) AA064 
 
1231.3 
1233.3 
1231.3 
1233.3 
100% (70%) 
AA002  1077.3 1077.3 100% (92%) AA065  1119.4 1119.4 100% (76%) 
AA003  1077.3 1077.3 100% (66%) AA066  1119.4 1119.4 100% (71%) 
AA004 
 
1111.3 1032.2[a] 100% (0%) AA067  1105.4 1105.4 100% (80%) 
AA005  1091.3 
879.3[b] 
976.3[c] 
100% (0%) 
100% (0%)[d] 
AA068 
 
1192.4 1092.4[g] 94% (69%) 
AA006 
 
1159.4 1159.4 100% (75%) AA069 
 
1192.4 1092.4[g] 100% (66%) 
AA007 
 
1154.4 
1154.3 
1168.3[e] 
62% (34%) 
100% (89%)[d] 
AA070 
 
1206.4 1106.4[g] 95% (72%) 
AA008 
 
1241.5 1241.4 100% (90%) AA071  1091.3 879.3
[b] 100% (<5%) 
AA009  1105.4 1105.3 100% (83%) AA072  1091.3 1091.4 100% (72%) 
AA010  1105.4 1105.3 100% (82%) AA073  
1101.3 1101.4 100% (66%) 
AA011 
 
1119.4 1074.3[f] 100% (0%) AA074  1119.4 1119.3 90% (60%) 
AA012  1063.3 1063.3 100% (92%) AA075  1091.3 1091.4 100% (72%) 
AA013  1077.3 1077.3 100% (82%) AA076  
1119.4 1119.4 94% (79%) 
AA014  1139.3 1139.3 100% (75%) AA077  1079.3 
879[b] 
1024.3[f] 
100% (0%) 
AA015  1153.4 1153.3 100% (79%) AA078  1209.4 1209.4 95% (73%) 
AA016 
 
1155.3 1155.3 
63% (39%) 
100% (78%)[d] 
AA079 
 
1147.4 
1147.4 
976.3[c] 
95% (42%) 
100% (32%)[d] 
AA017  1177.4 1177.3 100% (73%) AA080  1119.4 1119.4 100% (73%) 
AA018 
 
1157.4 1157.3 100% (91%) AA081  1133.4 1133.4 95% (32%) 
AA019 
 
1213.4 1213.3 95% (73%) AA082  1147.4 1147.4 90% (31%) 
AA020 
 
1169.4 
1169.3 
1183.3[e] 
63% (39%) 
100% (62%)[d] 
AA083  1102.3 1031.3
[f] 100% (0%) 
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AA021 
 
1169.4 1169.3 
71% (54%) 
100%(71%)[d] 
AA084 
 
1170.3 1170.3 100% (69%) 
AA022 
 
1183.4 1138.3 100% (0%) AA085  1159.3 879.3
[b] 100% (0%) 
AA023 
 
1421.2 1435.2[e] 
100% (35%) 
100% (63%)[d] 
AA086  1087.3 1087.4 93% (72%) 
AA024  1134.4 1134.3 100% (89%) AA087  1089.3 1089.4 100% (69%) 
AA025 
 
1093.3 1093.3 100% (86%) AA088  1089.3 1089.4 100% (75%) 
AA026 
 
1093.3 1093.3 100% (89%) AA089 
 
1129.4 1129.4 100% (75%) 
AA027  1119.4 1119.4 100% (72%) AA090  
1117.4 1117.4 97% (54%) 
AA028 
 
1133.4 1088.3[f] 100% (0%) AA091 
 
1131.4 1131.4 92% (78%) 
AA029 
 
1192.4 1192.3 100% (71%) AA092 
 
1131.4 1131.4 88% (65%) 
AA030 
 
1192.4 1192.3 100% (78%) AA093  1103.3 
1103.4 
1117.4[e] 
100% (45%) 
100% (70%)[d] 
AA031 
 
1206.4 879.3[b] 100% (<5%) AA094 
 
1089.3 1089.3 
36% (36%) 
100% (86%)[d] 
AA032 
 
1107.3 1107.3 100% (88%) AA095 
 
1159.4 879.3[b] 100% (0%) 
AA033 
 
1107.3 1107.3 100% (90%) AA096  1103.3 1103.4 
90% (37%) 
100%(24%)[d] 
AA034 
 
1107.3 1107.3 100% (90%) AA097 
 
1143.4 1143.3 98% (58%) 
AA035 
 
1107.3 1107.3 100% (90%) AA098 
 
1145.4 
1145.4 
1033.3[f] 
100% (<5%) 
AA036 
 
1207.4 1207.4 100% (86%) AA099 
 
1193.4 1193.3 100% (71%) 
AA037 
 
1207.4 1207.4 100% (89%) AA100 
 
1181.3 949.3[a] 56% (0%) 
AA038 
 
1220.4 1120.4[g] 94% (74%) AA101  1225.5 1225.4 95% (85%) 
AA039 
 
1119.4 1119.3 100% (72%) AA102  1143.4 1143.4 100% (60%) 
AA040 
 
1119.4 1119.4 100% (71%) AA103 
 
1159.4 1159.4 89% (43%) 
AA041 
 
1234.4 1134.4[g] 98% (75%) AA104  1148.3 910.2
[f] 95% (0%) 
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AA042 
 
1268.4 1268.4 100% (85%) AA105 
 
1167.3 879.3[b] 100% (0%) 
AA043 
 
1234.4 1134.4[g] 23% (13%) AA106 
 
1240.4 1240.4 93% (76%) 
AA044 
 
1137.3 1137.3 100% (76%) AA107 
 
1160.3 1160.3 93% (66%) 
AA045 
 
1137.3 1137.3 100% (78%) AA108 
 
1204.4 1204.4 100% (71%) 
AA046  1191.4 1191.4
[h] 100% (73%) AA109 
 
1251.4 1251.4 100% (73%) 
AA047 
 
1120.3 1120.3 100% (80%) AA110 
 
1203.4 1203.4 87% (71%) 
AA048  1103.3 1103.3 95% (72%) AA111  1167.4 1167.4 100% (63%) 
AA049  1103.3 1103.3 100% (82%) AA112 
 
1167.4 1167.4 95% (52%) 
AA050 
 
1117.4 
1117.3 
879.3[b] 
976.3[c] 
100% (<5%) 
100% (0%)[d] 
AA113 
 
1185.4 1185.4 95% (60%) 
AA051 
 
1117.4 1117.3 100% (<5%) AA114 
 
1179.4 1179.4 100% (50%) 
AA052 
 
1119.3 1119.3 100% (75%) AA115 
 
1197.4 1197.4 95% (73%) 
AA053 
 
1119.3 1119.3 100% (83%) AA116 
 
1181.4 1181.4 93% (51%) 
AA054  1101.3 1101.3 100% (82%) AA117 
 
1199.4 1199.4 100% (60%) 
AA055 
 
1153.4 1153.3 100% (75%) AA118 
 
1187.3 1187.4 93% (50%) 
AA056 
 
1153.4 1153.3 100% (78%) AA119 
 
1229.4 1229.4 94% (58%) 
AA057 
 
1167.4 
1167.3 
879.3[b] 
976.3[c] 
100% (<5%) 
100% (0%)[d] 
AA120 
 
1217.4 1217.4 94% (65%) 
AA058 
 
1198.3 1198.3 100% (74%) AA121 
 
1145.3 1145.3 95% (64%) 
AA059 
 
1198.3 1198.3 100% (57%) AA122 
 
1143.4 1143.3 100% (60%) 
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AA060 
 
1167.4 
879.3[b] 
1122.3[f] 
100% (<5%) AA123 
 
1247.4 1247.4 100% (76%) 
AA061 
 
1185.4 1185.4 100% (79%) AA124 
 
1143.4 1143.4 100% (74%) 
AA062 
 
1171.4 1171.4 100% (76%) AA125  1129.4
[e] 1129.3 100%(69%) 
AA063 
 
1171.4 1171.4 100% (76%) AA126 
 
1174.3[e] 1174.3 100%(77%) 
[a] Elimination reaction(s) to dehydroalanine species XA. [b] Terminal amide sideproduct XB. [c] Dihydrotriazinone XC [d] EDC/HOAt/DIPEA reaction conditions. 
[e] Trifunctional linker with n=2 [f] unknown species [g] Boc removal at ESI-MS conditions [h] tBu ester hydrolysis in ESI-MS also observed 
From Table 2 we found trends in reactivity for amide coupling depending on the amino acid structure. Generally, N-methylated amino 
acids did not couple (except AA013, sarcosine) as well as α, α - disubstituted amino acids (AA093 in combination with the 
EDC/HOAt/DIPEA system was the exception). Cyclic amino acids also showed a reactivity trend depending on the nature of the ring 
scaffold. The 4-membered ring amino acid (AA094) as well as the proline derivatives (AA048, AA049, AA052-AA054) worked well 
under the tested reaction conditions whereas homoprolines (AA050, AA051) did not work at all. Interestingly, β - and γ - 
homoprolines (AA091, AA092, AA099) yielded a good amount of the desired product, which leads to the conclusion that the 
arrangement of the functional groups in cyclic amino acids has a big influence on their reactivity. A very important but difficult group 
of compounds were linear β - amino acids. In the case of α - substituted β - amino acids (AA080, AA101, AA120) the couplings 
proceeded with good conversions and purities whereas with β - substituted β - amino acids only the members with flat, aromatic 
sidechains (AA111 - AA113, AA115 - AA119) gave good enough yields. The special case amino acids with electron - withdrawing 
substituents (AA083, AA085), good leaving groups (AA004), a hydroxylamine (AA077) and a thiazoline ring scaffold (AA104) 
generally showed no conversion to the desired products at all. Due to the reactivity of aromatic alcohols with DMTMM, tyrosine 
derivatives were only successfully coupled under EDC/HOAt/DIPEA conditions. We could identify by LC-MS the two major 
sideproducts that we observed during the test assay. 
 
Figure 9 Proposed structure of found common sideproducts. Elimination product to the dehydroalanine species XA, terminal amide product XB and 
dihydrotriazinone product XC. 
3.5 Amino Acid Couplings, DE-2 Attachment by Split Synthesis  
 
The amide coupling reactions were performed in U-shaped 96 well-plates (Eppendorf Microplate 96/U-PP, white border, PCR clean, 
250 µL well-volume). The stated reagent amounts apply per well. 
The DNA-DE-1 pool (90 µM in MOPS buffer, 6.5 µL, 1.0 eq.) was distributed in 102 wells on 2 plates. NMM (250 mM in DMSO, 
8.2 µL, 3500 eq.) was added, followed by the 102 amino acids (500 mM in DMSO, 1.2 µL, 1000 eq.). DMTMM-BF4 (150 mM in 
DMSO, 3.9 µL, 1000 eq.) was added and the solutions were thoroughly mixed. The plates were slowly shaken at RT for 20 h. NaOAc 
buffer (3M, pH 5.20, 2.5 µL) was added, followed by EtOH (75 µL). The plates were placed in the fridge overnight. The plates were 
centrifuged (3700 rpm, 4°C, 60 min) and the supernatant was discarded. The DNA pellets were washed with EtOH (75%, 2 x 50 µL) 
and the plates were centrifuged (3700 rpm, 4°C, 2 x 40 min). The purified pellets were dried in the air for 20 min. The DNA pellets 
were dissolved in H2O (20 µL) to yield 18-20 µM solutions (average of 9 measurements). For Amino Acids AA007, AA016, AA020, 
AA021, AA023, AA093 and AA094 NMM was replaced by DIPEA (250 mM in DMSO, 8.2 µL, 3500 eq.) and the coupling reagents 
were changed to EDC*HCl (300 mM in DMSO, 2 µL, 1000 eq.) and HOAt (300 mM in DMSO, 2 µL, 1000 eq.). 
3.6 Klenow Encoding of the Coupled DE-2 Building Blocks 
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The encodings were performed in PCR tube 96 well-plates (Eppendorf twin.tec PCR Plate 96 LoBind, semi-skirted, 250 µL well-
volume).The amino acid coupling products (20 µM in H2O, 20 µL) were transferred to the PCR 96 well-plates and diluted with H2O 
(146 µL) and 10 X NEBuffer 2 (20 µL). The DE-2-encoding DNA strand (100 µM in H2O, 8 µL, 2.0 eq.) with the general sequence  
5'-GTA GTT GGA TCC GCA CAC YYYY GAC AAT TCA CAC ACG TCC-3’ was added and the solution was annealed by heating to 
65°C for 5 min. YYYY represents the coding sequence for the DE-2 amino acids and the underline shows the BamHI restriction site. 
The used annealing gradient was:  65°C(5)-50°(0.5)-40°(0.5)-25°C. The dNTPs mixture (10 mM in H2O each dNTP, 4 µL, 100 eq.) 
was added, followed by the Klenow polymerase (5000 U/ml, 2 µL, 10 Units). The reaction was incubated at 25°C for 30 min while 
shaking (150 rpm). To stop the reaction, EDTA (500 mM, 5 µL) was added and the mixture was incubated at 75°C for 20 min. The 
102 encoded wells were combined in Eppendorf tubes (2 ml tubes, 14 pcs) and concentrated to 8 ml by SpeedVac (45°C, 6 h). 
NaOAc buffer (3M, pH 5.2, 960 µL) was added, followed by EtOH (28.8 mL). The mixture was left in the fridge (4°C) overnight. The 
suspension was centrifuged (4200 rpm, 4°C, 60 min) and the supernatant was discarded. The pellet was resuspended in EtOH (75%, 
2 x 8 ml) and centrifuged (4200 rpm, 2 x 30 min, 4°C). The clean pellet was dried in air for 20 min. The DNA was dissolved in MOPS 
buffer (300 mM, 500 mM NaCl, pH 8.2, 800 µL) to yield a 200 µM solution. Success of the encoding was checked by native DNA 
polyacrylamide gel electrophoresis (12%, TBE, 150 V, 75 min, SYBR Gold staining). 
 
Figure 10. Left: Scheme for the encoding of the 2nd diversity element by Klenow extension. Right: 12% DNA polyacrylamide gel, SYBR gold staining. L1: Low 
MW DNA ladder, L2: DNA-DE-1 pool, L3: DE-2 coding DNA strand, L4: Annealing of DNA-DE-1 pool and DE-2 coding DNA strand, L5: Klenow extension. 
3.7 Optimization of the Ester and NOSYL Deprotection 
 
Stock solutions: DNA test sample (NP1/AA001, 87 µM in 300 mM MOPS 500 mM NaCl buffer, 2.0 µL, 1.0 eq.), thiol (300 mM in 
DMSO, 2.0 µL, 3448 eq.) base (300 mM in DMSO, 2.0 µL, 3448 eq.).  
In a PCR tube all stock solutions were mixed and the solution was degassed with N2 for 30 s, followed by incubation according to 
Table 3. The sample was purified by ethanol precipitation, dissolved in H2O (6 uL) and further analyzed by HPLC and LC-MS.  
Table 3. NOSYL deprotection screening and optimization.  
Entry Thiol Base Temperature Time NOSYL Deprotection Ester Hydrolysis 
1 PhSH DIPEA 60°C 6 h Yes No 
2 BME DBU 60°C 6 h Yes Yes 
3 MPAA DIPEA 60°C 6 h Incomplete No 
4 NaTG[a] DIPEA 60°C 6 h No No 
5 PhSH DBU 60°C 2 h Incomplete Incomplete 
6 PhSH DBU 60°C 4 h Yes Yes 
7 PhSH DBU 60°C 6 h Yes Yes 
8 BME DBU RT 2 h Yes Yes 
9 BME DBU RT 4 h Yes Yes 
10 BME DBU RT 6 h Yes Yes 
11[b] MPAA DBU 60°C 6 h Incomplete Incomplete 
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12 BME DIPEA RT 6 h Incomplete No 
13 BME NMM RT 6 h No No 
[a] Stock solution 1:1 H2O:DMSO. [b] Reagent concentrations: 200 mM. 
We analyzed the influence of the sulfur nucleophile in combination with different bases at variable temperatures on product and 
sideproduct (mainly terminal amide XB) formations. Only thiophenol (PhSH) and β - mercaptoethanol (BME) completely removed the 
NOSYL group. Ester deprotection was uniquely achieved in combination with DBU. The mildest conditions with the least sideproduct 
formation were BME/DBU at RT (Table 3, Entry 10). These findings were well in accordance to a published procedure on NOSYL 
deprotection with DNA-encoded amino acids on a solid support from Halpin et al.[4] Ester hydrolysis (with LiOH) prior to NOSYL 
removal was very inefficient and led to a high amount of the undesired sideproduct. We further investigated the influence of the 
diversity element 2 structure on deprotection efficiencies. For this purpose we synthesized a series of encoded macrocycle 
precursors with constant DE-1 (NP19) and 20 diverse DE-2 elements (Figure 11). The best protecting group removal was achieved 
with proline derivatives (AA049, AA053 and AA106), but also the common amino acids Gly, Val and Phe (AA012, AA009, AA010, 
AA056, AA058) showed good deprotection. The size and bulkiness of the amino acids seemed to have a big influence. The sterically 
hindered dicyclohexylalanine (AA008) and the adamantyl amino acid (AA101) showed little to no conversion but the formation of a 
substantial amount of sideproduct. Despite good conversions to the desired products, sarcosine (AA013), methylhistidine (AA018) 
and serine (AA025) were amongst the members with the highest sideproduct formation of all tested compounds. L-Asparagine 
(AA047) with its nucleophilic amide sidechain underwent an intramolecular cyclization reaction with the adjacent ester to form the 
corresponding cyclic imide XD. From these findings especially the building blocks AA008, AA047 and AA101 should be excluded 
from the library assembly in a future modified resynthesis.  
 
 
 
 
 
 
 
 
 
Figure 11. Nosyl deprotection results with 20 representative DE-2 building blocks, including the most special amino acids in terms of size and structure. The 
desired products are shown with black pillars, the undesired terminal amide sideproduct XB is represented in red. 
3.8 Ester and NOSYL Deprotection 
 
In a 5 ml Eppendorf tube the encoded library (800 µL in 300 mM MOPS, 500 mM NaCl buffer), DBU (300 mM in DMSO, 800 µL) and 
BME (300 mM in DMSO, 800 µL) were mixed. The mixture was degassed with N2 for 30 s, followed by shaking at RT for 6 h. A white 
precipitate formed after BME addition. The suspension was treated with NaOAc buffer (3M, pH 5.2, 250 µL) and EtOH (8.1 ml) and 
was placed in the fridge (4°C) overnight. The mixture was centrifuged (4200 rpm, 4°C, 60 min) and the supernatant was discarded. 
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The pellet was washed with EtOH (75%, 2 x 1 ml) and centrifuged (4200 rpm, 4°C, 2 x 30 min), then dried in the air for 30 min. The 
DEML was dissolved in MOPS buffer (700 µL) to yield a 79 µM solution. Success of the transformation was checked by HPLC (peak 
shift). 
3.9 Macrocyclization Optimization 
 
In a PCR tube the DNA sample (NP1/AA001, 30 µM in MOPS buffer, 3.0 µL) was mixed with DMSO (2.4 µL), base (1.8 µL in DMSO) 
and coupling reagent (1.8 µL in DMSO). The reaction was left standing at RT for 18 h. The reaction was purified by ethanol 
precipitation and the DNA pellet was dissolved in H2O (5 µL) and analyzed by LC-MS.  
Table 4. Efficiency of the macrocyclization with different coupling reagents and amounts. 
Entry Coupling Reagent Equivalents Base Macrocyclization 
1 DMTMM-BF4 500 NMM Yes 
2 EEDQ 500 - No 
3 EDC*HCl/sulfo-NHS 500 DIPEA very little 
4 DMTMM-BF4 250 NMM Yes 
5[a] DMTMM-BF4 100 NMM Yes 
[a] Bigger amount of sideproduct formation. 
We tested the influence of different coupling reagents on the efficiency of the macrocyclization reaction. DMTMM-BF4 clearly showed 
to be superior compared to the other used reagents (see Table 4). Unlike for common amino acid couplings, the macrocyclizations 
could be performed with fewer equivalents of the reagents (250 - 500 eq.). Lowering the amount of coupling reagent to as low as 100 
eq. the cyclization reaction still occurred within the tested time frame, but a higher amount of sideproducts was found. We think that 
this results from the slower kinetics of the cyclization reaction, which then increases the sideproduct formation. Optimal conditions 
were found with 250 - 500 eq. of coupling reagent and 1000 eq. of base. The DNA concentration in the final mixture was 10 µM to 
avoid dimerization products. Even concentrations down to 1 µM still showed very efficient couplings. We further investigated on the 
influence of the DE-2 elements for macrocyclization reactions. As shown in Figure 12, the majority of the tested compounds showed 
cyclization ratios of >60%. Only amino acids that also caused difficulties during the preceding NOSYL deprotection (AA008, AA047 
and AA101) were not cyclized with this method. For AA008 and AA101 the bulky sidechains had an influence on the deprotection 
reaction by which only a very small amount or even no unprotected species was formed. Moreover, the bulky groups of these 
members potentially inhibited the activation of the carboxylic acid and/or prevented the amine from the nucleophilic attack. 
NP19/AA047 was not formed because the asparagine moiety was completely transformed to the imide sideproduct XD (Figure 11). 
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Figure 12. Macrocyclization efficiencies depending on the DE-2 building block. 
3.10 Macrocyclization of the Encoded DE-1/DE-2 Pool 
 
In a 5 ml Eppendorf tube the DEML (900 µL, 56 µM, in MOPS buffer) was diluted with MOPS buffer (1.35 ml) and DMSO (637 µL). 
NMM (50 mM in DMSO, 1.008 mL, 1000 eq.) and DMTMM-BF4 (25 mM in DMSO, 605 µL, 300 eq.) were mixed and shaken at RT for 
18 h. NaOAc buffer (3M, pH 5.2, 450 µL) was added, followed by EtOH (15 ml). The suspension was placed on ice for 2 h. followed 
by centrifugation (4200 rpm, 4°C, 60 min) and the supernatant was discarded. The DNA pellet was washed with EtOH (75%, 2 x 4 
ml), centrifuged (4200 rpm, 4°C, 2 x 30 min) and dried in the air for 30 min. The DEML pellet was dissolved in H2O (800 µL). The 
coupling was repeated once again.  
The DEML was purified by ssDNA digestion in 8 batches, followed by RP preparative Chromatography. The library (100 µL) was 
diluted with nuclease-free H2O (770 µL) and Exonuclease 1 buffer (100 µL) was added, followed by the Exonuclease 1 enzyme 
(20000 U/ml, 30 µL, 600 U). The solution was incubated at 37°C for 40 min and the enzyme was deactivated by heating to 80°C for 
20 min. The crude material was directly purified by prep HPLC (Method B). Product containing fractions were combined, lyophilized 
and dissolved in nuclease-free H2O (1.2 ml, 26 µM). 100 µL of the DEML solution was diluted with TRIS (10 mM, pH 8.0) to a 1 µM 
final concentration. The library was aliquoted (10 µL aliquots) and stored in the freezer (-20°C) for protein selection experiments 
(small DEML). 
Note: The macrocyclization was repeated once because the reference sample, which was synthesized simultaneously showed 
incomplete conversion. Increase of the coupling reagent amount (up to 500 eq.) and DMSO amount (>55%) should yield full 
macrocyclization in one step. 
 
Figure 13. Left: Preparative HPLC chromatogram at 254 nm for the purification of the DEML. Blue indication shows the DEML containing fractions. Right: HPLC 
chromatogram at 254 nm of the purified small DEML. The large peak at 4.568 min contained some residual coding DE-2 coding DNA strands from the last 
encoding step. 
0 
10 
20 
30 
40 
50 
60 
70 
80 
90 
100 
C
on
ve
rs
io
n 
in
 %
 
O
DE-1 HN
O
N
H
O
DE-2
CO2H
N3
H
N
O
NH2
O DE-1
O
HN
DE-2
N
H
O
O
NH
N
H
O
N3
DMTMM-BF4, NMM,
MOPS, DMSO, RT, 18 h
min
mV
0.0 2.5 5.0 7.5 10.0 12.5 15.0 17.5 20.0
0
10
20
30
40
50
60
70
80
90
5.
17
7
5.
61
1
6.
27
8 7.
67
0
8.
47
8
8.
63
8
8.
98
4
9.
22
2
9.
37
2
9.
83
1
10
.0
51
10
.7
94
11
.3
51 1
1.
57
5
12
.5
28
14
.2
69
min0 2 4 6 8 10
mAU
0
25
50
75
100
125
150
4.
56
8
4.
70
6
DEML fractions 
          
19 
 
3.11 BamHI-HF Restriction Digest 
 
The restriction digest of the DEML was performed in 20 batches; amounts per batch. 
In an Eppendorf tube, DEML (55 µL, 26 µM in H2O) was mixed with 10X CutSmart buffer (75 µL) and diluted with H2O (565 µL). 
BamHI-HF (55 µL, 1100 U, 20000 U/mL) was added and incubated at 37°C for 30 min. The success of the reaction was checked by 
native polyacrylamide gel electrophoresis (12%, TBE, 150 V, 70 min). The reaction was purified by phenol-chloroform extraction. A 
solution of phenol:chloroform:isoamylalcohol 24:24:1 (740 µL) was added to the reaction and the mixture was vortexed for 2 min. The 
biphasic mixture was centrifuged (16900 g, RT, 5 min) and the aqueous layer was carefully removed. The aqueous phase was 
washed with chloroform (740 µL), vortexed for 2 min and centrifuged (16900 g, RT, 5 min). The aqueous layer was carefully removed 
and concentrated in SpeedVac (45°C, 4 h). The 20 combined samples were diluted with H2O to 4 mL total volume. NaOAc buffer 
(3 M, pH 5.2, 0.4 mL) was added, followed by EtOH (13.2 ml). The mixture was placed on ice for 1 h and in the freezer at -80°C for 
1 h. The suspension was centrifuged (4200 rpm, 4°C, 1 h) and the supernatant was removed. The pellet was washed with EtOH 
(75%, 2 x 4 mL) and centrifuged (4200 rpm, 4°C, 2 x 20 min). The restricted DNA was dried in the air for 0.5 h. The DNA pellet was 
dissolved in TEAA buffer (0.5 M, pH 7.2, 2345 µL) to yield a 10.5 µM solution. 
 
Figure 14. Left: Restriction scheme. Underlined bases indicate the recognition site for the BamHI-HF enzyme, the arrows show the restriction sites. Right: Native 
PAGE gel of several restriction samples. L1: Low MW DNA ladder, L2: small DEML before restriction, L3-L7: Restricted samples. 
For the encoding of the third diversity element, the coding oligonucleotide was restricted with BamHI-HF to create a four bases 5' 
overhang (sticky end). The restriction process is shown in Figure 14 on the right. The enzyme did not completely restrict the DNA, 
about 20% uncut DNA was still found. Any condition changes (amount of enzyme, duration, double restriction) did not improve the 
restriction rate of the enzyme. The restricted library was used as obtained for further experiments. 
3.12 Click Reactions, DE-3 Incorporation by Split Synthesis  
 
The reactions were performed in U-shaped 96 well-plates (Eppendorf Microplate 96/U-PP, white border, PCR clean, 250 µL well-
volume). Columns 1 and 12 were left empty, 80 reactions per plate. 663 reactions were performed in 9 plates. The stated reagent 
amounts are given per well. Addition of the catalyst and the reducing agent was performed in a glove bag under an inert atmosphere 
(N2). 
The restricted DEML (3.5 µL, 10.5 µM in 0.5 M TEAA buffer, pH 7.2) was mixed with the DE-3 alkyne (3.7 µL, 1 mM in DMSO, 100 
eq.) and DMSO (2.5 µL). Under an inert atmosphere degassed NaOAsc solution (2.45 µL, 3 mM in H2O, 200 eq.) was added, 
followed by Cu(II)-TBTA complex solution (2.45 µL, 3 mM in 55% DMSO/H2O, 200 eq.). The plates were sealed (Starlab StarSeal 
sealing tape polyolefin) and left standing in the glove bag at RT for 16 h. NaOAc buffer (3M, pH 5.2, 2.5 µL) was added, followed by 
EtOH (65 µL). The plates were placed in the fridge over the weekend. The 96-well plates were centrifuged (3700 rpm, 4°C, 60 min) 
and the supernatant was removed. The DNA was washed with EtOH (75%, 2 x 50 µL) and centrifuged (3700 rpm, 4°C, 2 x 30 min). 
The DNA pellet was dissolved in nuclease-free H2O (10 µL) for the following encoding reaction.  
3.13 Encoding of DE-3 by T4 Ligation and Klenow Fill-in 
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The encoding was performed in PCR tube 96 well-plates (Eppendorf twin.tec PCR Plate 96 LoBind, semi-skirted, 250 µL well-
volume). The given amounts and volumes are valid per well. DE-3 encoding DNA strands (called insert DNA) consisted of a partially 
double stranded DNA piece, that was preformed by the annealing of the coding strand with the sequence 5'-GTT CAA GCC ACT 
TAC CTZ ZZZ ZZT GAT GCC TAC CTA TGA GA-3' and a 5' phosphorylated strand with the sequence 5'-P-GAT CCA AGT TCG 
GTG AAT GGA-3'. ZZZ ZZZ stands for the coding sequence of the DE-3 building blocks. 
The DEML (10 µL, approx. 3.7 µM) was diluted with nuclease-free H2O (15.3 µL) and mixed with the insert DNA (2.22 µL, 50 µM in 
H2O, 3 eq.). 10X ligase buffer (3.5 µL) and T4 DNA ligase (4 µL, 80 U, 20000 U/mL) were added. The 96-well plates were incubated 
at 16°C for 16 h. The reaction was stopped by heating to 65°C for 10 min. dNTPs solution (3.7 µL, 1 mM in H2O, 100 eq.) was added 
followed by Klenow polymerase (4 µL, 2 U, 500 U/mL) and incubated at 25°C for 30 min. The reaction was stopped by the addition of 
EDTA (125 mM in H2O, 4 µL) and heating to 75°C for 20 min. All 663 reactions were pooled in 2.0 mL Eppendorf tubes and 
concentrated in the SpeedVac at 60°C. The concentrates were mixed with NaOAc buffer (3M, pH 5.2, 840 µL) was added followed by 
EtOH (28 mL). The mixture was put on ice for 3 h and kept in the fridge overnight. The suspension was centrifuged (4200 rpm, 4°C, 
60 min) and the supernatant was discarded. The precipitate was washed with EtOH (75%, 2 x 8 mL) and centrifuged (4200 rpm, 4°C, 
2 x 20 min). The DNA pellet was dried in the air for 1 h and dissolved in H2O (1 mL). The encoded macrocycle library was purified by 
semi-preparative HPLC (Method C). The product-containing fractions were combined, lyophilized and dissolved in 10 mM TRIS buffer 
pH 7.42 to a final concentration of 9.4 µM (3890 µL). The library was aliquoted (10 µL) and stored in the freezer (-20°C). 
Figure 15a shows the encoding scheme for the last diversity element. After the encoding, the DEML was purified by semi-preparative 
HPLC (Figure 15b) to remove enzyme, buffer and excess DNA leftovers. The purification step was not completely successful since 
we still see bands for short DNA fragments in the final PAGE analysis (Figure 15c). Even though we considered the library useful 
without further purification since the HPLC chromatogram (Figure 15d) showed no potential purification improvement by the applied 
methods. The short DNA strands should not contain any attached small molecules and were not coding for the complete library. 
These excess oligonucleotides were finally washed away during protein selections. 
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Figure 15. a) Encoding scheme of the 3rd diversity element. Coding regions are colored according to the diversity elements. Underlined bases show the Bam-HI-
HF binding site. b) DEML purification on the semi-preparative column. Blue indication shows the library containing fractions. c) Full synthesis native DNA 
polyacrylamide gel (10%, TBE). L1: Low MW DNA ladder, L2: DNA alkyne, L3: DE-1 click reaction, L4: Trifunctional linker coupling, L5: Trifunctional linker ester 
hydrolysis, L6: DE-2 amide coupling and Klenow encoding, L7: Ester hydrolysis + NOSYL deprotection. L8: Macrocyclization (small DEML), L9: BamHI-HF 
restriction digest, L10: Click reaction with DE-3 and subsequent encoding by T4 ligation and Klenow fill-in. d) HPLC analysis of the purified final library. DEML and 
left-over DNA strands from the encoding steps overlap. 
 
Figure 16. The purified DEML in comparison with self-ligated library or insert DNA strands. L1: Low MW DNA ladder, L2: Purified DEML, L3: DEML self-ligation 
assay, L4: Insert DNA self-ligation assay, L5: Insert DNA self-ligation assay after Klenow extension. 
The palindromic nature of the BamHI-HF binding and restriction site made it possible for the restricted oligonucleotides with "sticky" 
ends to undergo ligation reactions with each other or with itself (self-ligation). The self-ligation of the DEML was particularly critical 
because in that case the last diversity element was not correctly encoded for and both DNA strands of the duplex would carry the 
macrocycle. To overcome this issue we used an excess of insert DNA to prevent DEML self-ligation. Comparison of lanes 2 and 3 in 
Figure 16 led to the conclusion that DEML self-ligation did not occur during DE-3 encoding. On the other hand the insert DNA formed 
the self-ligation product in good amount due to its excess in the mixture. Lanes 4 and 5 show the behavior of this excess during the 
DEML encoding steps. Unexpectedly, the Klenow fragment seemed to truncate the self-ligated DNA in some part rather than just turn 
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it into a full duplex DNA. These truncated short oligonucleotides were the main DNA impurity in our library, which we could not 
completely remove. 
4. Physicochemical Properties Analysis of the Macrocycle Library 
General information 
We developed an in-house software to construct the full library from its fragments (see detailed lists page....) and subsequently 
calculate chemical properties with software available for free. Our software suite is available on https://github.com/Gillingham-
Lab/DECL-Gen and has been developed in Python 3.6 with the following packages: Biopython, RDKit, numpy, scipy, and pandas. 
Chemical property calculations 
The following properties were calculated with RDKit for the macrocycle library: molecular weight, quantitative estimate of drug-
likeness, TPSA, aLogP, number of Hydrogen bond donors, number of Hydrogen bond acceptors, number of heteroatoms, number of 
rotatable bonds, number of N and O, number of NH and OH, number of rings, size of the biggest ring, fraction of carbons that are sp3 
and number of heavy atoms. We compared these calculated results with the guidelines from Whitty[5] and Kihlberg[6], which gave us 
an idea about the (oral) bioavailability of our potential macrocycles. 
Table 5. Comparison of the proposed guidelines from Whitty, Kihlberg and Lipinski. MW = molecular weight, AlogP = atom based partition coefficient (logP) 
calculation, TPSA = topological polar surface area, HBDs = hydrogen bond donors, HBAs = hydrogen bond acceptors, RotBs = rotatable bonds. 
 MW [g/mol] AlogP TPSA [Å2] No. HBDs No. HBAs No. RotBs 
Whitty[a] 600 ≤ x ≤1200 -2 ≤ x ≤6 180 ≤ x ≤ 320 ≤ 12 12 ≤ x ≤ 16 ≤ 15 
Kihlberg ≤ 1000 -2 ≤ x ≤ 10 ≤ 250 ≤ 6 ≤ 15 ≤ 20 
Lipinski ≤ 500 ≤ 5 ≤ 140[b] ≤ 5 ≤ 10 ≤ 10[b] 
[a] Proposed physicochemical guidelines for oral macrocyclic drugs. [b] From the enhanced rules for conventional small molecule drugs by Veber.[7] 
 
 
Figure 17. Most important calculated properties of the macrocycle collection that were potentially synthesized during library assembly. Coloring shows the 
comparison of the calculated properties with the guidelines from Whitty (blue) and Kihlberg (orange) for potential macrocyclic drugs beyond the rule of five 
chemical space. 
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The common rule of five (Ro5) from Lipinski[8][9] cannot be applied for this type of molecules since the occupied chemical space lies 
beyond the Ro5 which would predict that these compounds are pharmacologically uninteresting. But still, macrocycles show 
properties that allow them to be outside the Ro5 chemical space and still act as very potent orally bioavailable drugs. Comparing our 
results with the stated guidelines from Table 5 we directly see that with the Whitty and the Kihlberg rules fit well with our macrocycle 
library. The biggest deviation we found with the number of hydrogen bond acceptors (HBAs) in comparison to the Whitty parameters. 
The majority of our macrocycles possess 9 - 12 HBAs, which is a too low number for the Whitty definition. In contrast the Kihlberg 
parameters that arose from direct macrocycle measurements states that 15 or less HBAs is fine for a macrocyclic drug. A similiar but 
less drastic picture was found with the topological surface area (TPSA). For both guidelines some fraction of our library lay outside 
the parameters. Even though in both cases about 75% of our structures fulfilled the citeria. We performed a ring size distribution 
analysis to further highlight the diversity and potential applicability of the DEML in drug discovery (top left graph in Figure 17). The 
majority of the ring scaffolds contained 16 to 23 ring atoms, even though there were members with very large rings, containing up to 
33 ring atoms. 
5. DEML Protein Selections and Sequencing Results 
5.1 Protein Biotinylation of HSA and AGP 
Protein biotinylation was performed according to a modified procedure from Scheuermann et al.[10] The given procedure below was 
applied for HSA and AGP modifications. 
In a 1.5 ml Eppendorf tube the protein (1 mg/ml in PBS buffer, 1 ml) was mixed with NHS-LC-Biotin (10 mM in DMSO, 20 eq.) and 
the solution was incubated at 4°C for 3 h (Thermo Block, 500 rpm shaking). The reaction was quenched by the addition of TRIS*HCl 
buffer (1M, pH 7.42, 66 eq.) and incubated at 4°C for another 1 h. PBS buffer (1 ml) was added and the reaction buffer was 
exchanged using a Sartorius Vivaspin 2 10000 MWCO CTA column (4200 rpm, 4°C, 4 x 20 min, 3 x 2 ml PBS). The protein solution 
was collected and PBS was added to get a final protein concentration of 10 µM. The protein solution was aliquoted (20 µL aliquots) 
and stored in the freezer at -20°C. To check the success of the modification, a biotinylation band shift assay was performed. 
The modified protein (7.6 µL) was diluted with PBS (37.4 µL) and mixed with an equimolar amount of avidin (1 mg/ml in PBS, 5 µL). 
The solution was left standing at RT for 5 min and then placed on ice for 1 h. The result of the experiment was controlled by SDS-
PAGE (Coomassie stain). Only indicated control samples were treated by heat denaturation prior to loading. 
 
Figure 18. Protein biotinylation band shift assays, Coomassie stain. Left: HSA band shift, L1: Protein standards, L2: HSA unmodified, L3: HSA unmodified + 
avidin, L4: HSA modified, L5: HSA modified + avidin, L6: Avidin, L7: HSA unmodified + avidin (95°C), L8: HSA modified + avidin (95°C). Right: AGP band shift, 
L1: Protein standards, L2: AGP unmodified, L3: AGP modified, L4: AGP modified + avidin, L5: AGP modified + avidin (95°C), L6: AGP unmodified + avidin, L7: 
AGP unmodified + avidin (95°C), L8: Avidin. Avidin tetramer is not visible since it sticks to the stacking gel. 
5.2 DEML Protein Target Selections 
Stock solutions: 
- Biotin solution:  200 mM D-biotin in DMSO (2 ml) 
- PBST:  0.05% Tween-20 in PBS (10 ml)  
- PBST-Biotin:  1:1 mixture of Biotin stock solution + 50% DMSO in PBST (2 ml)-> do not put on ice! 
- Salmon Sperm DNA:  2 mg/ml in PBS 
- PBST-SS:  PBST containing 0.2 mg/ml Salmon Sperm DNA. Mix 1.8 ml PBST with 0.2 ml Salmon Sperm DNA stock 
(2 ml). 
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- DEML-WS:  DEML working solution. DEML stock (9.4 µM, 10 µL) was mixed with PBST-SS (50 µL) and diluted with 
PBST (940 µL) to yield the working solution (1 ml, 94 nM for 10 assays). 
- Protein solution:  biotinylated protein sample (10 µL, 10 µM) was diluted with PBS (90 µL) to the final concentration (1 µM, 
100 µL)  
 
All stock solutions were prepared as stated above. The DECL-WS and the protein solution were kept on ice. 0.1 mg hydrophilic 
streptavidin magnetic beads (25 µL, NEB S1421S) were placed in a magnetic rack and the buffer was discarded. The beads were 
washed with PBS (3 x 1 ml). The beads were kept in 1 ml PBS on ice until usage. 
The buffer was removed from the beads and the protein solution (100 µL, 100 pmol) was added. The mixture was incubated at 4°C 
for 30 min while gently mixing by rotation. The tube was placed in the magnetic rack and the buffer was discarded. The beads were 
suspended in PBST-Biotin (2 x 200 µL) and the supernatants were removed. The beads were washed with PBST (200 µL), 10% 
PBST in DMSO (200 µL, to remove biotin precipitate) and PBST (2 x 200 µL). The beads were transferred to a fresh tube and DEML-
WS (100 µL, 9.4 pmol DECL) was added. The mixture was incubated at 4°C for 1 h while gently mixing by rotation. The tube was 
transferred to the magnetic rack and the supernatant was discarded. The beads were washed with PBST (5 x 200 µL), exchanging 
the tube after 2 washing steps (reduce carryover of unbound DNA). The washed beads were suspended in TRIS buffer (10 mM, pH 
8.5, 100 µL) and the bound DNA was eluted from the protein by heat denaturation (95°C for 10 min). After cooling, the magnetic 
beads were removed and the buffer solution was stored in a 1.5 ml Eppendorf tube at -20°C. PCR amplification and high-throughput 
sequencing were used for analyzing the target binding results. 
Note: For the small DEML the procedure was analog to the described procedure. Due to the higher purity and smaller number of 
individual members the small DEML-WS was prepared from the 1 µM small DEML solution, giving a final work solution concentration 
of 10 nM. Target binding assays were performed in duplicates with two freshly prepared working solutions that were used on two 
consecutive days. Performed assays with AGP and HSA: 2 x small DEML, 2 x DEML, 4 x dummy selections (beads only, no bound 
target proteins). In total: 12 selection assays. 
5.3 PCR Amplification of Eluted DNA 
PCR 1 
Eluted DNA from selection:  5 µL 
Phusion HF buffer (5x):  10 µL 
Phusion MgCl2 (50 mM):  2 µL 
dNTPs (10 mM):  1.25 µL 
UniPrimAdapt (7.5 µM):  4 µL 
IndexPrimAdapt (10 µM):  3 µL 
Phusion (2U/µL):  0.25 µL 
H2O:  24.5 µL 
 
In a PCR vial all stock solutions were mixed and kept on ice. The polymerase was added shortly before the PCR program started. 22 
PCR cycles were performed. PCR cycle program: 98°C for 2:15 then 22 x 98°C (45 s) → 69°C (45 s) → 72°C (45 s), 72°C (5 min). 
The progress of the reactions was controlled by Native PAGE analysis (10%, TBE, 150 V, 45 min, SYBR Gold staining). The samples 
were purified by PCR clean up kit (Macherey&Nagel). Two washing steps were included and the purified PCR products were eluted 
with NE buffer (2 x 20 µl). The PCR products were diluted with NE buffer to a final concentration of 100 nM.  
For the fingerprint sample, an aliquot of the DEML (small DEML) working solution was diluted 1:10 and processed as stated above. 
 
UniPrimAdapt:  5‘-ACACGACGCTCTTCCGATCTGTAGTTGGATCCGCAC-3‘ (small DEML) 
 5‘-ACACGACGCTCTTCCGATCTAGAGTATCCATCCGTA-3‘ (DEML) 
IndexPrimAdapt:  5'-GACGTGTGCTCTTCCGATCTGGAGCTTGTGAATTCT-3’ (both libraries the same) 
 
Figure 19. 10% Native PAGE gels after PCR1 with the DEML selections (left) and the small DEML selections (right), SYBR gold staining. L1: Low MW DNA 
ladder, L2: (small) DEML, L3&L4: HSA selections, L5&6: Dummy selections, L7&8: AGP selections, L9&10: Library fingerprints. 
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PCR2 
PCR products from PCR1 were diluted 1:10 with NE buffer prior to PCR2 
PCR 1 DNA (10 nM):  10 µL 
Phusion HF buffer (5x):  20 µL 
Phusion MgCl2 (50 mM):  4 µL 
dNTPs (10 mM):  2.5 µL 
Universal Primer (10 µM):  3 µL 
Index Primer (10 µM):  3 µL 
Phusion (2U/µL):  0.5 µL 
H2O:  57 µL 
 
In a PCR vial all stock solutions were mixed and kept on ice. The polymerase was added shortly before the PCR program started. 15 
PCR cycles were performed. PCR cycle program: 98°C for 2:15 then 15 x 98°C (45 s) → 69°C (45 s) →72°C (45 s), 72°C (5 min). 
The progress of the reactions was controlled by Native PAGE analysis (8%, TBE, 150 V, 45 min, SYBR Gold staining). The samples 
were purified by Agarose Gel Electrophoresis (2%, TBE, 100 V, 45 min) and the desired bands were cut out of the gel with 
subsequent DNA isolation with the PCR clean up kit (Macherey&Nagel). Two washing steps were included and the purified PCR 
products were eluted with NE buffer (2 x 20 µl). After ethanol precipitation the amplified and indexed products were diluted with NE 
buffer to a final concentration of 100 nM. 
 
Primer sequences for Illumina Sequencing (NEBNext Multiplex Oligos for Illumina, Sets 1 and 3): 
 
UniPrimer:  5‘-AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCT-3‘ 
IndexPrimers:  5'-CAAGCAGAAGACGGCATACGAGATNNNNNNGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT-3’ 
 
NNNNNN represents the indexing codons (selection ID) defined by the NEB Kits. 
 
Figure 20. 8% Native PAGE gels after PCR2 amplification. L1: Low MW DNA ladder, L2&L11: PCR1 (HSA selection), L3, L6, L12, L15: HSA selections, L4, L7, 
L13, L16: Dummy selections, L5, L8, L14, L17: Fingerprints, L9, L10, L18, L19: AGP selections, L20: Primers. 
 
Figure 21. 8% Native PAGE gels after PCR2 purification. L1: Low MW DNA ladder, L2, L3, L10, L11: HSA selections, L4, L5, L12, L13: Dummy selections, L6, 
L7, L14, L15: AGP selections, L8, L9, L16, L17: Fingerprints. 
5.4 Next Generation Sequencing (NGS) 
We extracted the codon hit counts from next generation sequencing data files (.fq) with our DECL-Gen software suite on the 
University of Basel Computational Cluster (SciCore). The script aligns the theoretical DNA strand to the read with the pairwise2 
algorithm provided by the Biopython package, and then extracts the codons from the aligned read. This is done for the mate pair, too, 
and the two codon sets are controlled for identity, discarding the read if they do not match. After extraction, the counts for both 
replicates have been averaged and the list was cleaned from non-existing codon combinations deriving from random mutations 
during PCR or from sequencing errors. The results for each data set are summarized in Table 6. 
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Table 6. Summary of the enrichment assays that were analyzed by NGS. The counts of the different enrichments were averaged by replicate and then normalized 
by their mean. 
[a] Read counts are given in million mate reads. [b] In million reads. Only reads where both read mates have the same codons were considered. [c] Coverage is 
an indication of how many reads per codon that can be expected if all compounds are distributed equally in the sample. It was calculated by the following 
equation: "𝐶𝑜𝑣𝑒𝑟𝑎𝑔𝑒" = "𝑀𝑎𝑡𝑐ℎ𝑖𝑛𝑔 𝑐𝑜𝑑𝑜𝑛 𝑝𝑎𝑖𝑟𝑠" /"𝐿𝑖𝑏𝑟𝑎𝑟𝑦 𝑆𝑖𝑧𝑒" . [d] This number indicates how many codons were found that did not encode for a compound 
within a library. [e] Depending on sequencing depth, a part of the library population never gets sequenced in both replicates even if they are equally distributed. A 
lower number of found codons indicated a strong deviation in the population distribution due to enrichment. 
5.5 Results Analysis 
Hit identification (smDEML) 
 
Figure 22. Scatterplots for the selections of the smDEML, presented in 2D (upper) and 3D (lower) plots. For clarity, only the 100 most abundant compounds are 
shown. a) smDEML Fingerprint. b) smDEML Dummy selection (beads only). c) smDEML selection against AGP. d) smDEML selection against HSA. 
Potential binders were identified by comparison of the found hits in the AGP and HSA selections to the dummy selection and the 
fingerprint. Hits containing the DE-1 elements NP09, NP18, NP19 and NP20 were directly excluded, since these compounds were 
highly overrepresented in the fingerprint and dummy selection. These moieties seemed to favor binding to the magnetic beads 
(perhaps streptavidin), which led to the conclusion that these compounds were false positives. Macrocycle NP07/AA001 was found to 
be the most abundant compound in the fingerprint and reappeared in high amounts in all other selections, which led to its exclusion 
from the analysis. We created a list of the remaining potential macrocyclic protein binders (see Table 7) from which we chose the 
compounds to be synthesized and tested for their binding affinity. Only the top hit in the HSA selection (MC NP01/AA001 XZ36) was 
finally considered valuable for binding affinity tests. The AGP selection did not reveal any potentially interesting protein binders. 
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Entry Target Replicate Library Size Reads[a] Matching Codon Pairs[b] Coverage[c] Invalid Codon Content[d| Found Codons[e] 
1 Fingerprint 1 2’142 15.77 13.41 6260 
2.6% 2142 (100%) 
2  2 2’142 20.03 17.38 8114 
3 Beads 1 2’142 17.23 15.17 7082 
2.1% 2142 (100%) 
4  2 2’142 15.14 13.20 6160 
5 HSA 1 2’142 15.81 13.83 6457 
2.1% 2142 (100%) 
6  2 2’142 15.21 13.28 6200 
7 AGP 1 2’142 17.43 15.22 7106 
2.1% 2142 (100%) 
8  2 2’142 16.76 14.47 6755 
9 Fingerprint 1 1’420’146 13.07 8.55 6.02 
6.7% 1’318’952 (92.9%) 
10  2 1’420’146 11.95 7.87 5.54 
11 Beads 1 1’420’146 12.02 8.87 6.25 
4.2% 819’242 (57.7%) 
12  2 1’420’146 12.30 8.97 6.32 
13 HSA 1 1’420’146 12.33 9.06 6.38 
4.3% 838’791 (59.1%) 
14  2 1’420’146 13.28 9.77 6.88 
15 AGP 1 1’420’146 10.82 8.02 5.65 
4.0% 788’545 (55.5%) 
16  2 1’420’146 11.54 8.54 6.01 
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Hit identification (DEML) 
 
Figure 23. Scatterplots for the selections of the DEML in 3D. For clarity, only the 100 most abundant compounds are shown for the selections, 1000 compounds 
for the fingerprint plot. a) DEML Fingerprint. b) DEML Dummy selection (beads only). c) DEML selection against AGP. d) DEML selection against HSA. e) 
Structures of the indicated compounds (arrows). 
As with the smDEML, potential binders were identified by comparison of the found hits in the AGP and HSA selections to the dummy 
selection and the fingerprint. Hits containing the DE-1 elements NP09, NP18, NP19 and NP20 were excluded again, since these 
compounds were highly overrepresented in the fingerprint and dummy selection. The compound group NP07/AA001/TAX was highly 
overrepresented in the fingerprint, resulting from the same high abundance of macrocycle NP07/AA001. A summary of the found top 
hits of these selections is shown in Table 7. We chose four compounds from the AGP selection and one macrocycle from the HSA 
selection (see Figure 23 and Table 7 for the details) to be synthesized and tested for their protein binding affinity. In the case of 
macrocycle NP02/AA058/TA229 and NP13/AA070/TA333 the first diversity element was changed to NP01 and NP12 respectively. 
This was done due to the high similarity of these elements and to simplify the synthesis of the macrocycles (see the structures of 
XZ42 and XZ39). 
Table 7. Results for the different library-protein selections. The compounds were ranked after comparison of the protein selection with the dummy selection 
experiment and the fingerprint. Only the top 6 compounds are listed, the rest was considered too little enriched. Compounds in bold face were chosen for 
resynthesis and binding affinity measurements. 
Small DEML selection against HSA Small DEML selection against AGP 
Rank DE-1 DE-2 DE-3 Number Rank DE-1 DE-2 DE-3 Number 
1 NP01 AA001 none NP1/AA001 1 NP20 AA069 none NP20/AA069 
2 NP18 AA034 none NP18/AA034 2 NP19 AA088 none NP19/AA088 
3 NP17 AA070 none NP17/AA070 3 NP19 AA117 none NP19/AA117 
4 NP20 AA069 none NP20/AA069 4 NP18 AA053 none NP18/AA053 
5 NP19 AA029 none NP19/AA029      
6 NP20 AA072 none NP20/AA072      
DEML selection against HSA DEML selection against AGP 
Rank DE-1 DE-2 DE-3 Number Rank DE-1 DE-2 DE-3 Number 
1 NP21 AA026 TA423 NP21/AA026/TA423 1 NP07 AA026 TA256 NP07/AA026/TA256 
2 NP14 AA086 TA621 NP14/AA086/TA621 2 NP14 AA020 TA607 NP14/AA020/TA607 
3 NP02[a] AA058 TA229 NP02/AA058/TA229 3 NP13[b] AA070 TA333 NP13/AA070/TA333 
4 NP15 AA020 TA459 NP15/AA020/TA459 4 NP12 AA118 TA622 NP12/AA118/TA622 
NP07/AA001/TAX NP02/AA058/TA229 NP13/AA070/TA333 
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5 NP19 AA039 TA357 NP19/AA039/TA357 5 NP21 AA125 TA412 NP21/AA125/TA412 
6 NP12 AA029 TA553 NP12/AA029/TA553 6 NP09 AA029 TA443 NP09/AA029/TA443 
[a] Due to the high similarity and ease of chemical synthesis, NP02 was replaced by NP01 for off-DNA macrocycle synthesis. [b] Due to the high similarity and 
ease of chemical synthesis, NP13 was replaced by NP12 for off-DNA macrocycle synthesis. 
6. Macrocycle Resynthesis 
6.1 N-(2-aminoethyl)-2-nitrobenzenesulfonamide XZ1 
 
A solution of 2-nitrobenzenesulfonyl chloride (25.0 g, 113.0 mmol, 1.0 eq.) in DCM (250 ml) was added dropwise to a cooled solution 
of ethylenediamine (75.4 mL, 1.1 mol, 10.0 eq.) in DCM (250 ml) over 1.5 h. The mixture was stirred at RT for 3 h. The yellow mixture 
was washed with H2O (3 x 200 ml), brine (150 ml) and the organic layer was dried over Na2SO4 and concentrated (residual 
ethylenediamine was removed by hv) to yield the desired product as a thick yellow oil (12.2 g, 44%). The material was used without 
further purification for the next step. Analytical data was in agreement with reported data.[11] 
1H NMR (400 MHz, Chloroform-d) δ/ppm: 8.17 – 8.12 (m, 1H), 7.88 – 7.84 (m, 1H), 7.75 (m, 2H), 3.12 (dd, J = 6.5, 5.0 Hz, 2H), 2.87 
(dd, J = 6.5, 4.9 Hz, 2H). 
6.2 2-Iodo-N-(2-((2-nitrophenyl)sulfonamido)ethyl)benzamide XZ2 (Nos-Sc-I) 
 
In a 250 mL flask 2-iodobenzoic acid (8.2 g, 33.1 mmol, 1.0 eq.), XZ1 (12.2 g, 49.6 mmol, 1.5 eq.), HBTU (15.0 g, 39.7 mmol, 1.2 
eq.) and DIPEA (17.3 mL, 99.2 mmol, 3.0 eq.) were dissolved in THF (150 mL) and stirred at RT for 2 h after which UPLC-MS 
analysis showed 93% conversion to the desired product (HBTU dissolved after about 30 min reaction time). The solvent was 
removed in vacuo and the residue was dissolved in EtOAc (250 mL). The organic layer was washed with diluted HCl (20 mM, 3 x 100 
mL), half-saturated NaHCO3 (3 x 100 mL) and brine (100 mL). The organic layer was dried over MgSO4 and concentrated. The crude 
was purified by flash column chromatography on the ISOLERA (Silica, 2 x 340 g, cyclohexane:EtOAc 20% -> 70% EtOAc, UV). The 
product containing fractions were combined and concentrated. The obtained solid was dissolved in MeCN (100 mL), filtered over a 
G4 glass sintered funnel and concentrated to yield the desired product as a yellow solid (14.7 g, 94%).  
1H NMR (400 MHz, Acetonitrile-d3) δ/ppm: 8.10 – 8.03 (m, 1H), 7.91 – 7.83 (m, 2H), 7.83 – 7.76 (m, 2H), 7.41 (ddd, J = 7.5, 7.5, 1.1 
Hz, 1H), 7.32 (dd, J = 7.6, 1.7 Hz, 1H), 7.14 (ddd, J = 7.9, 7.4, 1.8 Hz, 1H), 6.90 (brs, 1H), 6.21 (t, J = 5.9 Hz, 1H), 3.44 (dt, J = 5.8, 
6.0 Hz, 2H), 3.30 – 3.22 (dt, 6.0, 6.1 Hz, 2H). 
13C NMR (101 MHz, CD3CN) δ/ppm: 170.75, 143.29, 140.57, 135.19, 135.10, 133.88, 133.80, 131.97, 131.40, 129.15, 128.88, 
126.02, 93.03, 43.98, 40.27. 
HRMS (ESI): C15H14IN3NaO5S+ calcd: 497.9591, found: 497.9597. 
6.3 Nos-Sc-NP12-OMe XZ3 
 
Under an inert atmosphere XZ2 (3.0 g, 6.3 mmol, 1.0 eq.) and Pd (π-cinnamyl) chloride dimer (327.0 mg, 631.0 µmol, 10 mol%) were 
dissolved in THF (60 mL) and the solution was cooled to 0°C. A solution of (S)-3-Methoxy-2-methyl-3-oxopropylzinc bromide (0.5 M 
in THF, 18.9 mL, 9.5 mmol, 1.5 eq.) was slowly added and the solution was stirred at 0°C for 15 min. The cooling bath was removed 
and the mixture was stirred at RT for 45 min after which UPLC analysis showed full consumption of the starting material. The reaction 
was stopped by the addition of H2O (5 mL) and the mixture was filtered over G4. The volatiles were removed in vacuo and the 
residue was dissolved in EtOAc (150 mL) and washed with half-saturated NH4Cl (100 mL) and H2O (2 x 100 mL). The combined 
aqueous layers were extracted with EtOAc (2 x 100 mL) and the combined organic layers were treated with brine (100 mL), dried 
over Na2SO4 and concentrated by rotary evaporation. The crude was purified by flash column chromatography on the ISOLERA 
(Silica, 340g, cyclohexane:EtOAc, UV). The product containing fractions were combined and concentrated to yield the desired 
product as a thick, slightly red oil (2.3 g, 80%). 
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1H NMR (400 MHz, Acetonitrile-d3) δ/ppm: 8.11 – 8.02 (m, 1H), 7.88 – 7.83 (m, 1H), 7.83 – 7.76 (m, 2H), 7.38 – 7.31 (m, 2H), 7.29 – 
7.18 (m, 2H), 6.96 (s, 1H), 6.30 (t, J = 5.7 Hz, 1H), 3.53 (s, 3H), 3.48 – 3.38 (m, 2H), 3.25 (dt, J = 5.7, 5.9 Hz, 2H), 3.12 – 3.03 (m, 
1H), 2.85 – 2.74 (m, 2H), 1.07 (d, J = 6.6 Hz, 3H). 
13C NMR (101 MHz, CD3CN) δ/ppm: 177.33, 171.17, 148.94, 138.72, 137.49, 135.06, 133.82, 133.81, 131.55, 131.40, 130.65, 
128.20, 127.28, 125.96, 52.04, 44.12, 41.99, 40.24, 37.43, 17.53. 
HRMS (ESI): C20H23N3NaO7S+ calcd: 472.1149, found: 472.1152. 
6.4 Nos-Sc-NP14-OEt XZ4 
 
Under an inert atmosphere XZ2 (3.0 g, 6.3 mmol, 1.0 eq.) and Pd (π-cinnamyl) chloride dimer (327.0 mg, 631.0 µmol, 10 mol%) were 
dissolved in THF (60 mL) and the solution was cooled to 0°C. 4-Ethoxy-4-oxobutylzinc bromide solution (0.5 M in THF, 18.9 mL, 
9.5 mmol, 1.5 eq.) was slowly added and the solution was stirred at 0°C for 15 min. The cooling bath was removed and the mixture 
was stirred at RT for 45 min after which UPLC analysis showed full consumption of the starting material. The reaction was stopped by 
the addition of H2O (5 mL). The mixture was filtered and the volatiles were removed in vacuo. The residue was dissolved in EtOAc 
(150 mL) and washed with half-saturated NH4Cl (100 mL) and H2O (2 x 100 mL). The combined aqueous layers were extracted with 
EtOAc (2 x 100 mL) and the combined organic layers were treated with brine (100 mL), dried over Na2SO4 and concentrated by 
rotary evaporation. The crude was purified by flash column chromatography on the ISOLERA (Silica, 340g, cycloxexane:EtOAc, UV) 
to yield the desired product as a thick, slightly yellow oil (2.4 g, 82%). 
1H NMR (400 MHz, Acetonitrile-d3) δ/ppm 8.09 – 8.03 (m, 1H), 7.88 – 7.83 (m, 1H), 7.82 – 7.76 (m, 2H), 7.35 (td, J = 7.5, 1.5 Hz, 
1H), 7.30 (dd, J = 7.6, 1.4 Hz, 1H), 7.25 (ddd, J = 7.6, 1.3, 0.6 Hz, 1H), 7.21 (td, J = 7.4, 1.4 Hz, 1H), 6.91 (s, 1H), 6.31 (t, J = 5.7 Hz, 
1H), 4.04 (q, J = 7.1 Hz, 2H), 3.44 (q, J = 5.9 Hz, 2H), 3.27 - 3.21 (m, 2H), 2.76 – 2.68 (m, 2H), 2.24 (t, J = 7.4 Hz, 2H), 1.88 – 1.78 
(m, 2H), 1.19 (t, J = 7.1 Hz, 3H). 
13C NMR (101 MHz, CD3CN) δ/ppm 174.10, 171.32, 140.76, 137.42, 135.06, 133.82, 131.40, 131.01, 130.71, 129.37, 127.99, 
127.94, 126.87, 125.95, 60.89, 44.21, 40.16, 34.38, 32.98, 27.52, 14.54. 
HRMS (ESI): C21H25N3NaO7S+ calcd: 486.1305, found: 486.1309. 
6.5 Nos-Sc-NP01-OH XZ5 
 
In a 250 mL flask XZ2 (3.0 g, 6.3 mmol, 1.0 eq.), 3-(2-carboxyvinyl)benzeneboronic acid (1.8 g, 9.5 mmol, 1.5 eq.), Pd (π-cinnamyl) 
chloride dimer (327.0 mg, 631.0 µmol, 10 mol%) and K3PO4 (4.0 g, 18.9 mmol, 3.0 eq.) were dissolved in EtOH (56 mL) and H2O (24 
mL). The solution was stirred at 50°C for 1 h after which UPLC-MS analysis showed full conversion to the desired product. The 
volatiles were removed and the residue was taken up in EtOAc (200 mL) and H2O (150 mL). The mixture was acidified with 
concentrated HCl to pH 1. The biphasic mixture was separated and the aqueous layer was extracted with EtOAc (2 x 100 mL, 1 x 
50 mL). The combined organic layers were washed with brine (100 mL), dried over Na2SO4 and were concentrated by rotary 
evaporation. The crude was purified by reversed phase flash chromatography on the ISOLERA (RP-Silica, 340 g, H2O/MeCN + 0.1% 
TFA, UV). The product-containing fractions were freeze dried to yield the desired product as off-white powder (2.2 g, 70%). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 8.22 (t, J = 5.8 Hz, 1H), 8.11 (t, J = 5.9 Hz, 1H), 7.99 (dd, J = 5.9, 3.4 Hz, 1H), 7.96 – 7.92 (m, 
1H), 7.91 – 7.86 (m, 2H), 7.64 – 7.54 (m, 3H), 7.54 - 7.48 (m, 1H), 7.47 – 7.40 (m, 3H), 7.38 – 7.30 (m, 2H), 6.50 (d, J = 16.0 Hz, 1H), 
3.14 (dt, J = 7.6, 6.0 Hz, 2H), 2.77 (dt, J = 7.6, 6.2 Hz, 2H). 
13C NMR (101 MHz, DMSO) δ/ppm: 169.19, 167.48, 147.70, 143.68, 140.77, 138.44, 136.94, 134.10, 132.71, 132.54, 130.14, 
129.81, 129.51, 129.38, 128.63, 127.94, 127.63, 127.34, 126.99, 124.57, 119.46, 41.56, 38.78. 
HRMS (ESI): C24H21N3NaO7S+ calcd: 518.0992, found: 518.0991. 
6.6 Nos-Sc-NP07-OEtOMe XZ6 
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In a 100 mL flask XZ2 (1.5 g, 3.2 mmol, 1.0 eq.), 2-(methylcarboxy)pyridine-5-boronic acid pinacol ester (1.0 g, 3.8 mmol, 1.2 eq.), 
Pd(dppf)Cl2 (348.0 mg, 475.0 µmol, 15 mol%) and triethylamine (883.0 µL, 6.3 mmol, 2.0 eq.) were dissolved in methoxyethanol 
(40 mL) and the mixture was stirred at 100°C for 4 h after which UPLC-MS analysis showed full conversion to the desired product as 
methoxyethylester. The solvent was removed in vacuo and the crude was taken up in EtOAc (100 mL). The organic layer was 
washed with diluted HCl (pH 1, 3 x 100 mL). The combined aqueous layers were extracted with EtOAc (3 x 100 mL) and the 
combined organic layers were washed with brine (100 mL), dried over Na2SO4 and concentrated by rotary evaporation. The crude 
was purified by reversed phase flash column chromatography on the ISOLERA (RP-Silica, 340 g, H2O/MeCN + 0.1% TFA, UV). The 
product-containing fractions were lyophilized to yield the desired product as dark brown waxy solid (884 mg, 53%). NMR analysis 
showed co-elution of some sideproducts. The product was used without further purification for the next steps. Characterization of the 
compound was performed after ester saponification to compound XZ9. 
6.7 Nos-Sc-NP12-OH XZ7 
 
In a 100 mL flask XZ3 (2.2 g, 4.9 mmol, 1.0 eq.) was dissolved in MeCN (30 mL) and a solution of LiOH *H2O (1.0 g, 24.7 mmol, 
5.0 eq.) in H2O (15 mL) was added. The mixture was stirred at RT for 2.5 h after which UPLC-MS analysis showed complete 
conversion to the desired product. Acidifying with concentrated HCl to pH 5-6 quenched the reaction. The volatiles were removed in 
vacuo and the aqueous residue was taken up in EtOAc (150 mL) and H2O (100 mL). The mixture was acidified to pH 1 with 
concentrated HCl. The layers were separated (addition of brine for good separation) and the aqueous layer was extracted with EtOAc 
(2 x 100 mL). The combined organic layers were washed with half-saturated brine (2 x 100 mL) and brine (100 mL), dried over 
Na2SO4 and concentrated by rotary evaporation. The desired product was obtained as an off-white solid (2.2 g, quant. 93% HPLC 
purity). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 12.06 (s, 1H), 8.34 (t, J = 5.7 Hz, 1H), 8.18 (t, J = 5.9 Hz, 1H), 8.06 – 8.00 (m, 1H), 8.00 – 7.95 
(m, 1H), 7.91 – 7.83 (m, 2H), 7.37 – 7.31 (m, 2H), 7.28 – 7.19 (m, 2H), 3.35 – 3.26 (m, 2H), 3.12 – 3.05 (m, 2H), 3.02 (dd, J = 13.3, 
6.9 Hz, 1H), 2.72 (dd, J = 13.3, 7.6 Hz, 1H), 2.67 – 2.57 (m, 1H), 0.97 (d, J = 6.9 Hz, 3H). 
13C NMR (101 MHz, DMSO) δ/ppm 177.00, 169.29, 147.70, 137.53, 136.89, 134.08, 132.72, 132.67, 130.29, 129.48, 129.25, 127.38, 
125.99, 124.51, 42.04, 40.28, 39.00, 36.05, 16.90. 
HRMS (ESI): C19H22N3O7S+ calcd: 436.1173, found: 436.1167. 
6.8 Nos-Sc-NP14-OH XZ8 
 
In a 100 mL flask XZ4 (2.3 g, 4.9 mmol, 1.0 eq.) was dissolved in MeCN (30 mL) and a solution of LiOH *H2O (1.0 g, 24.6 mmol, 
5.0 eq.) in H2O (15 mL) was added. The mixture was stirred at RT for 2.5 h after which UPLC-MS analysis showed complete 
conversion to the desired product. Acidifying with concentrated HCl to pH 5-6 quenched the reaction. The volatiles were removed and 
the aqueous residue was taken up in EtOAc (150 mL) and H2O (100 mL). The mixture was acidified to pH 1 with concentrated HCl. 
The layers were separated (addition of brine for good separation) and the aqueous layer was extracted with EtOAc (2 x 100 mL). The 
combined organic layers were washed with half-saturated brine (2 x 100 mL) and brine (100 ml), dried over Na2SO4 and concentrated 
by rotary evaporation to yield the desired product as yellow, waxy solid (2.1 g, quant. 73% HPLC purity). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 12.00 (s, 1H), 8.30 (t, J = 5.7 Hz, 1H), 8.17 (t, J = 5.9 Hz, 1H), 8.05 – 8.01 (m, 1H), 8.00 – 7.97 
(m, 1H), 7.89 – 7.85 (m, 2H), 7.38 – 7.29 (m, 2H), 7.28 – 7.17 (m, 2H), 3.34 – 3.28 (m, 2H), 3.11 – 3.05 (m, 2H), 2.74 – 2.58 (m, 2H), 
2.17 (t, J = 7.5 Hz, 2H), 1.82 – 1.65 (m, 2H). 
13C NMR (101 MHz, DMSO) δ/ppm: 174.24, 169.35, 147.71, 139.37, 136.80, 134.07, 132.72, 132.68, 129.48, 129.35, 128.22, 
127.22, 125.66, 124.49, 42.09, 38.97, 33.35, 31.85, 26.32. 
HRMS (ESI): C19H22N3O7S+ calcd: 436.1173, found: 436.1166. 
6.9 Nos-Sc-NP07-OH XZ9 
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In a 100 mL flask XZ6 (842 mg, 1.6 mmol, 1.0 eq.) was dissolved in MeCN (10 mL) and a solution of LiOH*H2O (334 mg, 8.0 mmol, 
5.0 eq.) in H2O (5 mL) was added. The mixture was stirred at RT for 2 h after which UPLC-MS analysis showed complete conversion 
to the desired product. Acidifying with concentrated HCl to pH 2 quenched the reaction. The volatiles were removed in vacuo and the 
aqueous residue was taken up in EtOAc (50 mL) and H2O (50 mL). The mixture was acidified to pH 1 with concentrated HCl. The 
layers were separated (addition of brine for good separation) and the aqueous layer was extracted with EtOAc (2 x 50 mL). The 
combined organic layers were washed with half-saturated brine (2 x 50 mL) and brine (50 mL), dried over Na2SO4 and were 
concentrated by rotary evaporation. The crude was purified by reversed phase flash column chromatography (RP-Silica, 340 g, 0.1% 
TFA in H2O/MeCN). Product-containing fractions were combined and lyophilized to yield the desired product as white solid (366 mg, 
49%). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 8.65 (dd, J = 2.3, 0.8 Hz, 1H), 8.46 (t, J = 5.7 Hz, 1H), 8.15 (t, J = 6.0 Hz, 1H), 8.03 (dd, J = 
8.1, 0.8 Hz, 1H), 8.02 – 7.94 (m, 2H), 7.92 (dd, J = 8.0, 2.3 Hz, 1H), 7.90 – 7.83 (m, 2H), 7.65 – 7.45 (m, 4H), 3.23 – 3.13 (m, 2H), 
2.96 – 2.85 (m, 2H). 
13C NMR (101 MHz, DMSO) δ/ppm: 168.59, 165.94, 148.46, 147.68, 146.72, 139.05, 136.93, 136.76, 135.18, 134.13, 132.76, 
132.58, 130.18, 130.06, 129.46, 128.41, 128.12, 124.55, 124.18, 41.77, 39.02. 
HRMS (ESI): C21H19N4O7S+ calcd: 471.0969, found: 471.0966. 
6.10 Imidazole-1-sulfonyl azide hydrochloride XZ10 
 
Synthesis according to a literature reported procedure.[12]  
Under an inert atmosphere NaN3 (3.9 g, 60.0 mmol, 1.0 eq.) was suspended in MeCN (60 mL) and cooled to 0°C in an ice bath. 
Sulfuryl chloride (4.9 mL, 60.0 mmol, 1.0 eq.) was added dropwise over 10 min. The mixture was stirred at RT for 18 h. After that, the 
mixture was cooled in an ice-bath and imidazole (7.8 g, 114.0 mmol, 1.9 eq.) was added portionwise. The mixture was continued 
stirring at RT for 3 h. EtOAc (120 mL) was added and the mixture was washed with H2O (2 x 120 mL), saturated NaHCO3 (2 x 120 
mL), dried over Na2SO4 and filtered. A solution of HCl in EtOH (prepared by the addition of AcCl (6.42 mL, 90 mmol) to dry EtOH 
(22.5 mL) while cooling) was added dropwise to the filtrate. The mixture was cooled in an ice bath and stirred for 1 h. The formed 
solid was filtered off, washed with EtOAc (3 x 10 mL) and dried at hν to yield the desired product as white solid (9.1 g, 72%). 
Analytical data was in agreement with reported data. 
1H NMR (400 MHz, Deuterium Oxide) δ/ppm: 9.44 (t, J = 1.4 Hz, 1H), 8.06 (dd, J = 2.2, 1.6 Hz, 1H), 7.65 (dd, J = 2.2, 1.2 Hz, 1H). 
6.11 Boc-Dab(N3)-OH XZ11 
 
The compound was synthesized according to a modified procedure by E.D. Goddard-Borger and R.V. Stick.[12] Compound is also 
commercially available as CHA salt. 
Under an inert atmosphere Boc-Dab-OH (5.9 g, 27.2 mmol, 1.0 eq.) and XZ10 (6.8 g, 32.7 mmol, 1.2 eq) were dissolved in MeOH 
(140 mL) and potassium carbonate (10.2 g, 73.5 mmol, 2.7 eq.) was added, followed by CuSO4 pentahydrate (68.0 mg, 272 µmol, 
1 mol%). The blue mixture was stirred at RT for 2 h after which TLC (5% MeOH in DCM, Ninhydrin) showed complete consumption of 
the starting material. The solvent was removed and the crude was dissolved in EtOAc (150 mL) and H2O (150 mL). The biphasic 
mixture was acidified with concentarted HCl to pH 1-2. The biphasic mixture separated and the aqueous layer was extracted with 
EtOAc (2 x 150 mL) and the combined organic layers were washed with H2O (2 x 150 mL), brine (150 mL), dried over Na2SO4 and 
concentrated by rotary evaporation to yield the desired product as slightly yellow oil (7.9 g, >100%). NMR analysis showed some 
unidentified peaks. The material was used as obtained without further purification.  
1H NMR (400 MHz, DMSO-d6) δ/ppm 12.60 (s, 1H), 3.96 (ddd, J = 9.9, 8.2, 4.5 Hz, 1H), 3.42 (ddd, J = 12.4, 7.2, 5.4 Hz, 1H), 3.34 
(ddd, J = 12.3, 8.0, 6.5 Hz, 1H), 1.97 – 1.84 (m, 1H), 1.85 – 1.71 (m, 1H), 1.38 (s, 9H). 
6.12 H-Dab(N3)-OMe XZ12 
 
Under an inert atmosphere XZ11 (7.9 g, 32.5 mmol, 1.0 eq.) was dissolved in MeOH (150 mL) and cooled in an ice bath. Thionyl 
chloride (19.0 mL, 260.0 mmol, 8.0 eq.) was added dropwise and the solution was stirred at 0°C for 15 min. The cooling bath was 
removed and the solution was stirred at RT for 24 h after which TLC (BAW, Ninhydrin, Rf=0.58) and NMR showed complete 
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conversion to the desired product. The solvent was removed by rotary evaporation and the residue was dissolved in half-saturated 
NaHCO3 solution (200 mL). The aqueous solution was extracted with EtOAc (10 x 100 mL) and the combined organic layers were 
dried over Na2SO4 and concentrated to yield the desired product as yellow liquid which solidified over time in the fridge (3.4 g, 66%).  
1H NMR (400 MHz, Methanol-d4) δ/ppm: 3.74 (s, 3H), 3.55 (dd, J = 7.5, 5.6 Hz, 1H), 3.45 (td, J = 6.6, 1.5 Hz, 2H), 1.98 (dddd, J = 
14.0, 7.3, 6.8, 5.6 Hz, 1H), 1.81 (ddt, J = 14.0, 7.5, 6.4 Hz, 1H). 
13C NMR (101 MHz, MeOD) δ/ppm: 176.65, 52.75, 52.60, 49.85, 34.47. 
HRMS (ESI): C5H11N4O2+ calcd: 159.0877, found: 159.0876. 
6.13 Nos-Sc-NP12-TFL2(N3)-OMe XZ13 
 
In a 100 mL flask XZ7 (2.2 g, 4.9 mmol, 1.0 eq.), XZ12 (937.0 mg, 5.9 mmol, 1.2 eq.), HBTU (2.2 g, 5.9 mmol, 1.2 eq.) and DIPEA 
(2.6 mL, 14.8 mmol, 3.0 eq.) were dissolved in THF (42 mL) and the mixture was stirred at RT for for 1 h after which UPLC-MS 
analysis showed full conversion to the desired product. The solvent was removed by rotary evaporation and the crude mixture was 
purified by flash column chromatography on the ISOLERA (Silica, 340 g, DCM/MeOH, UV). Product-containing fractions were 
combined and concentrated to yield the desired product as a thick, yellow oil (4.0 g, >100%). NMR showed co-eluted byproducts from 
the coupling reagent. The material was used without further purification for the next synthetic step. 
1H NMR (400 MHz, Chloroform-d) δ/ppm: 8.13 – 8.05 (m, 1H), 7.81 – 7.74 (m, 1H), 7.75 – 7.66 (m, 2H), 7.58 (t, J = 5.8 Hz, 1H), 7.41 
– 7.28 (m, 2H), 7.25 – 7.16 (m, 2H), 6.79 (d, J = 8.1 Hz, 1H), 6.75 (t, J = 6.0 Hz, 1H), 4.53 (td, J = 8.3, 4.6 Hz, 1H), 3.67 (s, 3H), 
3.66 – 3.61 (m, 1H), 3.54 – 3.44 (m, 1H), 3.42 – 3.30 (m, 2H), 3.19 – 3.05 (m, 2H), 2.87 – 2.80 (m, 2H), 2.71 – 2.63 (m, 1H), 1.88 
(dddd, J = 14.2, 7.7, 6.6, 4.7 Hz, 1H), 1.66 (ddt, J = 14.5, 8.4, 6.2 Hz, 1H), 1.21 (d, J = 6.7 Hz, 3H). 
13C NMR (101 MHz, CDCl3) δ/ppm: 176.43, 172.10, 171.06, 148.07, 137.35, 136.20, 133.75, 133.67, 132.81, 130.84, 130.32, 130.19, 
127.94, 126.69, 125.15, 52.66, 49.60, 47.10, 43.39, 43.22, 43.04, 40.39, 31.04, 18.21. 
HRMS (ESI): C24H29N7NaO8S+ calcd: 598.1691, found: 598.1693. 
6.14 Nos-Sc-NP14-TFL2(N3)-OMe XZ14 
 
In a 100 mL flask XZ8 (2.1 g, 4.9 mmol, 1.0 eq.), XZ12 (925.0 mg, 5.9 mmol, 1.2 eq.), HBTU (2.2 g, 5.9 mmol, 1.2 eq.) and DIPEA 
(2.5 mL, 14.6 mmol, 3.0 eq.) were dissolved in THF (42 mL) and the mixture was stirred at RT for 1.5 h after which UPLC-MS 
analysis showed full conversion to the desired product. The volatiles were removed in vacuo and the residue was dissolved in EtOAc 
(100 mL) and H2O (100 mL). The mixture was acidified to pH 1 by addition of concentrated HCl. The layers were separated and the 
aqueous phase was extracted with EtOAc (2 x 100 mL). The combined organic layers were washed with H2O (100 mL), brine 
(100 mL), dried over MgSO4 and concentrated by rotary evaporation. The crude material was purified by flash column 
chromatography on the ISOLERA (Silica, 340 g, DCM/MeOH, UV) to yield the desired product as yellow oil (2.7 g, 96%). 
1H NMR (400 MHz, Chloroform-d) δ/ppm: 8.13 – 8.07 (m, 1H), 7.81 – 7.76 (m, 1H), 7.72 – 7.69 (m, 2H), 7.33 – 7.27 (m, 2H), 7.21 – 
7.13 (m, 2H), 6.84 (t, J = 5.9 Hz, 1H), 6.74 (d, J = 7.8 Hz, 1H), 6.60 (t, J = 5.8 Hz, 1H), 4.59 (td, J = 7.7, 5.1 Hz, 1H), 3.71 (s, 3H), 
3.62 – 3.55 (m, 2H), 3.37 – 3.30 (m, 4H), 2.83 – 2.75 (m, 2H), 2.29 (t, J = 7.0 Hz, 2H), 2.08 (dtd, J = 14.0, 6.9, 5.1 Hz, 1H), 1.98 – 
1.89 (m, 3H). 
13C NMR (101 MHz, CDCl3) δ 173.52, 172.40, 171.16, 148.11, 139.75, 135.81, 133.46, 132.81, 130.98, 130.38, 130.28, 127.30, 
127.17, 126.24, 125.21, 52.67, 50.15, 47.90, 43.44, 39.80, 35.67, 32.65, 31.25, 27.06. 
HRMS (ESI): C24H29N7NaO8S+ calcd: 598.1691, found: 598.1701. 
6.15 Nos-Sc-NP01-TFL2(N3)-OMe XZ15 
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In a 500 mL flask XZ5 (2.2 g, 4.4 mmol, 1.0 eq.), XZ12 (841.0 mg, 5.3 mmol, 1.2 eq.), HBTU (2.0 g, 5.3 mmol, 1.2 eq.) and DIPEA 
(2.3 mL, 13.3 mmol, 3.0 eq.) were dissolved in THF (40 mL) and the mixture was stirred at RT for 1.5 h after which UPLC-MS 
analysis showed full conversion to the desired product. The volatiles were removed in vacuo and the crude was purified by flash 
column chromatography on the ISOLERA (Silica, 340 g, DCM/MeOH, UV) to yield the desired product as a thick, yellow oil (3.7 g, 
>100%). NMR showed co-eluted byproducts from the coupling reagents. The material was used without further purification for the 
next synthetic step.  
1H NMR (400 MHz, Chloroform-d) δ/ppm: 8.01 – 7.93 (m, 1H), 7.80 – 7.73 (m, 1H), 7.73 – 7.65 (m, 2H), 7.58 – 7.25 (m, 9H), 7.00 (d, 
J = 7.8 Hz, 1H), 6.54 (d, J = 15.7 Hz, 1H), 6.50 (t, J = 5.8 Hz, 1H), 5.92 (t, J = 5.9 Hz, 1H), 4.70 (td, J = 7.9, 5.0 Hz, 1H), 3.70 (s, 3H), 
3.37 (t, J = 6.7 Hz, 2H), 3.33 – 3.25 (m, 2H), 3.01 – 2.93 (m, 2H), 2.18 – 2.07 (m, 1H), 2.03 – 1.90 (m, 1H). 
13C NMR (101 MHz, CDCl3) δ/ppm: 172.26, 170.70, 166.13, 147.93, 140.97, 140.89, 139.09, 135.47, 135.00, 133.92, 133.07, 132.98, 
130.90, 130.44, 130.25, 130.11, 129.18, 128.23, 127.87, 127.75, 127.61, 125.30, 121.03, 52.68, 50.34, 47.81, 43.06, 39.85, 31.19. 
HRMS (ESI): C29H29N7NaO8S+ calcd: 658.1691, found: 658.1693. 
6.16 Nos-Sc-NP07-TFL2(N3)-OMe XZ16 
 
In a 50 mL flask XZ9 (315.0 mg, 670.0 µmol, 1.0 eq.), XZ12 (127.0 mg, 803.0 µmol, 1.2 eq.), HBTU (305.0 g, 803.0 µmol, 1.2 eq.) 
and DIPEA (350.0 µL, 2.0 mmol, 3.0 eq.) were dissolved in THF (5 mL) and DMF (1 mL) and the mixture was stirred at RT for 1 h 
after which UPLC-MS analysis showed full conversion to the desired product. The volatiles were removed in vacuo and the residue 
was dissolved in EtOAc (50 mL) and H2O (50 mL). The mixture was acidified to pH 1 by addition of concentrated HCl. The layers 
were separated and the aqueous phase was extracted with EtOAc (2 x 50 mL). The combined organic layers were washed with H2O 
(50 mL), brine (50 mL), dried over MgSO4 and concentrated by rotary evaporation The crude material was purified by flash column 
chromatography on the ISOLERA (Silica, 120 g, DCM/MeOH, UV) to yield the desired product as a yellowish solid (397 mg, 97%).  
1H NMR (400 MHz, Chloroform-d) δ/ppm: 8.67 (d, J = 8.3 Hz, 1H), 8.65 (dd, J = 2.3, 0.9 Hz, 1H), 8.19 (dd, J = 8.0, 0.8 Hz, 1H), 
8.09 – 8.04 (m, 1H), 7.93 (dd, J = 8.0, 2.2 Hz, 1H), 7.87 – 7.79 (m, 1H), 7.80 – 7.68 (m, 2H), 7.64 (dd, J = 7.6, 1.2 Hz, 1H), 7.54 (td, J 
= 7.6, 1.5 Hz, 1H), 7.47 (td, J = 7.5, 1.4 Hz, 1H), 7.37 (dd, J = 7.6, 0.9 Hz, 1H), 6.51 (t, J = 5.8 Hz, 1H), 5.87 (t, J = 6.1 Hz, 1H), 4.89 
(td, J = 7.9, 5.0 Hz, 1H), 3.79 (s, 3H), 3.50 – 3.40 (m, 4H), 3.18 – 3.11 (m, 2H), 2.28 (dtd, J = 14.1, 6.9, 5.0 Hz, 1H), 2.12 (ddt, J = 
14.3, 7.9, 6.5 Hz, 1H). 
13C NMR (101 MHz, CDCl3) δ/ppm: 171.62, 169.34, 161.89, 148.13, 145.35, 140.99, 140.62, 135.96, 134.43, 133.87, 133.12, 133.02, 
131.11, 130.98, 130.59, 129.64, 128.70, 125.32, 124.15, 52.85, 50.86, 47.89, 42.95, 39.92, 31.24. 
HRMS (ESI): C26H26N8NaO8S+ calcd: 633.1487, found: 633.1495. 
6.17 Nos-Sc-NP12-TFL2(N3)-OH XZ17 
 
In a 100 mL flask XZ13 (3.9 g, 6.8 mmol, 1.0 eq.) was dissolved in MeCN (40 mL) and a solution of LiOH*H2O (1.4 g, 34.0 mmol, 5.0 
eq.) in H2O (20 mL) was added. The mixture was stirred at RT for 1.5 h after which UPLC-MS analysis showed full conversion. 
Acidifying the mixture to pH 5-6 with concentrated HCl quenched the reaction and the volatiles were removed in vacuo. The residue 
was taken up in EtOAc (100 mL) and H2O (100 mL). The biphasic mixture was acidified to pH 1 with concentrated HCl and the layers 
were separated. The aqueous layer was extracted with EtOAc (2 x 100 mL) and the combined organic layers were washed with half-
saturated brine (2 x 100 mL) and brine (100 mL), dried over MgSO4 and concentrated to yield the desired product as a slightly yellow 
solid (2.8 g, 73%). NMR showed some residual tetramethylurea from the HBTU coupling step. The material was used without further 
purification for the next synthetic step.  
1H NMR (400 MHz, DMSO-d6) δ/ppm: 12.65 (s, 1H), 8.31 (t, J = 5.7 Hz, 1H), 8.21 (t, J = 5.9 Hz, 1H), 8.06 – 8.01 (m, 1H), 8.01 – 7.94 
(m, 2H), 7.91 – 7.83 (m, 2H), 7.37 – 7.28 (m, 2H), 7.27 – 7.17 (m, 2H), 4.23 (ddd, J = 9.7, 8.1, 4.4 Hz, 1H), 3.48 – 3.20 (m, 3H), 
3.18 – 2.98 (m, 4H), 2.95 – 2.83 (m, 1H), 2.76 – 2.62 (m, 1H), 1.86 (dtd, J = 13.9, 7.7, 4.5 Hz, 1H), 1.76 – 1.57 (m, 1H), 0.98 (d, 
J = 6.4 Hz, 3H). 
13C NMR (101 MHz, DMSO) δ/ppm: 175.30, 173.04, 169.30, 147.72, 137.80, 136.86, 134.07, 132.70, 132.67, 129.93, 129.47, 
129.13, 127.32, 125.82, 124.49, 48.94, 47.25, 42.08, 41.26, 36.33, 30.13, 17.83. 
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HRMS (ESI): C23H27N7NaO8S+ calcd: 584.1534, found: 584.1540. 
6.18 Nos-Sc-NP14-TFL2(N3)-OH XZ18 
 
In a 100 mL flask XZ14 (2.6 g, 4.5 mmol, 1.0 eq.) was dissolved in MeCN (25 mL) and a solution of LiOH*H2O (943.0 mg, 22.5 mmol, 
5.0 eq.) in H2O (12.5 mL) was added. The mixture was stirred at RT for 1.5 h after which UPLC-MS analysis showed full conversion 
to the desired product. Acidifying the mixture to pH 5-6 with concentrated HCl quenched the reaction and the volatiles were removed 
in vacuo. The residue was taken up in EtOAc (100 mL) and H2O (100 mL). The biphasic mixture was acidified to pH 1 with 
concentrated HCl and the layers were separated. The aqueous layer was extracted with EtOAc (2 x 100 mL) and the combined 
organic layers were washed with half-saturated brine (2 x 100 mL) and brine (100 mL), dried over MgSO4 and concentrated by rotary 
evaporation to yield the desired product as a yellowish solid (2.5 g, 98%). NMR showed some residual tetramethylurea from the 
HBTU coupling step. The material was used without further purification for the next synthetic step. 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 12.65 (s, 1H), 8.29 (t, J = 5.7 Hz, 1H), 8.19 (t, J = 5.8 Hz, 1H), 8.11 (d, J = 7.9 Hz, 1H), 8.06 – 
8.01 (m, 1H), 8.01 – 7.96 (m, 1H), 7.90 – 7.84 (m, 2H), 7.38 – 7.28 (m, 2H), 7.28 – 7.17 (m, 2H), 4.27 (ddd, J = 9.6, 7.9, 4.6 Hz, 1H), 
3.46 – 3.34 (m, 2H), 3.34 – 3.27 (m, 2H), 3.12 – 3.05 (m, 2H), 2.65 (dd, J = 8.8, 6.7 Hz, 2H), 2.11 (t, J = 7.5 Hz, 2H), 1.98 – 1.88 (m, 
1H), 1.88 – 1.79 (m, 1H), 1.79 – 1.70 (m, 2H). 
13C NMR (101 MHz, DMSO) δ/ppm: 173.21, 172.21, 169.35, 147.70, 139.64, 136.70, 134.05, 132.71, 132.70, 129.72, 129.46, 
129.33, 127.23, 125.59, 124.48, 49.27, 47.57, 42.07, 39.00, 34.89, 32.06, 30.14, 27.12. 
HRMS (ESI): C23H27N7NaO8S+ calcd: 584.1534, found: 584.1546. 
6.19 Nos-Sc-NP01-TFL2(N3)-OH XZ19 
 
In a 100 mL flask XZ15 (3.6 g, 5.7 mmol, 1.0 eq.) was dissolved in MeCN (34 mL) and a solution of LiOH*H2O (1.2 g, 28.5 mmol, 
5.0 eq.) in H2O (17 mL) was added. The mixture was stirred at RT for 1.5 h after which UPLC-MS analysis showed full conversion to 
the desired product. Acidifying the mixture to pH 5-6 with concentrated HCl quenched the reaction and the volatiles were removed in 
vacuo. The residue was taken up in EtOAc (100 mL) and H2O (100 mL). The biphasic mixture was acidified to pH 1 with concentrated 
HCl and the layers were separated. The aqueous layer was extracted with EtOAc (2 x 100 mL) and the combined organic layers were 
washed with half-saturated brine (2 x 100 mL) and brine (100 mL), dried over MgSO4 and concentrated by rotary evaporation to yield 
the desired product as a yellowish solid (2.8 g, 79%). NMR showed some residual tetramethylurea from the HBTU coupling step. The 
material was used without further purification for the next synthetic step. 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 12.81 (s, 1H), 8.46 (d, J = 7.9 Hz, 1H), 8.18 (t, J = 5.8 Hz, 1H), 8.09 (t, J = 6.0 Hz, 1H), 8.02 – 
7.97 (m, 1H), 7.96 – 7.92 (m, 1H), 7.92 – 7.87 (m, 2H), 7.55 – 7.49 (m, 2H), 7.48 – 7.40 (m, 5H), 7.37 – 7.29 (m, 2H), 6.73 (d, J = 
15.8 Hz, 1H), 4.44 (ddd, J = 9.2, 7.9, 4.8 Hz, 1H), 3.51 – 3.38 (m, 2H), 3.14 (dt, J = 7.9, 6.1 Hz, 2H), 2.79 – 2.72 (m, 2H), 2.05 (dtd, J 
= 13.9, 7.4, 4.8 Hz, 1H), 1.95 – 1.85 (m, 1H). 
13C NMR (101 MHz, DMSO) δ/ppm: 173.06, 169.12, 165.00, 147.70, 140.79, 139.12, 138.57, 136.90, 134.63, 134.10, 132.73, 
132.48, 129.72, 129.56, 129.52, 129.39, 128.62, 127.65, 127.60, 127.33, 126.27, 124.54, 121.81, 49.63, 47.53, 41.56, 38.75, 30.40. 
HRMS (ESI): C28H27N7NaO8S+ calcd: 644.1534, found: 644.1537. 
6.20 Nos-Sc-NP07-TFL2(N3)-OH XZ20 
 
In a 50 mL flask XZ16 (367 mg, 601.0 µmol, 1.0 eq.) was dissolved in MeCN (5 mL) and a solution of LiOH*H2O (126 mg, 3.0 mmol, 
5.0 eq.) in H2O (2.5 mL) was added. The mixture was stirred at RT for 1.5 h after which UPLC-MS analysis showed full conversion to 
the desired product. Acidifying the mixture to pH 5-6 with concentrated HCl quenched the reaction and the volatiles were removed in 
vacuo. The residue was taken up in EtOAc (50 mL) and H2O (50 mL). The biphasic mixture was acidified to pH 1 with concentrated 
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HCl and the layers were separated. The aqueous layer was extracted with EtOAc (2 x 50 mL) and the combined organic layers were 
washed with half-saturated brine (2 x 50 mL) and brine (50 mL), dried over MgSO4 and concentrated by rotary evaporation to yield 
the desired product as a thick, waxy oil (400 mg, >100%). NMR showed some residual tetramethylurea from the HBTU coupling step. 
The material was used without further purification for the next synthetic step. 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 12.92 (s, 1H), 8.98 (d, J = 8.3 Hz, 1H), 8.62 (dd, J = 2.2, 0.9 Hz, 1H), 8.47 (t, J = 5.7 Hz, 1H), 
8.15 (t, J = 5.9 Hz, 1H), 8.02 (dd, J = 8.1, 0.8 Hz, 1H), 8.00 – 7.96 (m, 2H), 7.93 (dd, J = 8.1, 2.2 Hz, 1H), 7.91 – 7.81 (m, 2H), 7.65 – 
7.46 (m, 4H), 4.58 (dt, J = 8.2, 6.9 Hz, 1H), 3.48 (dt, J = 12.4, 6.2 Hz, 1H), 3.39 (dt, J = 12.5, 7.2 Hz, 1H), 3.19 (q, J = 6.4 Hz, 2H), 
2.94 (q, J = 6.5 Hz, 2H), 2.15 (q, J = 6.8 Hz, 2H). 
13C NMR (101 MHz, DMSO) δ/ppm: 172.76, 168.56, 163.86, 147.94, 147.66, 147.57, 138.80, 137.16, 136.72, 135.31, 134.10, 
132.71, 132.57, 130.18, 130.01, 129.42, 128.29, 128.10, 124.49, 121.46, 49.77, 47.76, 41.81, 38.98, 30.03. 
HRMS (ESI): C25H24N8NaO8S+ calcd: 619.1330, found: 619.1332. 
6.21 Nos-Sc-NP12-TFL2(N3)-AA070-OMe XZ21 
 
In a 50 mL flask XZ17 (1.3 g, 2.3 mmol, 1.0 eq.) was dissolved in THF (20 mL) and H-Dab(Boc)-OMe hydrochloride (747.0 mg, 2.8 
mmol, 1.2 eq.) was added, followed by DIPEA (1.2 mL, 6.9 mmol, 3.0 eq.) and HATU (1.1 g, 2.8 mmol, 1.2 eq.). The mixture was 
stirred at RT for 1 h after which UPLC-MS analysis showed full conversion to the desired product. The volatiles were removed in 
vacuo and the residue was taken up in EtOAc (100 mL) and half-saturated NH4Cl solution (100 mL). The biphasic mixture was 
separated and the aqueous layer was extracted with EtOAc (2 x 100 mL) and the combined organic layers were washed with 
saturated NH4Cl solution (2 x 100 mL), brine (100 mL), dried over Na2SO4 and concentrated by rotary evaporation. The crude was 
purified by flash column chromatography on the ISOLERA (Silica, 120 g, DCM/MeOH, UV) to yield the desired product as a slightly 
yellow solid (1.8 g, >100%). NMR showed some residual tetramethylurea from the coupling step. The material was used without 
further purification for the next synthetic transformation. 
1H NMR (400 MHz, Acetonitrile-d3) δ/ppm: 8.11 – 8.04 (m, 1H), 7.88 – 7.82 (m, 1H), 7.82 – 7.77 (m, 2H), 7.41 – 7.31 (m, 3H), 7.31 – 
7.20 (m, 2H), 7.06 (d, J = 8.5 Hz, 1H), 6.93 (d, J = 8.1 Hz, 1H), 6.89 – 6.81 (m, 1H), 5.40 (s, 1H), 4.38 (ddd, J = 9.1, 8.0, 4.8 Hz, 1H), 
4.30 (ddd, J = 9.0, 8.0, 4.8 Hz, 1H), 3.64 (s, 3H), 3.63 – 3.51 (m, 1H), 3.42 – 3.34 (m, 1H), 3.33 – 3.12 (m, 3H), 3.11 – 3.02 (m, 2H), 
3.01 – 2.84 (m, 3H), 2.82 – 2.76 (m, 2H), 1.82 (dtd, J = 14.0, 7.6, 4.9 Hz, 1H), 1.70 (ddt, J = 14.7, 9.1, 6.0 Hz, 1H), 1.57 (dddd, J = 
14.4, 9.0, 7.1, 5.6 Hz, 1H), 1.38 (s, 9H), 1.14 (d, J = 6.5 Hz, 3H). 
13C NMR (101 MHz, CD3CN) δ/ppm: 177.24, 173.07, 172.00, 171.26, 156.86, 148.97, 138.68, 137.59, 135.00, 133.97, 133.79, 
131.40, 131.30, 130.70, 128.48, 127.28, 125.84, 80.09, 53.61, 52.89, 51.25, 50.77, 48.16, 44.01, 43.47, 40.60, 37.68, 32.43, 31.66, 
28.60, 18.36. 
HRMS (ESI): C33H45N9NaO11S+ calcd: 798.2851, found: 798.2862. 
6.22 Nos-Sc-NP12-TFL2(N3)-AA118-OMe XZ22 
 
In a 25 mL flask XZ17 (350.0 mg, 623.0 µmol, 1.0 eq.) was dissolved in THF (5 mL) and methyl 3-amino-3-(2-
chlorophenyl)propanoate (160.0 mg, 748.0 µmol, 1.2 eq.) was added, followed by DIPEA (326.0 µL, 1.9 mmol, 3.0 eq.) and HATU 
(284 mg, 746.0 µmol, 1.2 eq.). The mixture was stirred at RT for 1 h after which UPLC-MS analysis showed full conversion to the 
desired product. The volatiles were removed in vacuo and the residue was taken up in EtOAc (50 mL) and H2O (50 mL). The mixture 
was acidified with concentrated HCl to pH 1. The layers were separated and the aqueous phase was extracted with EtOAc (2 x 
50 mL) and the combined organic layers were washed with diluted HCl solution (1%, 2 x 50 mL), brine (50 mL), dried over Na2SO4 
and concentrated by rotary evaporation. The crude was purified by flash column chromatography on the ISOLERA (Silica, 120 g, 
DCM/MeOH, UV) to yield the desired product as a slightly yellow solid (403 mg, 85%). NMR and UPLC-MS analysis showed a 
mixture of four diastereomers in the ratio 7:36:42:15. 
1H NMR (500 MHz, Acetonitrile-d3) δ/ppm: 8.12 – 7.99 (m, 1H), 7.91 – 7.80 (m, 1H), 7.80 – 7.70 (m, 2H), 7.40 – 7.34 (m, 3H), 7.34 – 
7.13 (m, 7H), 6.96 (t, J = 6.0 Hz, 1H), 6.86 (d, J = 8.1 Hz, 1H), 5.58 – 5.44 (m, 1H), 4.42 – 4.14 (m, 1H), 3.59 – 3.55 (m, 3H), 3.49 – 
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3.11 (m, 4H), 3.12 – 3.03 (m, 1H), 2.90 (dddd, J = 14.5, 12.7, 7.3, 5.4 Hz, 1H), 2.83 – 2.73 (m, 3H), 2.72 – 2.56 (m, 2H), 1.83 – 1.67 
(m, 1H), 1.61 – 1.44 (m, 1H), 1.18 (d, J = 6.6 Hz, 3H). 
13C NMR (101 MHz, CD3CN) δ/ppm: 177.21, 171.70, 171.23, 166.26, 149.09, 139.60, 139.45, 138.74, 137.70, 137.56, 134.93, 
132.74, 131.45, 131.24, 131.13, 130.54, 129.82, 128.52, 128.42, 128.31, 127.28, 125.75, 52.29, 51.25, 48.45, 48.08, 43.80, 43.43, 
40.56, 39.37, 37.52, 31.36, 18.33. 
HRMS (ESI): C33H37ClN8NaO9S+ calcd: 779.1985, found: 779.1992. 
6.23 Nos-Sc-NP14-TFL2(N3)-AA020-OMe XZ23 
 
In a 50 mL flask XZ18 (1.3 g, 2.3 mmol, 1.0 eq.) was dissolved in THF (20 mL) and H-Tyr-OMe (542.0 mg, 2.8 mmol, 1.2 eq.) was 
added, followed by DIPEA (1.2 mL, 6.9 mmol, 3.0 eq.) and HATU (1.1 g, 2.8 mmol, 1.2 eq.). The mixture was stirred at RT for 1 h 
after which UPLC-MS analysis showed full conversion to the desired product. The volatiles were removed in vacuo and the residue 
was taken up in EtOAc (100 mL) and H2O (100 mL). The mixture was acidified with concentrated HCl to pH 1. The layers were 
separated and the aqueous phase was extracted with EtOAc (2 x 100 mL) and the combined organic layers were washed with diluted 
HCl solution (1%, 2 x 100 mL), brine (100 mL), dried over Na2SO4 and concentrated by rotary evaporation. The crude was purified by 
flash column chromatography on the ISOLERA (Silica, 120 g, DCM/MeOH, UV) to yield the desired product as a slightly yellow solid 
(1.1 g, 66%). 
1H NMR (400 MHz, Acetonitrile-d3) δ/ppm: 8.11 – 8.02 (m, 1H), 7.88 – 7.81 (m, 1H), 7.81 – 7.73 (m, 2H), 7.39 – 7.31 (m, 2H), 7.28 – 
7.20 (m, 2H), 7.04 (t, J = 6.0 Hz, 1H), 7.00 – 6.89 (m, 3H), 6.76 (d, J = 8.0 Hz, 1H), 6.72 – 6.64 (m, 2H), 6.51 (t, J = 5.8 Hz, 1H), 4.56 
(td, J = 7.7, 5.3 Hz, 1H), 4.36 (td, J = 8.4, 5.5 Hz, 1H), 3.64 (s, 3H), 3.53 – 3.41 (m, 2H), 3.38 – 3.27 (m, 2H), 3.27 – 3.21 (m, 2H), 
3.00 (dd, J = 14.0, 5.3 Hz, 1H), 2.86 (dd, J = 14.0, 7.7 Hz, 1H), 2.78 – 2.65 (m, 2H), 2.17 (dt, J = 7.2, 3.5 Hz, 2H), 2.01 – 1.91 (m, 
1H), 1.86 – 1.69 (m, 3H). 
13C NMR (101 MHz, CD3CN) δ/ppm: 173.98, 172.67, 171.86, 171.76, 156.84, 148.96, 140.91, 137.25, 137.16, 135.04, 133.83, 
131.34, 131.32, 131.11, 130.87, 128.42, 128.08, 126.89, 125.91, 116.07, 54.61, 52.74, 51.42, 48.78, 43.97, 40.36, 37.07, 36.15, 
33.30, 31.38, 28.05. 
HRMS (ESI): C33H38N8NaO10S+ calcd: 761.2324, found: 761.2320. 
6.24 Nos-Sc-NP01-TFL2(N3)-AA001-OMe XZ24 
 
In a 50 mL flask XZ19 (1.1 g, 1.8 mmol, 1.0 eq.) was dissolved in THF (16 mL) and H-Ala-OMe hydrochloride (298.0 mg, 2.1 mmol, 
1.2 eq.) was added, followed by DIPEA (931.0 µL, 5.3 mmol, 3.0 eq.) and HATU (810.0 mg, 2.1 mmol, 1.2 eq.). The mixture was 
stirred at RT for 1 h after which UPLC-MS analysis showed full conversion to the desired product. The volatiles were removed in 
vacuo and the residue was taken up in EtOAc (100 mL) and H2O (100 mL). The mixture was acidified with concentrated HCl to pH 1. 
The layers were separated and the aqueous phase was extracted with EtOAc (2 x 100 mL) and the combined organic layers were 
washed with diluted HCl solution (1%, 2 x 100 mL), brine (100 mL), dried over Na2SO4 and concentrated by rotary evaporation. The 
crude was purified by flash column chromatography on the ISOLERA (Silica, 120 g, DCM/MeOH, UV) to yield the desired product as 
a slightly yellow solid (1.0 g, 81%). 
1H NMR (400 MHz, Acetonitrile-d3) δ/ppm: 8.02 – 7.95 (m, 1H), 7.88 – 7.83 (m, 1H), 7.83 – 7.78 (m, 2H), 7.58 – 7.51 (m, 2H), 7.51 – 
7.45 (m, 3H), 7.44 – 7.38 (m, 2H), 7.37 – 7.33 (m, 2H), 7.19 (d, J = 7.0 Hz, 1H), 7.05 (d, J = 8.0 Hz, 1H), 6.70 – 6.55 (m, 2H), 6.12 (t, 
J = 5.9 Hz, 1H), 4.58 (td, J = 8.2, 5.4 Hz, 1H), 4.42 – 4.32 (m, 1H), 3.66 (s, 3H), 3.42 (ddd, J = 9.9, 5.0, 2.4 Hz, 2H), 3.22 (q, J = 6.2 
Hz, 2H), 2.93 (q, J = 6.1 Hz, 2H), 2.05 (ddd, J = 14.3, 7.1, 5.5 Hz, 1H), 1.92 – 1.83 (m, 1H), 1.32 (d, J = 7.3 Hz, 3H). 
13C NMR (101 MHz, CD3CN) δ/ppm: 173.90, 171.89, 170.91, 166.40, 148.89, 142.01, 140.90, 140.03, 137.31, 135.94, 135.11, 
133.87, 133.65, 131.40, 131.01, 130.93, 130.88, 129.79, 128.81, 128.76, 128.55, 127.87, 126.02, 122.39, 51.64, 49.14, 48.67, 43.67, 
40.08, 38.82, 32.29, 17.53. 
HRMS (ESI): C32H34N8NaO9S+ calcd: 729.2062, found: 729.2060. 
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6.25 Nos-Sc-NP01-TFL2(N3)-AA058-OMe XZ25 
 
In a 50 mL flask XZ19 (1.1 g, 1.8 mmol, 1.0 eq.) was dissolved in THF (16 mL) and H-p-Nitro-D-Phe-OMe hydrochloride (560.0 mg, 
2.2 mmol, 1.2 eq.) was added, followed by DIPEA (936.0 µL, 5.4 mmol, 3.0 eq.) and HATU (815.0 mg, 2.1 mmol, 1.2 eq.). The 
mixture was stirred at RT for 1 h after which UPLC-MS analysis showed full conversion to the desired product. The volatiles were 
removed in vacuo and the residue was taken up in EtOAc (100 mL) and H2O (100 mL). The mixture was acidified with concentrated 
HCl to pH 1. The layers were separated and the aqueous phase was extracted with EtOAc (2 x 100 mL) and the combined organic 
layers were washed with diluted HCl solution (1%, 2 x 100 mL), brine (100 mL), dried over Na2SO4 and concentrated by rotary 
evaporation. The crude was purified by flash column chromatography on the ISOLERA (Silica, 120 g, DCM/MeOH, UV) to yield the 
desired product as a slightly yellow solid (1.3 g, 88%). 
1H NMR (400 MHz, Acetonitrile-d3) δ/ppm: 8.14 – 8.03 (m, 2H), 8.01 – 7.94 (m, 1H), 7.92 – 7.73 (m, 3H), 7.64 – 7.54 (m, 1H), 7.54 – 
7.44 (m, 4H), 7.44 – 7.37 (m, 4H), 7.38 – 7.31 (m, 2H), 7.19 (d, J = 8.2 Hz, 1H), 6.97 (d, J = 7.8 Hz, 1H), 6.63 (t, J = 6.1 Hz, 1H), 6.58 
(d, J = 15.7 Hz, 1H), 6.11 (t, J = 5.8 Hz, 1H), 4.78 – 4.68 (m, 1H), 4.47 (dtd, J = 13.4, 8.3, 5.3 Hz, 1H), 3.66 (s, 3H), 3.38 – 3.18 (m, 
5H), 3.09 (dt, J = 13.9, 8.6 Hz, 1H), 3.01 – 2.88 (m, 2H), 2.03 – 1.85 (m, 1H), 1.85 – 1.68 (m, 1H). 
13C NMR (101 MHz, CD3CN) δ/ppm: 172.12, 171.96, 170.93, 166.48, 147.93, 145.95, 142.00, 141.08, 140.02, 137.29, 135.88, 
135.11, 133.86, 133.65, 131.47, 131.46, 131.40, 131.02, 130.96, 130.94, 129.80, 128.85, 128.78, 128.57, 127.91, 126.02, 124.33, 
122.16, 53.85, 53.02, 51.95, 48.62, 43.70, 40.09, 37.59, 31.78. 
HRMS (ESI): C38H37N9NaO11S+ calcd: 850.2225, found: 850.2225. 
6.26 Nos-Sc-NP07-TFL2(N3)-AA026-OMe XZ26 
 
In a 50 mL flask XZ20 (345.0 mg, 578.0 µmol, 1.0 eq.) was dissolved in THF (5 mL) and H-D-Ser-OMe hydrochloride (108.0 mg, 
694.0 µmol, 1.2 eq.) was added, followed by DIPEA (302.0 µL, 1.7 mmol, 3.0 eq.) and HATU (263.0 mg, 692.0 µmol, 1.2 eq.). The 
mixture was stirred at RT for 1 h after which UPLC-MS analysis showed full conversion to the desired product. The volatiles were 
removed in vacuo and the residue was taken up in EtOAc (50 mL) and H2O (50 mL). The mixture was acidified with concentrated HCl 
to pH 1. The layers were separated and the aqueous phase was extracted with EtOAc (2 x 100 mL) and the combined organic layers 
were washed with diluted HCl solution (1%, 2 x 50 mL), brine (50 mL), dried over Na2SO4 and concentrated by rotary evaporation. 
The crude was purified by flash column chromatography on the ISOLERA (Silica, 120 g, DCM/MeOH, UV) to yield the desired 
product as a waxy solid (403.0 mg, 94%). 
1H NMR (500 MHz, Acetonitrile-d3) δ/ppm: 8.62 (dd, J = 2.3, 0.8 Hz, 1H), 8.57 (d, J = 8.2 Hz, 1H), 8.08 (dd, J = 8.0, 0.8 Hz, 1H), 8.05 
– 8.00 (m, 1H), 7.92 (dd, J = 8.1, 2.2 Hz, 1H), 7.89 – 7.84 (m, 1H), 7.81 (dd, J = 5.9, 3.4 Hz, 2H), 7.61 – 7.55 (m, 2H), 7.53 – 7.49 (m, 
1H), 7.48 (ddd, J = 7.5, 1.4, 0.6 Hz, 1H), 7.25 (d, J = 7.8 Hz, 1H), 6.89 (t, J = 6.0 Hz, 1H), 6.12 (s, 1H), 4.74 (td, J = 8.3, 5.1 Hz, 1H), 
4.48 (dt, J = 8.1, 4.1 Hz, 1H), 3.89 – 3.82 (m, 1H), 3.76 (ddd, J = 11.2, 5.5, 3.8 Hz, 1H), 3.66 (s, 3H), 3.46 (ddd, J = 7.5, 6.2, 3.1 Hz, 
2H), 3.29 (q, J = 6.0 Hz, 2H), 3.22 (t, J = 6.0 Hz, 1H), 3.08 (q, J = 5.7 Hz, 2H), 2.19 (ddd, J = 14.5, 7.3, 2.2 Hz, 1H), 2.05 (ddt, J = 
14.5, 8.4, 6.3 Hz, 1H). 
13C NMR (126 MHz, CD3CN) δ/ppm: 171.88, 171.56, 170.37, 164.98, 148.92, 140.13, 138.27, 137.39, 136.61, 135.13, 133.82, 
133.67, 131.38, 131.35, 131.29, 129.55, 129.52, 128.99, 125.99, 122.42, 62.49, 55.69, 52.79, 51.85, 48.86, 43.76, 40.06, 32.30. 
HRMS (ESI): C29H31N9NaO10S+ calcd: 720.1807, found: 720.1813. 
6.27 NH2-Sc-NP12-TFL2(N3)-AA070-OH XZ27 
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Under an inert (N2) atmosphere XZ21 (1.8 g, 2.3 mmol, 1.0 eq.) was dissolved in MeCN (24 mL) and DIPEA (4.0 mL, 22.8 mmol, 
10.0 eq.) was added, followed by thiophenol (1.2 mL, 11.4 mmol, 5. 0 eq.). The yellow solution was stirred at RT for 2 h after which 
UPLC-MS analysis showed complete Nosyl deprotection. A solution of LiOH*H2O (764.0 mg, 18.2 mmol, 8.0 eq.) in H2O (8 mL) was 
added and the mixture was stirred for 1.5 h after which UPLC-MS analysis showed complete ester deprotection. The volatiles were 
removed by rotary evaporation and the crude was purified by reversed phase flash column chromatography on the ISOLERA (RP-
Silica, 340 g, H2O/MeCN, UV (200/215 nm)). Product-containing fractions were combined and lyophilized to yield the desired product 
as a white solid (999 mg, 76%). NMR and LC-MS analysis showed 19% epimerized product. 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 8.55 (t, J = 5.9 Hz, 1H), 8.25 (d, J = 8.1 Hz, 1H), 7.66 (d, J = 6.9 Hz, 1H), 7.48 – 7.26 (m, 2H), 
7.27 – 7.02 (m, 2H), 6.66 (t, J = 5.7 Hz, 1H), 4.16 (td, J = 8.8, 8.2, 4.2 Hz, 1H), 3.73 (q, J = 6.5 Hz, 1H), 3.50 – 3.34 (m, 1H), 3.37 – 
3.20 (m, 1H), 3.15 – 2.52 (m, 9H), 2.03 – 1.61 (m, 2H), 1.63 – 1.39 (m, 2H), 1.35 (s, 9H), 1.04 (d, J = 6.2 Hz, 3H). 
13C NMR (101 MHz, DMSO) δ/ppm: 175.43, 173.73, 169.99, 169.43, 155.34, 137.73, 137.19, 130.05, 129.03, 127.24, 125.79, 77.34, 
52.51, 50.27, 47.31, 41.60, 39.80, 39.51, 37.31, 36.28, 33.22, 30.68, 28.26, 17.95. 
HRMS (ESI): C26H41N8O7+ calcd: 577.3093, found: 577.3101. 
6.28 NH2-Sc-NP12-TFL2(N3)-AA118-OH XZ28 
 
Under an inert (N2) atmosphere XZ22 (406.0 mg, 536.0 µmol, 1.0 eq.) was dissolved in MeCN (5 mL) and DIPEA (934.0 µL, 5.4 
mmol, 10.0 eq.) was added, followed by thiophenol (273.0 µL, 2.7 mmol, 5. 0 eq.). The yellow solution was stirred at RT for 2 h after 
which UPLC-MS analysis showed complete Nosyl deprotection. A solution of LiOH*H2O (171.0 mg, 4.1 mmol, 8.0 eq.) in H2O 
(1.5 mL) was added and the mixture was stirred for 1.5 h after which UPLC-MS analysis showed complete ester deprotection. The 
mixture was acidified to pH 5-6 by the addition of concentrated HCl. The volatiles were removed by rotary evaporation and the crude 
was purified by reversed phase flash column chromatography on the ISOLERA (RP-Silica, 120 g, H2O/MeCN + 0.1% TFA, UV 
(200/215 nm)). Product-containing fractions were combined and lyophilized to yield the desired product as a white solid (331 mg, 
>100%). Co-elution of unknown sideproducts. NMR and LC-MS analysis showed a diastereomeric ratio of 9:36:43:12. 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 8.56 (d, J = 7.7 Hz, 1H), 8.39 (t, J = 5.4 Hz, 1H), 8.17 – 7.58 (m, 4H), 7.57 – 6.82 (m, 8H), 5.48 
(dd, J = 8.0, 6.3 Hz, 1H), 4.38 – 4.21 (m, 1H), 3.58 – 3.17 (m, 2H), 3.09 – 2.81 (m, 4H), 2.80 – 2.54 (m, 4H), 2.48 – 2.33 (m, 1H), 1.80 
– 1.44 (m, 2H), 0.96 (d, J = 6.3 Hz, 3H). 
13C NMR (101 MHz, DMSO) δ/ppm: 171.41, 171.35, 170.06, 169.71, 139.51, 139.48, 137.97, 136.41, 131.70, 131.50, 130.07, 
129.41, 128.80, 127.47, 127.34, 125.84, 49.78, 47.17, 46.98, 41.23, 39.22, 38.63, 36.91, 36.48, 31.14, 17.76. 
HRMS (ESI): C26H33ClN7O5+ calcd: 558.2226, found: 558.2218. 
6.29 NH2-Sc-NP14-TFL2(N3)-AA020-OH XZ29 
 
Under an inert (N2) atmosphere XZ23 (1.1 g, 1.5 mmol, 1.0 eq.) was dissolved in MeCN (15 mL) and DIPEA (2.6 mL, 14.8 mmol, 
10.0 eq.) was added, followed by thiophenol (757.0 µL, 7.4 mmol, 5. 0 eq.). The yellow solution was stirred at RT for 2 h after which 
UPLC-MS analysis showed complete Nosyl deprotection. A solution of LiOH*H2O (489.0 mg, 11.7 mmol, 8.0 eq.) in H2O (5 mL) was 
added and the mixture was stirred for 1.5 h after which UPLC-MS analysis showed complete ester deprotection. The mixture was 
acidified to pH 5-6 by the addition of concentrated HCl. The volatiles were removed by rotary evaporation and the crude was purified 
by reversed phase flash column chromatography on the ISOLERA (RP-Silica, 340 g, H2O/MeCN + 0.1% TFA, UV (200/215 nm)). 
Product-containing fractions were combined and lyophilized to yield the desired product as white solid (1.0 g, >100%). Co-elution of 
unknown sideproducts. NMR and LC-MS analysis showed 16% epimerized product. 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 8.39 (t, J = 5.6 Hz, 1H), 8.07 (d, J = 7.7 Hz, 1H), 7.99 (d, J = 8.2 Hz, 1H), 7.90 (brs, 3H), 7.43 
(dd, J = 7.9, 1.5 Hz, 1H), 7.37 (td, J = 7.5, 1.5 Hz, 1H), 7.25 (dtd, J = 7.5, 3.8, 1.3 Hz, 2H), 7.05 – 6.93 (m, 2H), 6.69 – 6.57 (m, 2H), 
4.34 (dtd, J = 16.0, 8.4, 5.2 Hz, 2H), 3.46 (q, J = 6.2 Hz, 2H), 3.37 – 3.18 (m, 2H), 2.98 (q, J = 6.0 Hz, 2H), 2.92 (dd, J = 14.0, 5.1 Hz, 
1H), 2.79 (dd, J = 13.9, 8.5 Hz, 1H), 2.68 (t, J = 7.8 Hz, 2H), 2.20 – 2.02 (m, 2H), 1.88 (dtd, J = 13.1, 7.6, 4.7 Hz, 1H), 1.81 – 1.66 (m, 
3H). 
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13C NMR (101 MHz, DMSO) δ/ppm: 172.83, 172.03, 171.09, 169.77, 155.97, 139.86, 136.22, 130.04, 129.87, 129.61, 127.46, 
127.33, 125.62, 114.98, 53.80, 49.79, 47.55, 38.56, 36.94, 35.75, 34.96, 32.20, 31.14, 27.12. 
HRMS (ESI): C26H34N7O6+ calcd: 540.2565, found: 540.2560. 
6.30 NH2-Sc-NP01-TFL2(N3)-AA001-OH XZ30 
 
Under an inert (N2) atmosphere XZ24 (1.0 g, 1.4 mmol, 1.0 eq.) was dissolved in MeCN (12 mL) and DIPEA (2.5 mL, 14.2 mmol, 
10.0 eq.) was added, followed by thiophenol (725.0 µL, 7.1 mmol, 5. 0 eq.). The yellow solution was stirred at RT for 2 h after which 
UPLC-MS analysis showed complete Nosyl deprotection. A solution of LiOH*H2O (468.0 mg, 11.2 mmol, 8.0 eq.) in H2O (4 mL) was 
added and the mixture was stirred for 1.5 h after which UPLC-MS analysis showed complete ester deprotection. The mixture was 
acidified to pH 5-6 by the addition of concentrated HCl. The volatiles were removed by rotary evaporation and the crude was purified 
by reversed phase flash column chromatography on the ISOLERA (RP-Silica, 340 g, H2O/MeCN + 0.1% TFA, UV (254/280 nm)). 
Product-containing fractions were combined and lyophilized to yield the desired product as white solid (810 mg, >100%). Co-elution 
of unknown sideproducts. NMR and LC-MS analysis showed 18% epimerized product. 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 8.44 (d, J = 7.1 Hz, 1H), 8.38 – 8.28 (m, 2H), 7.81 (brs, 3H), 7.59 – 7.51 (m, 4H), 7.49 – 7.41 
(m, 4H), 7.37 (dt, J = 7.6, 1.5 Hz, 1H), 6.81 (d, J = 15.8 Hz, 1H), 4.54 (td, J = 8.2, 5.2 Hz, 1H), 4.27 – 4.16 (m, 1H), 3.40 (tdd, J = 
10.1, 8.8, 5.7 Hz, 2H), 3.28 (q, J = 6.5 Hz, 2H), 2.74 (q, J = 6.3 Hz, 2H), 2.02 – 1.90 (m, 1H), 1.83 (dtd, J = 13.8, 7.9, 6.1 Hz, 1H), 
1.30 (d, J = 7.2 Hz, 3H). 
13C NMR (101 MHz, DMSO) δ/ppm: 173.94, 170.77, 169.58, 164.77, 140.82, 138.69, 136.50, 134.82, 132.39, 129.84, 129.76, 
129.49, 128.77, 127.87, 127.64, 127.36, 126.33, 122.24, 49.97, 47.57, 47.45, 38.11, 36.74, 31.59, 16.89. 
HRMS (ESI): C25H30N7O5+ calcd: 508.2303, found: 508.2297. 
6.31 NH2-Sc-NP01-TFL2(N3)-AA058-OH XZ31 
 
Under an inert (N2) atmosphere XZ25 (1.3 g, 1.6 mmol, 1.0 eq.) was dissolved in MeCN (15 mL) and DIPEA (2.7 mL, 15.5 mmol, 
10.0 eq.) was added, followed by thiophenol (788.0 µL, 7.7 mmol, 5. 0 eq.). The yellow solution was stirred at RT for 2 h after which 
UPLC-MS analysis showed complete Nosyl deprotection. A solution of LiOH*H2O (511.0 mg, 12.2 mmol, 8.0 eq.) in H2O (5 mL) was 
added and the mixture was stirred for 1.5 h after which UPLC-MS analysis showed complete ester deprotection. The mixture was 
acidified to pH 5-6 by the addition of concentrated HCl. The volatiles were removed by rotary evaporation and the crude was purified 
by reversed phase flash column chromatography on the ISOLERA (RP-Silica, 340 g, H2O/MeCN + 0.1% TFA, UV (254/280 nm)). 
Product-containing fractions were combined and lyophilized to yield the desired product as white solid (940 mg, 97%). NMR and LC-
MS analysis showed 25% epimerized product. 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 8.55 (d, J = 8.5 Hz, 1H), 8.33 (t, J = 5.6 Hz, 1H), 8.28 (dd, J = 8.3, 2.9 Hz, 1H), 8.13 (dd, J = 
8.8, 7.1 Hz, 2H), 7.80 (brs, 3H), 7.64 – 7.50 (m, 6H), 7.50 – 7.41 (m, 4H), 7.37 (dt, J = 7.6, 1.5 Hz, 1H), 6.79 (d, J = 15.9 Hz, 1H), 
4.56 (dddd, J = 10.3, 8.0, 6.4, 3.7 Hz, 1H), 4.48 (td, J = 8.7, 5.5 Hz, 1H), 3.37 – 3.10 (m, 4H), 3.10 – 2.99 (m, 2H), 2.80 – 2.62 (m, 
2H), 1.95 – 1.68 (m, 1H), 1.66 – 1.50 (m, 1H). 
13C NMR (101 MHz, DMSO) δ/ppm: 172.29, 170.72, 169.57, 164.70, 146.29, 146.00, 140.82, 138.97, 138.68, 136.49, 134.79, 
130.64, 130.57, 129.83, 129.75, 128.75, 127.86, 127.63, 127.36, 123.18, 123.13, 122.15, 52.65, 50.04, 47.22, 38.10, 36.73, 36.47, 
31.45. 
HRMS (ESI): C31H33N8O7+ calcd: 629.2467, found: 629.2463. 
6.32 NH2-Sc-NP07-TFL2(N3)-AA026-OH XZ32 
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Under an inert (N2) atmosphere XZ26 (374.0 mg, 536.0 µmol, 1.0 eq.) was dissolved in MeCN (5 mL) and DIPEA (934.0 µL, 5.4 
mmol, 10.0 eq.) was added, followed by thiophenol (273.0 µL, 2.7 mmol, 5. 0 eq.). The yellow solution was stirred at RT for 2 h after 
which UPLC-MS analysis showed complete Nosyl deprotection. A solution of LiOH*H2O (170.0 mg, 4.1 mmol, 8.0 eq.) in H2O 
(1.5 mL) was added and the mixture was stirred for 1.5 h after which UPLC-MS analysis showed complete ester deprotection. The 
mixture was acidified to pH 5-6 by the addition of concentrated HCl. The volatiles were removed by rotary evaporation and the crude 
was purified by reversed phase flash column chromatography on the ISOLERA (RP-Silica, 120 g, H2O/MeCN + 0.1% TFA, UV 
(254/280 nm)). Product-containing fractions were combined and lyophilized to yield the desired product as a white solid (292 mg, 
>100%). Co-elution of unknown sideproducts. NMR and LC-MS analysis showed 19% epimerized product. 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 8.85 (d, J = 8.6 Hz, 1H), 8.65 (dd, J = 2.3, 0.9 Hz, 1H), 8.56 (t, J = 5.6 Hz, 1H), 8.47 (d, J = 7.9 
Hz, 1H), 8.08 (dd, J = 8.1, 0.8 Hz, 1H), 7.97 (dd, J = 8.1, 2.2 Hz, 1H), 7.80 (brs, 3H), 7.67 (dd, J = 7.5, 1.5 Hz, 1H), 7.62 (td, J = 7.5, 
1.5 Hz, 1H), 7.60 – 7.49 (m, 2H), 4.77 (td, J = 8.4, 5.1 Hz, 1H), 4.31 (ddd, J = 7.8, 5.3, 4.1 Hz, 1H), 3.72 (dd, J = 10.8, 5.4 Hz, 1H), 
3.66 (dd, J = 10.9, 4.2 Hz, 1H), 3.49 – 3.26 (m, 4H), 2.92 – 2.76 (m, 2H), 2.06 (dddd, J = 19.8, 13.7, 9.2, 5.5 Hz, 2H). 
13C NMR (101 MHz, DMSO) δ/ppm: 171.61, 170.66, 168.93, 163.24, 147.86, 147.68, 138.89, 137.28, 136.28, 135.45, 132.35, 
130.31, 130.26, 128.24, 121.48, 61.17, 54.78, 50.37, 47.60, 38.22, 36.88, 31.99. 
HRMS (ESI): C22H27N8O6+ calcd: 499.2048, found: 499.2041. 
6.33 MC NP12/AA070 XZ33 
 
In a 1L flask XZ27 (955.0 mg, 1.7 mmol, 1.0 eq.) was dissolved in THF (600 mL) and DIPEA (865.0 µL, 5.0 mmol, 3.0 eq.) was added, 
followed by HATU (1.1 g, 3.0 mmol, 1.8 eq.). The mixture was stirred at RT for 2 h after which UPLC-MS analysis showed complete 
conversion to the desired product. The mixture was concentrated by rotary evaporation and purified by reversed phase flash column 
chromatography on the ISOLERA (RP-Silica, 340 g, H2O:MeCN, UV 200/215 nm) to yield the desired product as a white solid 
(370.0 mg, 40%). 89 mg of the product were purified again by preparative RP-HPLC (Method A, no TFA) for final analytics and 
protein binding assays. Mixture of diastereomers with the ratio 10:85:5 (UPLC-MS analysis). 
1H NMR (500 MHz, DMSO-d6) δ/ppm: 8.20 (d, J = 5.4 Hz, 1H), 8.09 (t, J = 5.4 Hz, 1H), 7.74 – 7.68 (m, 1H), 7.66 (d, J = 8.0 Hz, 1H), 
7.36 (td, J = 7.4, 1.6 Hz, 1H), 7.29 (d, J = 7.2 Hz, 1H), 7.27 (dd, J = 7.6, 1.6 Hz, 1H), 7.22 (td, J = 7.4, 1.3 Hz, 1H), 6.76 (t, J = 5.5 Hz, 
1H), 4.05 (ddd, J = 10.2, 7.9, 4.3 Hz, 1H), 3.72 (dt, J = 8.5, 5.8 Hz, 1H), 3.53 – 3.46 (m, 1H), 3.46 – 3.37 (m, 2H), 3.29 – 3.19 (m, 
3H), 3.16 – 3.09 (m, 1H), 2.98 – 2.87 (m, 2H), 2.72 – 2.62 (m, 1H), 2.56 (dd, J = 13.9, 7.1 Hz, 1H), 2.06 – 1.99 (m, 1H), 1.99 – 1.89 
(m, 2H), 1.78 – 1.69 (m, 1H), 1.36 (s, 9H), 1.18 (d, J = 7.0 Hz, 3H). 
13C NMR (101 MHz, DMSO) δ/ppm: 176.63, 171.27, 171.08, 169.56, 155.53, 137.72, 137.34, 129.51, 129.09, 127.47, 125.84, 77.52, 
53.44, 51.25, 47.65, 42.21, 38.84, 38.72, 37.17, 35.67, 30.40, 29.33, 28.27, 17.94. 
HRMS (ESI): C26H38N8NaO6+ calcd: 581.2807, found: 581.2808. 
6.34 MC NP12/AA118 XZ34 
 
In a 500 mL flask XZ28 (298.0 mg, 534 µmol, 1.0 eq.) was dissolved in THF (250 mL) and DIPEA (326.0 µL, 1.9 mmol, 3.5 eq.) was 
added, followed by HATU (406.0 mg, 1.1 mmol, 2.0 eq.). The mixture was stirred at RT for 1.5 h after which UPLC-MS analysis 
showed complete conversion to the desired product. The mixture was concentrated by rotary evaporation and purified by reversed 
phase flash column chromatography on the ISOLERA (RP-Silica, 120 g, H2O:MeCN +0.1% TFA, UV 200/215 nm) to yield the desired 
product as a white solid (148.0 mg, 51%). 32 mg of the product were purified again by preparative RP-HPLC (Method A) for final 
analytics and protein binding assays. Mixture of diastereomers with the ratio 50:38:12 (UPLC-MS analysis). 
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1H NMR (500 MHz, DMSO-d6) δ/ppm: 8.75 (dd, J = 7.0, 3.7 Hz, 1H), 8.39 (d, J = 7.1 Hz, 1H), 8.01 (d, J = 4.7 Hz, 1H), 7.85 (t, J = 5.6 
Hz, 1H), 7.42 – 7.39 (m, 2H), 7.37 – 7.35 (m, 1H), 7.34 – 7.33 (m, 1H), 7.31 – 7.29 (m, 1H), 7.26 (dd, J = 5.3, 2.2 Hz, 2H), 7.21 (td, J 
= 7.4, 1.3 Hz, 1H), 5.35 (ddd, J = 10.2, 7.1, 2.9 Hz, 1H), 3.75 – 3.57 (m, 3H), 3.38 – 3.30 (m, 2H), 3.17 – 3.14 (m, 1H), 3.13 – 3.10 
(m, 2H), 2.90 – 2.80 (m, 1H), 2.63 – 2.58 (m, 1H), 2.49 – 2.46 (m, 1H), 2.37 (dd, J = 15.5, 3.0 Hz, 1H), 1.72 – 1.62 (m, 1H), 1.64 – 
1.53 (m, 1H), 1.13 (d, J = 6.7 Hz, 3H). 
13C NMR (101 MHz, DMSO) δ/ppm: 175.93, 170.03, 169.33, 168.88, 140.21, 137.89, 137.63, 131.18, 129.42, 129.33, 129.16, 
128.66, 127.72, 127.40, 125.93, 125.67, 51.25, 47.22, 40.98, 40.83, 39.17, 39.16, 38.99, 35.51, 29.13, 18.36. 
HRMS (ESI): C26H30ClN7NaO4+ calcd: 562.1940, found: 562.1940. 
6.35 MC NP14/AA020 XZ35 
 
In a 1 L flask XZ29 (967.0 mg, 1.8 mmol, 1.0 eq.) was dissolved in THF (800 mL) and DIPEA (1.1 mL, 6.3 mmol, 3.5 eq.) was added, 
followed by HATU (1.4 g, 3.6 mmol, 2.0 eq.). The mixture was stirred at RT for 1.5 h after which UPLC-MS analysis showed complete 
conversion to the desired product. The mixture was concentrated by rotary evaporation and purified by reversed phase flash column 
chromatography on the ISOLERA (RP-Silica, 340 g, H2O:MeCN +0.1% TFA, UV 200/215 nm) to yield the desired product as a white 
solid (655.0 mg, 70%). 38 mg of the product were purified again by preparative RP-HPLC (Method A) for final analytics and protein 
binding assays. Mixture of diastereomers with the ratio 43:57 (UPLC-MS analysis). 
1H NMR (500 MHz, DMSO-d6) δ/ppm: 8.26 (d, J = 4.4 Hz, 1H), 7.99 (t, J = 5.6 Hz, 1H), 7.49 – 7.43 (m, 2H), 7.34 (td, J = 7.4, 1.7 Hz, 
1H), 7.28 (dd, J = 7.5, 1.6 Hz, 1H), 7.25 (td, J = 7.3, 1.2 Hz, 2H), 6.96 – 6.92 (m, 2H), 6.64 – 6.61 (m, 2H), 4.32 – 4.29 (m, 1H), 3.78 
(ddd, J = 8.1, 6.1, 4.3 Hz, 1H), 3.44 (ddt, J = 13.4, 5.4, 3.3 Hz, 1H), 3.37 – 3.33 (m, 2H), 3.18 – 3.07 (m, 3H), 3.02 – 2.95 (m, 1H), 
2.85 (ddd, J = 13.9, 8.6, 5.5 Hz, 1H), 2.73 (dd, J = 14.4, 10.4 Hz, 1H), 2.64 (dt, J = 13.8, 8.1 Hz, 1H), 2.17 (t, J = 7.0 Hz, 2H), 1.90 – 
1.82 (m, 1H), 1.74 – 1.63 (m, 2H), 1.64 – 1.56 (m, 1H). 
13C NMR (101 MHz, DMSO) δ/ppm: 174.56, 171.21, 171.01, 169.89, 155.79, 138.69, 137.68, 129.75, 129.68, 129.13, 128.19, 
127.27, 125.84, 114.94, 53.93, 53.14, 47.08, 39.24, 38.82, 35.31, 33.29, 31.82, 29.75, 24.78. 
HRMS (ESI): C26H31N7NaO5+ calcd: 544.2279, found: 544.2279. 
6.36 MC NP01/AA001 XZ36 
 
In a 1 L flask XZ30 (764.0 mg, 1.5 mmol, 1.0 eq.) was dissolved in THF (700 mL) and DIPEA (787.0 µL, 4.5 mmol, 3.0 eq.) was 
added, followed by HATU (1.0 g, 2.7 mmol, 1.8 eq.). The mixture was stirred at RT for 2 h after which UPLC-MS analysis showed 
complete conversion to the desired product. The mixture was concentrated by rotary evaporation and purified by reversed phase 
flash column chromatography on the ISOLERA (RP-Silica, 340 g, H2O:MeCN +0.1% TFA, UV 254/280 nm). Further purification was 
necessary due to co-eluted impurities. The impure material was purified by reversed phase preparative HPLC (Method A) followed by 
flash column chromatography on the ISOLERA (Silica, DCM:MeOH, UV). Product-containing fractions were combined and 
concentrated by rotary evaporation. The oily product was dissolved in MeCN/H2O and lyophilized to yield the desired product as a 
white solid (37.0 mg, 5%). Mixture of diastereomers with the ratio 87:13 (UPLC-MS analysis). 
1H NMR (500 MHz, DMSO-d6) δ/ppm: 8.47 (t, J = 5.4 Hz, 1H), 8.37 (d, J = 7.6 Hz, 1H), 7.74 – 7.66 (m, 2H), 7.61 (dt, J = 7.4, 1.7 Hz, 
1H), 7.54 – 7.52 (m, 2H), 7.51 – 7.48 (m, 2H), 7.48 – 7.45 (m, 2H), 7.44 – 7.41 (m, 2H), 6.55 (d, J = 15.8 Hz, 1H), 4.22 (ddd, J = 13.8, 
8.9, 6.7 Hz, 2H), 3.51 – 3.39 (m, 2H), 3.31 – 3.25 (m, 1H), 3.12 – 3.07 (m, 2H), 2.90 – 2.82 (m, 1H), 1.93 – 1.86 (m, 2H), 1.18 (d, J = 
7.0 Hz, 3H). 
13C NMR (101 MHz, DMSO) δ/ppm: 172.30, 170.85, 169.91, 166.04, 140.50, 140.02, 138.27, 137.81, 135.00, 129.49, 129.44, 
129.30, 129.14, 129.05, 127.40, 127.12, 124.49, 123.14, 53.33, 48.61, 47.59, 39.60, 38.62, 29.99, 17.61. 
HRMS (ESI): C25H27N7NaO4+ calcd: 512.2017, found: 512.2011. 
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In a 50 mL flask XZ31 (15.0 mg, 23.9 µmol, 1.0 eq.) was dissolved in DMF (20 mL) and DIPEA (12.5 µL, 71.6 µmol, 3.0 eq.) was 
added, followed by HATU (18.0 mg, 47.7 µmol, 2.0 eq.). The mixture was stirred at RT for 2 h after which UPLC-MS analysis showed 
full conversion of the starting material. The mixture was concentrated by rotary evaporation and purified by preparative reversed 
phase HPLC (Method A). Product-containing fractions were combined and lyophilized to yield the desired product as white solid (13.0 
mg, 89%).  
1H NMR (600 MHz, DMSO-d6) δ/ppm: 8.61 – 8.59 (m, 1H), 8.57 (d, J = 8.5 Hz, 1H), 8.38 (d, J = 9.2 Hz, 1H), 8.13 – 8.12 (m, 2H), 
7.61 – 7.58 (m, 1H), 7.57 – 7.54 (m, 2H), 7.53 – 7.52 (m, 2H), 7.48 – 7.47 (m, 4H), 7.43 – 7.41 (m, 2H), 7.41 – 7.39 (m, 1H), 6.47 (d, 
J = 15.9 Hz, 1H), 4.51 – 4.48 (m, 1H), 4.32 (q, J = 7.6 Hz, 1H), 3.28 – 3.26 (m, 1H), 3.19 – 3.17 (m, 2H), 3.17 – 3.14 (m, 2H), 3.13 – 
3.11 (m, 1H), 2.95 (dd, J = 13.8, 10.2 Hz, 2H), 1.89 – 1.82 (m, 1H), 1.78 – 1.72 (m, 1H). 
13C NMR (600 MHz, 2D NMR, DMSO) δ/ppm: 170.52, 170.49, 169.97, 166.13, 146.76, 146.14, 140.0, 137.92, 137.82, 134.76, 
130.30, 130.28, 129.25, 129.15, 128.90, 128.85, 128.54, 127.19, 126.84, 124.78, 122.89, 122.58, 53.53, 50.33, 47.32, 39.10, 38.11, 
35.58, 28.75  
HRMS (ESI): C31H30N8NaO6+ calcd: 633.2181, found: 633.2176. 
6.38 MC-NP07/AA026 XZ38 
 
In a 500 mL flask XZ32 (261.0 mg, 524.0 µmol, 1.0 eq.) was dissolved in THF (260 mL) and DIPEA (319.2 µL, 1.8 mmol, 3.5 eq.) was 
added, followed by HATU (398 mg, 1.1 mmol, 2.0 eq.). The mixture was stirred at RT for 1.5 h after which UPLC-MS analysis 
showed complete conversion to the desired product. The mixture was concentrated by rotary evaporation and purified by reversed 
phase flash column chromatography on the ISOLERA (RP-Silica, 340 g, H2O:MeCN +0.1% TFA, UV 254/280 nm) to yield the desired 
product as a white solid (79.0 mg, 31%). 18 mg of the product were purified again by preparative RP-HPLC (Method A) for final 
analytics and protein binding assays. Mixture of diastereomers with the ratio 43:57 (UPLC-MS analysis). 
1H NMR (500 MHz, DMSO-d6) δ/ppm: 9.30 (d, J = 9.6 Hz, 1H), 8.56 (d, J = 2.6 Hz, 1H), 8.17 – 8.14 (m, 1H), 8.09 (dd, J = 8.0, 2.2 Hz, 
1H), 7.67 (t, J = 4.9 Hz, 1H), 7.66 – 7.63 (m, 1H), 7.62 – 7.59 (m, 1H), 7.53 – 7.51 (m, 2H), 7.24 (d, J = 8.9 Hz, 1H), 6.92 (t, J = 5.3 
Hz, 1H), 4.62 (td, J = 9.6, 5.1 Hz, 1H), 4.19 – 4.15 (m, 1H), 3.58 – 3.54 (m, 1H), 3.53 – 3.46 (m, 3H), 3.21 – 3.13 (m, 2H), 2.91 – 2.81 
(m, 2H), 2.23 – 2.15 (m, 1H), 2.10 – 2.02 (m, 1H). 
13C NMR (500 MHz, 2D NMR, DMSO) δ/ppm: 170.6, 17.40, 169.24, 165.10, 147.99, 147.43, 137.54, 137.24, 134.38, 134.20, 129.64, 
128.90, 128.30, 127.87, 121.79, 60.80, 54.84, 50.42, 47.73, 40.32, 39.07, 28.51.  
HRMS (ESI): C22H24N8NaO5+ calcd: 503.1762, found: 503.1764. 
6.39 MC NP12/AA070/TA333 XZ39 
 
In a 10 mL flask XZ33 (150.0 mg, 269.0 µmol, 1.0 eq.) and TA333 (66.1 mg, 269.0 µmol, 1.0 eq.) were dissolved in DMSO (2.9 mL) 
and a solution of sodium ascorbate (31.9 mg, 161.0 µmol, 0.6 eq.) in H2O (537 µL) was added. The solution was degassed by 
bubbling N2 through the solution for 1 min. A solution of copper(II) sulfate pentahydrate (20.1 mg, 80.6 µmol, 0.3 eq.) in H2O (403 µL) 
was added and the mixture was degassed again for 1 min. The reaction was stirred at RT for 2 h after which UPLC-MS analysis 
showed full conversion to the desired product. The solution was directly purified by preparative RP-HPLC (Method A, no TFA) and 
the product-containing fractions were lyophilized to yield the desired product as a white solid (142 mg, 66%). Mixture of 
diastereomers in the ratio 87:6:7 (NMR). 
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1H NMR (500 MHz, DMSO-d6) δ/ppm: 8.24 (d, J = 5.3 Hz, 1H), 8.11 (t, J = 5.6 Hz, 1H), 7.91 (s, 1H), 7.72 – 7.67 (m, 2H), 7.65 (d, J = 
8.1 Hz, 2H), 7.55 (dd, J = 7.6, 1.4 Hz, 1H), 7.48 (td, J = 7.5, 1.5 Hz, 1H), 7.41 (d, J = 7.6 Hz, 1H), 7.39 – 7.34 (m, 2H), 7.33 – 7.29 (m, 
2H), 7.28 – 7.25 (m, 2H), 7.22 (td, J = 7.4, 1.2 Hz, 1H), 6.76 (t, J = 5.7 Hz, 1H), 5.33 (s, 2H), 4.36 (t, J = 7.2 Hz, 2H), 4.06 (ddd, J = 
10.5, 8.0, 4.3 Hz, 1H), 3.61 (dt, J = 8.8, 5.8 Hz, 1H), 3.49 – 3.46 (m, 1H), 3.30 – 3.23 (m, 3H), 3.23 – 3.17 (m, 1H), 3.16 – 3.10 (m, 
1H), 2.91 (ddt, J = 20.5, 13.6, 5.9 Hz, 2H), 2.68 – 2.57 (m, 1H), 2.27 – 2.16 (m, 2H), 2.15 (s, 3H), 2.04 – 1.96 (m, 1H), 1.75 – 1.66 (m, 
1H), 1.31 (s, 9H), 1.14 (d, J = 7.0 Hz, 3H). 
13C NMR (101 MHz, DMSO) δ/ppm: 176.72, 171.08, 171.02, 169.54, 155.54, 152.28, 141.80, 140.64, 138.00, 137.69, 137.29, 
134.10, 130.50, 130.22, 129.51, 129.09, 128.77, 128.48, 127.48, 125.86, 125.80, 123.63, 122.90, 122.60, 118.48, 111.47, 77.52, 
53.40, 51.12, 46.60, 42.25, 39.40, 38.78, 38.77, 37.10, 35.68, 30.72, 30.47, 28.24, 19.43, 17.83. 
HRMS (ESI): C43H53N10O6+ calcd: 805.4144, found: 805.4142. 
6.40 MC NP12/AA118/TA622 XZ40 
 
In a 10 mL flask XZ34 (100.0 mg, 185.0 µmol, 1.0 eq.) and TA622 (38.6 mg, 185.0 µmol, 1.0 eq.) were dissolved in DMSO (2 mL) 
and a solution of sodium ascorbate (22.0 mg, 111.0 µmol, 0.6 eq.) in H2O (370 µL) was added. The solution was degassed by 
bubbling N2 through the solution for 1 min. A solution of copper(II) sulfate pentahydrate (13.9 mg, 55.6 µmol, 0.3 eq.) in H2O (278 µL) 
was added and the mixture was degassed again for 1 min. The reaction was stirred at RT for 14 h after which UPLC-MS analysis 
showed full conversion to the desired product. The solution was directly purified by preparative RP-HPLC (Method A) and the 
product-containing fractions were lyophilized to yield the desired product as a white solid (129 mg, 93%). Mixture of diastereomers in 
the ratio 57:31:11 (UPLC). NMR showed the protonated species of the tertiary amine sidechain. 
1H NMR (500 MHz, DMSO-d6) δ/ppm: 9.77 (s, 1H), 9.09 – 9.00 (m, 1H), 8.81 (dd, J = 6.8, 3.8 Hz, 1H), 8.31 (d, J = 7.3 Hz, 1H), 8.14 
(d, J = 5.7 Hz, 1H), 7.93 (t, J = 5.7 Hz, 1H), 7.87 (s, 1H), 7.47 – 7.42 (m, 1H), 7.42 – 7.40 (m, 1H), 7.40 – 7.38 (m, 1H), 7.38 – 7.35 
(m, 1H), 7.32 – 7.23 (m, 4H), 5.40 (ddd, J = 10.3, 7.3, 3.2 Hz, 1H), 4.37 (t, J = 5.7 Hz, 2H), 4.18 (ddd, J = 14.2, 9.0, 5.6 Hz, 1H), 4.10 
(ddd, J = 13.8, 8.9, 6.6 Hz, 1H), 3.87 (s, 2H), 3.80 – 3.78 (m, 1H), 3.69 – 3.65 (m, 1H), 3.52 – 3.43 (m, 1H), 3.34 – 3.30 (m, 2H), 3.29 
– 3.24 (m, 1H), 3.24 – 3.20 (m, 1H), 3.19 – 3.11 (m, 1H), 2.92 – 2.82 (m, 1H), 2.64 (dd, J = 13.6, 6.5 Hz, 1H), 2.59 – 2.53 (m, 2H), 
2.49 – 2.35 (m, 2H), 2.12 – 2.03 (m, Hz, 1H), 2.00 – 1.93 (m, 2H), 1.93 – 1.88 (m, 1H), 1.73 (d, J = 13.0 Hz, 1H), 1.15 (d, J = 6.8 Hz, 
3H), 0.86 (d, J = 6.6 Hz, 6H), 0.76 (q, J = 12.2 Hz, 1H). 
13C NMR (101 MHz, DMSO) δ/ppm: 175.89, 169.77, 169.38, 168.95, 163.93, 143.62, 140.17, 137.85, 136.99, 131.19, 129.44, 
129.40, 129.37, 128.65, 127.92, 127.64, 127.39, 125.80, 122.98, 57.75, 56.79, 51.03, 47.46, 46.23, 40.87, 40.81, 39.39, 39.18, 
38.55, 35.78, 34.23, 30.73, 28.15, 18.26, 17.97. 
HRMS (ESI): C38H51ClN9O5+ calcd: 748.3696, found: 748.3685. 
6.41 MC NP14/AA020/TA607 XZ41 
 
In a 10 mL flask XZ35 (150.0 mg, 288.0 µmol, 1.0 eq.) and TA607 (32.0 mg, 288.0 µmol, 1.0 eq.) were dissolved in DMSO (3 mL) 
and a solution of sodium ascorbate (34.2 mg, 173.0 µmol, 0.6 eq.) in H2O (575 µL) was added. The solution was degassed by 
bubbling N2 through the solution for 1 min. A solution of copper(II) sulfate pentahydrate (21.5 mg, 86.3 µmol, 0.3 eq.) in H2O (431 µL) 
was added and the mixture was degassed again for 1 min. The reaction was stirred at RT for 2 h after which UPLC-MS analysis 
showed full conversion to the desired product. The solution was directly purified by preparative RP-HPLC (Method A) and the 
product-containing fractions were lyophilized to yield the desired product as a white solid (90 mg, 50%). Mixture of diastereomers in 
the ratio 27:23:50 (UPLC).  
1H NMR (500 MHz, DMSO-d6) δ/ppm: 8.37 (d, J = 4.6 Hz, 1H), 8.00 (t, J = 5.6 Hz, 1H), 7.93 (t, J = 5.7 Hz, 1H), 7.74 (s, 1H), 7.54 (d, 
J = 8.4 Hz, 1H), 7.47 (t, J = 5.6 Hz, 1H), 7.34 (td, J = 7.4, 1.8 Hz, 1H), 7.26 (dtd, J = 18.1, 7.5, 1.5 Hz, 3H), 6.97 – 6.92 (m, 2H), 6.64 
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– 6.60 (m, 2H), 4.30 (ddd, J = 10.2, 8.4, 4.5 Hz, 1H), 4.25 – 4.19 (m, 1H), 4.15 – 4.11 (m, 1H), 3.67 (ddd, J = 8.2, 6.2, 4.5 Hz, 1H), 
3.44 (dtd, J = 13.5, 5.6, 5.2, 2.7 Hz, 1H), 3.38 – 3.33 (m, 2H), 3.30 – 3.25 (m, 2H), 3.11 (dd, J = 14.4, 4.4 Hz, 1H), 3.04 – 2.96 (m, 
1H), 2.84 (ddd, J = 14.1, 8.7, 5.5 Hz, 1H), 2.78 – 2.72 (m, 3H), 2.65 (dt, J = 13.8, 7.8 Hz, 1H), 2.19 (t, J = 6.9 Hz, 2H), 2.04 – 1.94 (m, 
2H), 1.86 (ddd, J = 13.7, 8.5, 7.1 Hz, 1H), 1.79 (s, 3H), 1.74 – 1.65 (m, 1H). 
13C NMR (101 MHz, DMSO) δ/ppm: 174.60, 171.15, 170.99, 169.88, 169.25, 155.73, 144.34, 138.71, 137.67, 129.72, 129.46, 
129.14, 128.22, 127.26, 125.83, 122.43, 115.01, 54.07, 52.98, 45.97, 39.06, 38.78, 38.42, 35.26, 33.35, 31.83, 31.08, 25.58, 24.90, 
22.64. 
HRMS (ESI): C32H40N8NaO6+ calcd: 655.2963, found: 655.2964. 
6.42 MC-NP01/AA058/TA229 XZ42 
 
In a 1.5 mL Eppendorf tube XZ37 (10.0 mg, 16.4 µmol, 1.0 eq.) and TA229 (4.2 mg, 16.4 µmol, 1.0 eq.) were dissolved in DMSO 
(200 µL) and a solution of sodium ascorbate (2.0 mg, 9.8 µmol, 0.6 eq.) in H2O (32.8 µL) was added. The solution was degassed by 
bubbling N2 through the solution for 1 min. A solution of copper(II) sulfate pentahydrate (1.2 mg, 4.9 µmol, 0.3 eq.) in H2O (24.6 µL) 
was added and the mixture was degassed again for 1 min. The reaction was agitated at RT for 12 h after which UPLC-MS analysis 
showed full conversion to the desired product. The solution was directly purified by preparative RP-HPLC (Method A) and the 
product-containing fractions were lyophilized to yield the desired product as a white solid (5 mg, 35%). Mixture of diastereomers in 
the ratio 61:39 (UPLC)/47:42:6:5 (NMR).  
1H NMR (500 MHz, DMSO-d6) δ 9.24 – 9.19 (m, 1H), 8.89 (d, J = 3.3 Hz, 1H), 8.64 (d, J = 8.4 Hz, 1H), 8.61 – 8.55 (m, 1H), 8.34 (dt, 
J = 7.0, 4.3 Hz, 1H), 8.27 (d, J = 9.2 Hz, 1H), 8.11 (t, J = 8.3 Hz, 2H), 8.00 (s, 1H), 7.91 – 7.89 (m, 1H), 7.65 (t, J = 5.6 Hz, 1H), 7.63 
– 7.59 (m, 1H), 7.55 – 7.54 (m, 1H), 7.53 – 7.50 (m, 2H), 7.49 – 7.47 (m, 2H), 7.47 – 7.45 (m, 2H), 7.43 – 7.41 (m, 2H), 7.41 – 7.37 
(m, 2H), 6.55 (d, J = 15.8 Hz, 1H), 6.16 (s, 1H), 4.56 – 4.53 (m, 2H), 4.52 – 4.47 (m, 1H), 4.28 – 4.23 (m, 1H), 4.23 – 4.18 (m, 2H), 
3.20 – 3.17 (m, 2H), 3.13 – 3.08 (m, 2H), 2.96 – 2.87 (m, 2H), 2.61 (s, 3H), 2.21 (s, 3H), 2.10 – 2.02 (m, 1H), 2.00 – 1.92 (m, 1H). 
13C NMR (500 MHz, 2D NMR, DMSO) δ/ppm: 175.58, 169.91, 165.81, 165.69, 163.64, 154.18, 149.45, 146.76, 146.08, 145.84, 
145.80, 144.42, 141.08, 139.93, 137.76, 137.62, 134.50, 130.17, 130.14, 129.53, 128.95, 128.47, 127.13, 126.85, 126.16, 124.76, 
123.84, 122.84, 122.74, 122.59, 122.45, 113.83, 109.57, 53.29, 50.13, 45.89, 39.11, 36.52, 35.71, 34.54, 30.68, 14.30, 13.06.  
HRMS (ESI): C45H44N12NaO7+ calcd: 887.3348, found: 887.3346. 
6.43 MC-NP07/AA026/TA256 XZ43 
 
In a 2.0 mL Eppendorf tube XZ38 (45.0 mg, 93.7 µmol, 1.0 eq.) and TA256 (28.1 mg, 93.7 µmol, 1.0 eq.) were dissolved in DMSO 
(990 µL) and a solution of sodium ascorbate (11.1 mg, 56.2 µmol, 0.6 eq.) in H2O (187 µL) was added. The solution was degassed by 
bubbling N2 through the solution for 1 min. A solution of copper(II) sulfate pentahydrate (7.0 mg, 28.1 µmol, 0.3 eq.) in H2O (140 µL) 
was added and the mixture was degassed again for 1 min. The reaction was agitated at RT for 2 h after which UPLC-MS analysis 
showed full conversion to the desired product. The solution was directly purified by preparative RP-HPLC (Method A) and the 
product-containing fractions were lyophilized to yield the desired product as a white solid (60 mg, 82%). 
1H NMR (500 MHz, DMSO-d6) δ 9.40 (d, J = 9.5 Hz, 1H), 8.73 (s, 1H), 8.57 (d, J = 8.5 Hz, 1H), 8.47 (t, J = 5.5 Hz, 1H), 8.17 (d, J = 
8.0 Hz, 1H), 8.09 (dd, J = 8.0, 2.2 Hz, 1H), 7.94 – 7.88 (m, 1H), 7.70 – 7.65 (m, 1H), 7.64 (s, 1H), 7.63 – 7.54 (m, 1H), 7.53 (d, J = 
4.2 Hz, 1H), 7.51 – 7.45 (m, 1H), 7.39 – 7.31 (m, 2H), 7.31 – 7.28 (m, 1H), 7.28 – 7.21 (m, 1H), 6.92 (t, J = 5.4 Hz, 1H), 6.13 (t, J = 
6.0 Hz, 1H), 4.58 – 4.48 (m, 2H), 4.21 – 4.10 (m, 1H), 3.59 – 3.53 (m, 2H), 3.46 (dd, J = 10.8, 4.9 Hz, 1H), 3.42 – 3.29 (m, 2H), 3.28 
– 3.05 (m, 4H), 2.91 – 2.81 (m, 1H), 2.81 – 7.23 (m, 1H), 2.66 – 2.54 (m, 1H), 2.49 – 2.37 (m, 1H), 2.34 – 2.15 (m, 1H), 2.01 (dt, J = 
12.6, 4.2 Hz, 1H), 1.73 – 1.67 (m, 1H), 1.67 – 1.61 (m, 1H), 1.58 – 1.49 (m, 1H), 1.40 – 1.29 (m, 1H), 1.24 – 1.11 (m, 2H), 1.11 – 1.02 
(m, 1H), 0.96 (d, J = 6.5 Hz, 3H). 
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13C NMR (500 MHz, 2D NMR, DMSO) δ/ppm: 172.64, 170.34, 169.19, 165.29, 154.92, 150.59, 148.03, 147.49, 146.19, 140.86, 
137.55, 137.27, 136.26, 134.28, 131.03, 129.65, 129.03, 128.91, 128.32, 121.82, 121.43, 117.91, 116.83, 113.99, 82.89, 67.07, 
60.77, 54.87, 50.39, 46.56, 40.37, 39.40, 39.09, 37.57, 33.05, 30.66, 29.84, 24.86, 24.22, 18.49. 
HRMS (ESI): C40H48N10NaO7+ calcd: 803.3600, found: 803.3585. 
7. Macrocycle Binding Evaluation 
7.1 Differential Scanning Fluorimetry (DSF) 
Stock solutions: 
MC NP12/AA118 XZ34 500 µM (PBS buffer) 
MC NP14/AA020 XZ35 500 µM (PBS buffer) 
MC NP07/AA026 XZ38 500 µM (PBS buffer) 
MC NP12/AA118/TA622 XZ40 500 µM (PBS buffer) 
MC NP14/AA020/TA607 XZ41 500 µM (PBS buffer) 
AGP 10 mg/ml (PBS buffer) 
MC NP12/AA070 XZ33 500 µM (5% DMSO/PBS buffer) 
MC NP01/AA001 XZ36 250 µM (25% DMSO/PBS buffer) 
MC NP07/AA026/TA256 XZ43 500 µM (25% DMSO/PBS buffer) 
MC NP01/AA058 XZ37 250 µM (25% DMSO/PBS buffer) 
MC NP01/AA058/TA229 XZ42 250 µM (25% DMSO/PBS buffer) 
HSA 10 mg/ml (PBS buffer) 
 
Sample preparation:  
The MC stock solution (97.5 µL) was mixed with the protein solution (2.5 µL), giving a final protein concentration of 0.25 mg/ml and 
487.5 µM MC concentration in the according buffer. For every buffer system, a reference sample (buffer + protein) was prepared. All 
MCs were tested against HSA and AGP (XZ37 and XZ42 were not completely soluble). The measurements were performed in 
triplicates on a Prometheus NT.48 with a rate of 1.5°C per minute in a temperature range from 20°C - 95°C.  
Remark: XZ39 could not be tested due to high fluorescence activity of the compound. AGP (10 mg/ml, 1 mL) was dialyzed against 
PBS (3 x 1000 mL, 4°C, 3 x 18 h) prior to the binding assay.  
 
Figure 24. Normalized first derivatives of the DSF measurements. a) Measurements of AGP with MC ligands in PBS buffer. b) Measurement of AGP with MC 
ligand XZ33 in 5% DMSO in PBS. c) Measurements of AGP with MC ligands in 25% DMSO in PBS. d) Measurements of HSA with MC ligands in PBS buffer. e) 
Measurement of HSA with MC ligand XZ33 in 5% DMSO in PBS. f) Measurements of AGP with MC ligands in 25% DMSO in PBS. 
Table 8. Found ΔTm shifts during macrocycle-protein binding events. Positive ΔTm values imply stabilization of the protein structure, negative ΔTm values imply a 
destabilization of the protein structure. Macrocycles XZ37 and XZ42 are not shown in this analysis due to their poor solubility, which resulted in 0°C shift of the 
protein melting temperature. 
Compound ΔTm for AGP [°C] ΔTm for HSA [°C] % DMSO Comments 
XZ33 1.16 -0.44 5  
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XZ34 5.94 N/A[a] 0 AGP Binder 
XZ40 4.32 0.67 0 AGP Binder 
XZ35 0.49 0.83 0  
XZ35[b] 0.37 - 5  
XZ41 -1.21 1.27 0  
XZ41[b] -0.78	 - 5  
XZ36 0.32 9.47[c] 25 Bad peak shape 
XZ38 1.37 -0.07 0  
XZ38[b] 1.38	 - 5  
XZ43 0.32 8.65[c] 25 Bad peak shape 
[a] Peak is too broad to determine a ΔTm value. [b] Due to a broadened peak shape of pure AGP in PBS the assay was repeated in 5% DMSO in PBS which 
showed a sharper melting peak. [c] Unreliable data. Curve shape is too unsteady for accurate meting temperature shift measurements. 
From the found temperature shifts we chose XZ34, XZ39 (no DSF measurements possible), XZ40 and XZ41 for ITC measurements 
with AGP and XZ36, XZ40 and XZ41 for ITC measurements with HSA. 
7.2 Isothermal Calorimetry (ITC) 
General: 
For ITC measurements the protein solution (50 µM in PBS, approx. 300 µL) was placed in the sample cell and the ligand 
(macrocycle) solution (500 µM in PBS, approx. 40 µL) was placed in the syringe. The titrations were performed at 25°C or 10°C with 
a stirring rate of 750 rpm. Reference power was set to 6 µcal/s. In total 17 injections were performed with an initial delay of 300 s. 
The added volume per injection was 2.3 µL over a duration of 4.6 s (first injection 0.5 µL in 1.0 s) with a spacing of 150 s between the 
additions and a filter time of 2 s. The data was analyzed by NitPick and Sedphat for fitting and KD determinations.  
XZ34 versus AGP: 
 
Figure 25. The three ITC titrations of XZ34 versus AGP. All graphs were analyzed and integrated using NITPIC. For the physicochemical calculations all three 
measurements were fitted and processed using SEDPHAT. 
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For optimal binding constant analysis ligand XZ34 was used as a 260 µM solution in PBS buffer with 50 µM AGP in PBS buffer at 
25°C. Triplicate measurements were conducted as well as the reference titration (XZ34 into PBS buffer). After subtraction of the 
reference titration from the binding measurements, the data was globally fitted to give the following calculated values: 
KD = 4.1 µM with a confidence interval (95%) from 2.9 - 6.1 µM. 
ΔH = -4.78 kcal/mol = -20.01 kJ/mol with a confidence interval (95%) from -5.51 - -4.28 kcal/mol. 
ΔG = -30.75 kJ/mol from 𝛥𝐺 = 𝑅𝑇𝑙𝑛 𝐾! =  𝛥𝐻 − 𝑇𝛥𝑆 with R = 8.314472 J mol-1 K-1 and T = 298.15 K. 
ΔS = 36.01 J mol-1 K-1 
XZ39 and XZ41 versus AGP:  
 
Figure 26. a) ITC titration of XZ39 versus AGP with the reference titration XZ39 vs PBS buffer. The data was not analyzed and integrated. b) ITC titration of XZ41 
versus AGP. The data was not analyzed and integrated. 
The titrations were performed at 50 µM AGP and 260 µM macrocycle ligand (5% DMSO in PBS for XZ39, pure PBS for XZ41) in 
single measurements at 25°C. A reference titration of XZ39 was conducted to evaluate the solvation enthalpy. The measurements 
were not further improved nor the data analyzed due to the very weak binding. We assumed no binding for XZ41 due to the very 
weak differential power (DP) changes, that probably uniquely arose from the solvation enthalpy 
XZ40 versus AGP:  
 
Figure 27. The three ITC titrations of XZ40 versus AGP. All graphs were analyzed and integrated using NITPIC. For the physicochemical calculations all three 
measurements were fitted and processed using SEDPHAT. 
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The optimal conditions were found to be 100 µM AGP and 520 µM XZ40 in PBS buffer. Triplicate measurements were performed with 
a reference titration. Due to the small binding enthalpies the temperature of the assay was lowered to 10°C. After subtraction of the 
reference titration from the binding measurements, the data was globally fitted to give the following calculated values: 
KD = 7.0 µM with a confidence interval (95%) from 4.7 - 10.7 µM. 
ΔH = 2.72 kcal/mol = 11.39 kJ/mol with a confidence interval (95%) from 2.43 - 3.14 kcal/mol. 
ΔG = -29.96 kJ/mol from 𝛥𝐺 = 𝑅𝑇𝑙𝑛 𝐾! =  𝛥𝐻 − 𝑇𝛥𝑆 with R = 8.314472 J mol-1 K-1 and T = 283.15 K. 
ΔS = 138.97 J mol-1 K-1 
XZ36, XZ40 and XZ41 versus HSA:  
 
Figure 28. ITC titrations of XZ36, XZ40 and XZ41 versus HSA. The data was not analyzed and integrated. Reference titrations not shown. 
The XZ36 versus HSA assay was performed at 25 µM HSA in 25% DMSO/PBS and 250 µM macrocycle ligand in 25% DMSO/PBS at 
25°C. Care was taken to exactly match the DMSO/PBS ratios in all samples and buffers.  
XZ40 and XZ41 versus HSA measurements were performed at 50µM/500µM in PBS buffer at 25°C. 
In all three assays no strong binding events were observed. Therefore, no further measurement optimizations and analyses were 
conducted. 
8. Quantitative PCR (qPCR) of Chemical Reactions on DNA 
General Procedure 
DNA damage evaluations were made with representative DNA strands, based on the same structure as the coding DNA strands of 
the DEML. For the evaluation of chemical modifications on a single-stranded DNA we used DNA with the sequence 5'-
GGAGCTTGTGAATTCTGGATGGGACGTGTGTGAATTGTCTTTTGTGTGCGGATCCAAGTTCGGTGAATGGATTTTTTACTACGGA
TGGATACTCT-3' (DNA1).  
Chemical modifications on a double stranded system were evaluated on a DNA pair consisting of DNA1 annealed to its reverse 
complementary strand with the sequence 5'-AGAGTATCCATCCGTAGTAAAAAATCCATTCACCGAACTTGGATCCGCA 
CACAAAAGACAATTCACACACGTCCCATCCAGAATTCACAAGCTCC-3' (DNA2).  
The annealing of DNA1 and DNA2 was performed with the following gradient: 95°C(1 min)-70°C(2 min)-45°C(2 min) to yield the 
double-stranded DNA3. DNA1 and DNA3 were diluted with H2O to a final concentration of 0.45 ng/µL. Primer1 had the following 
sequence: 5'-AGAGTATCCATCCGTAGT-3' and Primer2: 5'-GGAGCTTGTGAATTCTGG-3'.  
For the qPCR assay the following solutions were mixed in a 96-well plate: DNA1 or DNA3 (3 µL, 0.45 ng/µL in H2O), Primer1 (0.5 µL, 
2.5 µM in H2O), Primer2 (0.5 µL, 2.5 µM in H2O), H2O (3.5 µL) and SYBR Green Master Mix (5 µL). After mixing and centrifugation of 
the plate, the PCR was run according to the following program: 95°C(2 min)-40 x (95°C(15 s)-60°C(1 min)). The progress of the DNA 
amplification was observed by fluorescence emission of the DNA-SYBR complex formed during the PCR. All assays were performed 
with three or more valid replicates that were further processed. Standard curves with unmodified DNA1 or DNA3 at four 
concentrations (1x, 10x, 100x, 1000x dilutions) were generated as well as dummy samples (no primers and primer only). 
The quantity of remaining intact DNA could be calculated by the number of PCR cycles necessary for complete consumption of the 
primers of each assay relative to the generated standard curves. For this purpose the standard curves were fitted with logarithmic 
trendlines in Excel. For single stranded assays we calculated the following trendline: 𝑦 = −4.384𝑙𝑛(𝑥) + 7.4961,𝑅! = 0.99126, with y= 
the number of PCR cycles and x= the remaining intact DNA quantity. For double-stranded DNA we calculated the trendline: 𝑦 = −3.421𝑙𝑛(𝑥) + 11.458,𝑅! = 0.98647. 
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Ester Deprotection Conditions 
In a PCR tube DNA1 (3.0 µL, 110 µM in H2O, 1.0 eq.) was mixed with H2O (2 µL), MeCN (3.5 µL) and a solution of LiOH hydrate 
(1.65 µL, 100 mM in H2O, 500 eq.). The mixture was left standing at RT for 16 h, followed by EtOH purification. The washed DNA 
pellet was dissolved in H2O (30 µL) and further diluted to the desired concentration for qPCR. 
Click Reaction Conditions 
In a PCR tube DNA1 (3.0 µL, 110 µM in H2O, 1.0 eq.) was mixed with TEAA (1 M, pH 7.2, 3 µL), DMSO (7 µL), a solution of TA662 
(3.3 µL, 10 mM in DMSO, 100 eq.) and a solution of sodium ascorbate (3.3 µL, 20 mM in H2O, 200 eq.). The mixture was degassed 
for 30 s by bubbling a stream of N2 gas through the solution. Cu(II)-TBTA complex solution (6.6 µL, 10 mM in 55% DMSO, 200 eq.) 
was added and the mixture was degassed again for 30 s. The mixture was left standing at RT for 16 h, followed by EtOH purification. 
The washed DNA pellet was dissolved in H2O (30 µL) and further diluted to the desired concentration for qPCR. For the double-
stranded assay DNA1 was replaced by DNA3 (6.0 µL, 50 µM, 1.0 eq.) 
DMTMM Coupling with Excess Amine Conditions 
In a PCR tube DNA1 (3.0 µL, 110 µM in H2O, 1.0 eq.) was mixed with MOPS buffer (300 mM, pH 8.2, 0.5 µL), NMM (2.2 µL, 300 mM 
in DMSO, 2000 eq.), AA001 (3.3 µL, 100 mM in DMSO, 1000 eq.) and DMTMM-BF4 (1.7 µL, 200 mM in DMSO, 1000 eq.). The 
mixture was left standing at RT for 16 h, followed by EtOH purification. The washed DNA pellet was dissolved in H2O (30 µL) and 
further diluted to the desired concentration for qPCR. For the double-stranded assay DNA1 was replaced by DNA3 (6.0 µL, 50 µM, 
1.0 eq.) 
DMTMM Coupling with Excess Acid Conditions 
In a PCR tube DNA1 (3.0 µL, 110 µM in H2O, 1.0 eq.) was mixed with MOPS buffer (300 mM, pH 8.2, 0.5 µL), NMM (2.2 µL, 300 mM 
in DMSO, 2000 eq.), 1-H-indazole-3-carboxylic acid (3.3 µL, 100 mM in DMSO, 1000 eq.) and DMTMM-BF4 (1.7 µL, 200 mM in 
DMSO, 1000 eq.). The mixture was left standing at RT for 16 h, followed by EtOH purification. The washed DNA pellet was dissolved 
in H2O (30 µL) and further diluted to the desired concentration for qPCR. For the double-stranded assay DNA1 was replaced by 
DNA3 (6.0 µL, 50 µM, 1.0 eq.) 
EDC/HOAt Coupling with Excess Amine Conditions 
In a PCR tube DNA1 (3.0 µL, 110 µM in H2O, 1.0 eq.) was mixed with MOPS buffer (300 mM, pH 8.2, 0.5 µL), DIPEA (3.7 µL, 180 
mM in DMSO, 2000 eq.), AA001 (3.3 µL, 100 mM in DMSO, 1000 eq.), EDC hydrochloride (1.7 µL, 200 mM in DMSO, 1000 eq.) and 
HOAt (1.7 µL, 200 mM in DMSO, 1000 eq.). The mixture was left standing at RT for 16 h, followed by EtOH purification. The washed 
DNA pellet was dissolved in H2O (30 µL) and further diluted to the desired concentration for qPCR. For the double-stranded assay 
DNA1 was replaced by DNA3 (6.0 µL, 50 µM, 1.0 eq.) 
EDC/HOAt Coupling with Excess Acid Conditions 
In a PCR tube DNA1 (3.0 µL, 110 µM in H2O, 1.0 eq.) was mixed with MOPS buffer (300 mM, pH 8.2, 0.5 µL), DIPEA (3.7 µL, 
180 mM in DMSO, 2000 eq.), 1-H-indazole-3-carboxylic acid (3.3 µL, 100 mM in DMSO, 1000 eq.), EDC hydrochloride (1.7 µL, 
200 mM in DMSO, 1000 eq.) and HOAt (1.7 µL, 200 mM in DMSO, 1000 eq.). The mixture was left standing at RT for 16 h, followed 
by EtOH purification. The washed DNA pellet was dissolved in H2O (30 µL) and further diluted to the desired concentration for qPCR. 
For the double-stranded assay DNA1 was replaced by DNA3 (6.0 µL, 50 µM, 1.0 eq.) 
NOSYL Deprotection Conditions 
In a PCR tube DNA1 (3.0 µL, 110 µM in H2O, 1.0 eq.) was mixed with MOPS buffer (600 mM, pH 8.2, 3.0 µL), DBU (6.0 µL, 300 mM 
in DMSO, 5455 eq.) and BME (6.0 µL, 300 mM in DMSO, 5455 eq.). The mixture was degassed by bubbling N2 through the solution 
for 30 s and then left standing at RT for 16 h, followed by EtOH purification. The washed DNA pellet was dissolved in H2O (30 µL) 
and further diluted to the desired concentration for qPCR.  
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Figure 29. qPCR results from all tested reaction conditions with single- or double-stranded DNA. Not all of these conditions were applied during DEML assembly, 
but some are routinely used in DECL synthesis (e.g. EDC acid coupling). 
9. Synthesis and Codon Sequences of the Building Blocks 
9.1 Synthesis of 3-azidopropan-1-amine XZ44 
 
3-Bromopropan-1-amine hydrobromide (5.0 g, 22.8 mmol, 1.0 eq.) and sodium azide (4.5 g, 68.5 mmol, 3.0 eq.) were dissolved in 
H2O (20 mL) and heated to 80°C for 22 h. After cooling a solution of KOH (6 g, 106.9 mmol, 4.7 eq.) in H2O (10 mL) was added while 
cooling in an ice bath. The solution was extracted with DCM (4 x 50 mL) and the combined organic layers were washed with brine (50 
mL) and dried over Na2SO4. The solvent was removed in vacuo (40°C, 250 mbar) to yield the desired product as slightly yellow liquid 
(2.0 g, 87.4%). Analytical data was in agreement with reported data.[13] 
1H NMR (400 MHz, Chloroform-d) δ/ppm: 3.42 (t, J = 6.6 Hz, 2H), 2.89 (t, J = 6.8 Hz, 2H), 2.79 (s, 2H), 1.81 (p, J = 6.8 Hz, 2H). 
9.2 Synthesis of methyl 4-((3-azidopropyl)carbamoyl)-2-iodobenzoate XZ45 
 
3-Iodo-4-methoxycarbonylbenzoic acid (1.0 g, 3.3 mmol, 1.0 eq.), XZ44 (491.0 mg, 4.9 mmol, 1.5 eq.), HATU (1.9 g, 4.9 mmol, 
1.5 eq.) and DIPEA (1.7 mL, 9.8 mmol, 3.0 eq.) were dissolved in THF (30 mL) and DMF (7 mL). The mixture was stirred at RT for 
2 h after which UPLC-MS analysis showed complete conversion to the desired product. The volatiles were removed by rotary 
evaporation and the residue was dissolved in EtOAc (100 mL) and washed with half-saturated NH4Cl solution (3 x 80 mL) and H2O 
(80 mL). The combined aqueous layers were extracted with EtOAc (100 mL). The combined organic layers were washed with brine 
(50 mL), dried over Na2SO4 and concentrated in vacuo. The crude product was purified by flash column chromatography (Silica, 150 
g, cyclohexane:EtOAc 2:1, Rf= 0.28, UV). Product-containing fractions were combined and concentrated in vacuo to yield the desired 
product as a yellowish oil (1.2 g, 95%).  
1H NMR (400 MHz, Chloroform-d) δ/ppm: 8.34 (d, J = 1.7 Hz, 1H), 7.84 (d, J = 8.0 Hz, 1H), 7.77 (dd, J = 8.1, 1.7 Hz, 1H), 6.41 (s, 
1H), 3.95 (s, 3H), 3.56 (td, J = 6.6, 5.8 Hz, 2H), 3.47 (t, J = 6.4 Hz, 2H), 1.92 (p, J = 6.6 Hz, 2H). 
13C NMR (101 MHz, CDCl3) δ/ppm: 166.51, 165.27, 139.77, 138.11, 137.85, 131.11, 126.49, 94.24, 52.91, 49.78, 38.31, 28.77. 
HRMS (ESI): C12H14IN4O3+ calcd: 389.0105, found: 389.0109. 
9.3 Synthesis of 4-((3-azidopropyl)carbamoyl)-2-iodobenzoic acid XZ46 
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XZ45 (1.2 g, 3.1 mmol, 1.0 eq.) was dissolved in MeCN (10 mL) and a solution of LiOH hydrate (646.0 mg, 15.4 mmol, 5.0 eq.) in 
H2O (10 mL) was added. The solution was stirred at RT for 4 h after which UPLC-MS analysis showed complete conversion to the 
desired product. The reaction mixture was acidified with TFA to pH 2-3 and directly purified by reversed phase flash column 
chromatography on the ISOLERA (Rp-Silica, 100 g, H2O/MeCN + 0.1% TFA, UV, 2 runs). Product-containing fractions were 
combined and lyophilized to yield the desired product as a white solid (1.1 g, 98%).  
1H NMR (400 MHz, DMSO-d6) δ/ppm: 13.54 (s, 1H), 8.72 (t, J = 5.6 Hz, 1H), 8.38 (d, J = 1.6 Hz, 1H), 7.90 (dd, J = 8.0, 1.6 Hz, 1H), 
7.76 (d, J = 8.0 Hz, 1H), 3.41 (t, J = 6.7 Hz, 2H), 3.32 (q, J = 6.5 Hz, 2H), 1.78 (p, J = 6.8 Hz, 2H). 
13C NMR (101 MHz, DMSO) δ/ppm: 168.02, 164.17, 138.70, 137.16, 129.56, 126.94, 93.82, 48.50, 36.80, 28.22. 
HRMS (ESI): C11H11IN4NaO3+ calcd: 396.9768, found: 396.9769. 
9.4 Synthesis of (NOSYL)ethyl-4-((3-azidopropyl)carbamoyl)-2-iodobenzoic amide XZ47 
 
XZ46 (1.1 g, 3.0 mmol, 1.0 eq.), XZ1 (1.1 g, 4.5 mmol, 1.5 eq.), HATU (1.4 g, 3.6 mmol, 1.2 eq.) and DIPEA (1.6 mL, 9.0 mmol, 
3.0 eq.) were dissolved in DMF (12 mL) and stirred at RT for 3 h after which UPLC-MS analysis showed complete conversion of the 
starting material. The volatiles were removed in vacuo and the residue was dissolved in EtOAc (90 mL). The organic layer was 
washed with saturated NH4Cl (3 x 80 mL) and H2O (80 mL) and the combined aqueous layers were extracted with EtOAc (100 mL). 
The combined organic layers were washed with brine (50 mL), dried over Na2SO4 and concentrated by rotary evaporation. The crude 
was purified by flash column chromatography (Silica, 180 g, 1:4 cyclohexane:EtOAc, Rf = 0.2, UV) to yield the desired product as a 
yellow solid (1.6 g, 92%).  
1H NMR (400 MHz, Acetonitrile-d3) δ/ppm: 8.25 (d, J = 1.6 Hz, 1H), 8.08 (dd, J = 5.9, 3.4 Hz, 1H), 7.89 – 7.85 (m, 1H), 7.84 – 7.76 
(m, 3H), 7.37 (d, J = 7.9 Hz, 1H), 7.16 (s, 1H), 6.95 (s, 1H), 6.19 (s, 1H), 3.49 – 3.43 (m, 2H), 3.43 – 3.36 (m, 4H), 3.27 (t, J = 6.0 Hz, 
2H), 1.83 (t, J = 6.7 Hz, 2H). 
13C NMR (101 MHz, CDCl3) δ/ppm: 169.91, 166.24, 148.14, 144.06, 138.37, 136.61, 133.90, 133.63, 133.06, 131.15, 127.77, 126.70, 
92.40, 49.58, 43.39, 40.13, 39.11, 28.75. 
HRMS (ESI): C19H20IN7NaO6S+ calcd: 624.0133, found: 624.0144. 
9.5 Synthesis of NP01 
 
XZ47 (43.0 mg, 71.5 µmol, 1.0 eq.), 3-(2-carboxyvinyl)phenylboronic acid (27.5 mg, 143.0 µmol, 2.0 eq.), Pd (π-cinnamyl) chloride 
dimer (7.4 mg, 14.3 µmol, 20 mol%) and K3PO4 (45.5 mg, 215.0 µmol, 3.0 eq.) were suspended in EtOH (800 µL) and H2O (400 µL). 
The mixture was stirred at 50°C for 1 h after which UPLC-MS analysis showed complete conversion to the desired product. The black 
mixture was filtered and purified by reversed-phase preparative HPLC (Method A). Product-containing fractions were combined and 
lyophilized to yield the desired product as white solid (28 mg, 63%).  
1H NMR (500 MHz, DMSO-d6) δ/ppm: 12.43 (s, 1H), 8.65 (t, J = 5.7 Hz, 1H), 8.33 (t, J = 5.9 Hz, 1H), 8.14 (t, J = 6.0 Hz, 1H), 8.00 
(dd, J = 5.8, 3.3 Hz, 1H), 7.96 – 7.92 (m, 1H), 7.92 – 7.85 (m, 4H), 7.69 – 7.66 (m, 1H), 7.64 – 7.55 (m, 2H), 7.53 (d, J = 8.4 Hz, 1H), 
7.42 – 7.33 (m, 2H), 6.52 (d, J = 16.0 Hz, 1H), 3.41 (t, J = 6.7 Hz, 2H), 3.37 – 3.34 (m, 2H), 3.15 (dt, J = 7.9, 6.1 Hz, 2H), 2.77 (dt, J = 
8.2, 6.1 Hz, 2H), 1.79 (p, J = 6.8 Hz, 2H). 
13C NMR (500 MHz, HMBC/HMQC, DMSO-d6) δ/ppm: 166.97, 168.24, 165.11, 147.52, 143.29, 139.92, 139.83, 139.56, 138.75, 
138.04, 134.89, 133.88, 132.47, 129.89, 129.09, 128.43, 128.17, 127.70, 127.49, 127.04, 126.05, 124.31, 119.37, 48.22, 41.17, 
38.46, 36.42, 28.00. 
HRMS (ESI): C28H27N7NaO8S+ calcd: 644.1534, found: 644.1534. 
9.6 Synthesis of NP02 
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XZ47 (20.0 mg, 33.3 µmol, 1.0 eq.), 4-(2-carboxyvinyl)phenylboronic acid (12.8 mg, 66.5 µmol, 2.0 eq.), Pd (π-cinnamyl) chloride 
dimer (3.5 mg, 6.7 µmol, 20 mol%) and K3PO4 (21.2 mg, 99.8 µmol, 3.0 eq.) were suspended in EtOH (400 µL) and H2O (200 µL). 
The mixture was stirred at 50°C for 2 h after which UPLC-MS analysis showed complete conversion to the desired product. The black 
mixture was filtered and purified by reversed-phase preparative HPLC (Method A). Product-containing fractions were combined and 
lyophilized to yield the desired product as white solid (16 mg, 77%).  
1H NMR (400 MHz, Acetone-d6) δ/ppm: 8.13 – 8.08 (m, 1H), 8.05 (t, J = 5.7 Hz, 1H), 7.99 – 7.94 (m, 1H), 7.93 – 7.86 (m, 4H), 7.71 – 
7.64 (m, 3H), 7.59 (d, J = 8.5 Hz, 1H), 7.55 – 7.45 (m, 3H), 6.75 (t, J = 6.0 Hz, 1H), 6.54 (d, J = 16.1 Hz, 1H), 3.54 – 3.44 (m, 4H), 
3.39 (q, J = 6.3 Hz, 2H), 3.13 (q, J = 6.1 Hz, 2H), 1.90 (p, J = 6.7 Hz, 2H). 
13C NMR (500 MHz, HMBC/HMQC, Acetone-d6) δ/ppm: 169.71, 167.35, 166.37, 148.91, 144.75, 142.56, 142.47, 139.76, 136.73, 
134.80, 134.53, 133.85, 133.43, 131.21, 129.91, 129.19, 128.89, 128.79, 127.04, 125.66, 119.28, 49.60, 43.32, 39.89, 37.60, 29.35. 
HRMS (ESI): C28H27N7NaO8S+ calcd: 644.1534, found: 644.1534. 
9.7 Synthesis of NP03 
 
XZ47 (20.0 mg, 33.3 µmol, 1.0 eq.), 3-(2-carboxyethyl)phenylboronic acid (12.9 mg, 66.5 µmol, 2.0 eq.), Pd (π-cinnamyl) chloride 
dimer (3.5 mg, 6.7 µmol, 20 mol%) and K3PO4 (21.2 mg, 99.8 µmol, 3.0 eq.) were suspended in EtOH (400 µL) and H2O (200 µL). 
The mixture was stirred at 50°C for 2 h after which UPLC-MS analysis showed complete conversion to the desired product. The black 
mixture was filtered and purified by reversed-phase preparative HPLC (Method A). Product-containing fractions were combined and 
lyophilized to yield the desired product as white solid (15 mg, 72%).  
1H NMR (500 MHz, Acetone-d6) δ/ppm: 8.13 – 8.07 (m, 1H), 7.99 – 7.94 (m, 1H), 7.95 – 7.90 (m, 2H), 7.88 (dd, J = 7.9, 1.8 Hz, 1H), 
7.86 (dd, J = 1.8, 0.6 Hz, 1H), 7.56 (dd, J = 7.8, 0.5 Hz, 1H), 7.32 – 7.29 (m, 1H), 7.28 (dd, J = 7.1, 0.7 Hz, 1H), 7.26 – 7.21 (m, 2H), 
3.48 (dt, J = 15.6, 6.8 Hz, 4H), 3.33 (t, J = 6.5 Hz, 2H), 3.05 (t, J = 6.5 Hz, 2H), 2.91 (t, J = 7.7 Hz, 2H), 2.61 (t, J = 7.7 Hz, 2H), 1.90 
(p, J = 6.7 Hz, 2H). 
13C NMR (500 MHz, HMBC/HMQC, Acetone-d6) δ/ppm: 173.62, 169.79, 166.57, 148.92, 141.85, 141.25, 140.59, 140.40, 139.74, 
136.55, 134.74, 133.42, 131.20, 129.31, 129.23, 129.02, 128.74, 128.29, 127.09, 126.57, 125.64, 49.57, 43.17, 39.78, 37.53, 35.51, 
31.16, 29.32. 
HRMS (ESI): C28H29N7NaO8S+ calcd: 646.1691, found: 646.1695. 
9.8 Synthesis of NP04 
 
XZ47 (20.0 mg, 33.3 µmol, 1.0 eq.), 4-(2-carboxyethyl)phenylboronic acid (12.9 mg, 66.5 µmol, 2.0 eq.), Pd (π-cinnamyl) chloride 
dimer (3.5 mg, 6.7 µmol, 20 mol%) and K3PO4 (21.2 mg, 99.8 µmol, 3.0 eq.) were suspended in EtOH (400 µL) and H2O (200 µL). 
The mixture was stirred at 50°C for 2 h after which UPLC-MS analysis showed complete conversion to the desired product. The black 
mixture was filtered and purified by reversed-phase preparative HPLC (Method A). Product-containing fractions were combined and 
lyophilized to yield the desired product as white solid (14 mg, 68%).  
1H NMR (500 MHz, Acetone-d6) δ/ppm: 8.14 – 8.09 (m, 1H), 8.00 – 7.95 (m, 1H), 7.96 – 7.90 (m, 2H), 7.87 (dd, J = 7.9, 1.8 Hz, 1H), 
7.84 (d, J = 1.6 Hz, 1H), 7.55 (d, J = 7.9 Hz, 1H), 7.37 – 7.30 (m, 2H), 7.29 – 7.23 (m, 2H), 3.48 (dt, J = 15.9, 6.8 Hz, 4H), 3.34 (t, J = 
6.3 Hz, 2H), 3.09 (t, J = 6.3 Hz, 2H), 2.91 (t, J = 7.7 Hz, 2H), 2.62 (t, J = 7.7 Hz, 2H), 1.90 (p, J = 6.7 Hz, 2H). 
13C NMR (500 MHz, HMBC/HMQC, Acetone-d6) δ/ppm: 173.60, 169.93, 166.46, 148.91, 141.23, 140.33, 140.22, 139.62, 138.36, 
136.49, 134.78, 133.43, 131.22, 129.31, 129.19, 128.97, 128.81, 126.56, 125.66, 49.58, 43.30, 39.84, 37.56, 35.45, 30.89, 29.33. 
HRMS (ESI): C28H29N7NaO8S+ calcd: 646.1691, found: 646.1692. 
9.9 Synthesis of NP05 
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XZ47 (20.0 mg, 33.3 µmol, 1.0 eq.), 3-carboxyphenylboronic acid (12.9 mg, 77.8 µmol, 2.3 eq.), Pd (π-cinnamyl) chloride dimer (3.5 
mg, 6.7 µmol, 20 mol%) and K3PO4 (21.2 mg, 99.8 µmol, 3.0 eq.) were suspended in EtOH (400 µL) and H2O (200 µL). The mixture 
was stirred at 50°C for 2 h after which UPLC-MS analysis showed complete conversion to the desired product. The black mixture was 
filtered and purified by reversed-phase preparative HPLC (Method A). Product-containing fractions were combined and lyophilized to 
yield the desired product as white solid (16 mg, 81%).  
1H NMR (500 MHz, DMSO-d6) δ 8.70 (t, J = 5.7 Hz, 1H), 8.39 (t, J = 5.8 Hz, 1H), 8.13 (t, J = 6.0 Hz, 1H), 8.02 – 7.97 (m, 2H), 7.97 – 
7.93 (m, 1H), 7.92 – 7.85 (m, 5H), 7.61 (ddd, J = 7.6, 1.9, 1.2 Hz, 1H), 7.54 (d, J = 7.8 Hz, 1H), 7.46 (t, J = 7.7 Hz, 1H), 3.41 (t, J = 
6.7 Hz, 2H), 3.34 (td, J = 6.8, 5.5 Hz, 2H), 3.14 (dt, J = 7.9, 6.0 Hz, 2H), 2.82 (dt, J = 8.3, 6.1 Hz, 2H), 1.79 (p, J = 6.8 Hz, 2H). 
13C NMR (500 MHz, HMBC/HMQC, DMSO-d6) δ/ppm: 168.29, 166.84, 165.12, 147.44, 139.64, 139.44, 138.90, 137.93, 135.09, 
133.92, 132.57, 132.52, 130.52, 129.16, 129.04, 128.25, 128.14, 128.11, 127.69, 126.23, 124.35, 48.28, 41.25, 38.56, 36.48, 28.05. 
HRMS (ESI): C26H25N7NaO8S+ calcd: 618.1378, found: 618.1381. 
9.10 Synthesis of NP06 
 
XZ47 (20.0 mg, 33.3 µmol, 1.0 eq.), 5-carboxythiophene-2-boronic acid pinacol ester (16.9 mg, 66.5 µmol, 2.0 eq.), Pd (π-cinnamyl) 
chloride dimer (3.5 mg, 6.7 µmol, 20 mol%) and K3PO4 (21.2 mg, 99.8 µmol, 3.0 eq.) were suspended in EtOH (400 µL) and H2O 
(200 µL). The mixture was stirred at 50°C for 2 h after which UPLC-MS analysis showed complete conversion to the desired product. 
The black mixture was filtered and purified by reversed-phase preparative HPLC (Method A). Product-containing fractions were 
combined and lyophilized to yield the desired product as white solid (2 mg, 10%).  
1H NMR (500 MHz, DMSO-d6) δ/ppm: 8.72 (t, J = 5.6 Hz, 1H), 8.59 (t, J = 5.8 Hz, 1H), 8.18 (t, J = 6.0 Hz, 1H), 8.03 – 7.94 (m, 3H), 
7.92 – 7.85 (m, 3H), 7.64 (d, J = 3.9 Hz, 1H), 7.52 (d, J = 7.9 Hz, 1H), 7.26 (d, J = 3.9 Hz, 1H), 3.44 – 3.40 (m, 2H), 3.37 – 3.32 (m, 
2H), 3.24 (dt, J = 7.4, 6.1 Hz, 2H), 2.98 (dt, J = 7.8, 6.1 Hz, 2H), 1.80 (p, J = 6.8 Hz, 2H). 
13C NMR (500 MHz, HMBC/HMQC, DMSO-d6) δ/ppm: 168.00, 164.76, 162.44, 147.44, 146.74, 138.67, 135.06, 134.38, 134.00, 
133.23, 132.61, 132.20, 130.16, 129.27, 128.09, 127.96, 127.55, 127.15, 124.38, 48.33, 41.45, 38.75, 36.56, 28.06. 
HRMS (ESI): C24H22N7O8S2- calcd: 600.0977, found: 600.0985. 
9.11 Synthesis of NP07 
 
XZ47 (20.0 mg, 33.3 µmol, 1.0 eq.), 2-methoxycarbonylpyridine-5-boronic acid (16.9 mg, 93.4 µmol, 2.8 eq.), Pd (π-cinnamyl) 
chloride dimer (3.5 mg, 6.7 µmol, 20 mol%) and K3PO4 (21.2 mg, 99.8 µmol, 3.0 eq.) were suspended in EtOH (400 µL) and H2O 
(200 µL). The mixture was stirred at 50°C for 2 h after which UPLC-MS analysis showed complete conversion to the desired product. 
The black mixture was filtered and purified by reversed-phase preparative HPLC (Method A). Product-containing fractions were 
combined and lyophilized to yield the impure methyl ester of the product as beige solid (7.0 mg, 35%). The material was dissolved in 
MeCN (0.5 mL) and a solution of LiOH monohydrate (4.8 mg, 115.0 µmol, 10.0 eq.) in H2O (382 µL) was added. The solution was 
stirred at RT for 2 h after which UPLC-MS analysis showed full conversion to the desired product. The reaction mixture was purified 
by reversed-phase preparative HPLC (Method A). Product-containing fractions were combined and lyophilized to yield the desired 
product as white solid (6.0 mg, 88%). 
1H NMR (500 MHz, DMSO-d6) δ/ppm: 8.75 – 8.66 (m, 2H), 8.57 (t, J = 5.8 Hz, 1H), 8.18 (t, J = 6.0 Hz, 1H), 8.06 (dd, J = 8.0, 0.8 Hz, 
1H), 8.02 – 7.92 (m, 5H), 7.91 – 7.84 (m, 2H), 7.64 (d, J = 7.9 Hz, 1H), 3.42 (t, J = 6.8 Hz, 2H), 3.35 (td, J = 6.8, 5.5 Hz, 2H), 3.19 (q, 
J = 6.4 Hz, 2H), 2.92 (dt, J = 7.5, 6.1 Hz, 2H), 1.80 (p, J = 6.8 Hz, 2H). 
13C NMR (500 MHz, HMBC/HMQC, DMSO-d6) δ/ppm: 167.81, 165.73, 165.03, 148.41, 147.44, 146.84, 138.34, 138.27, 136.70, 
135.24, 134.97, 133.92, 132.56, 132.30, 129.23, 128.58, 128.06, 127.04, 124.32, 123.98, 48.26, ,41.43, 38.76, 36.50, 28.03. 
HRMS (ESI): C25H23N8O8S- calcd: 595.1365, found: 595.1371. 
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9.12 Synthesis of NP08 
 
XZ47 (20.0 mg, 33.3 µmol, 1.0 eq.), 3-methoxycarbonyl-5-trifluoromethylphenylboronic acid pinacol ester (22.0 mg, 66.5 µmol, 
2.0 eq.), Pd (π-cinnamyl) chloride dimer (3.5 mg, 6.7 µmol, 20 mol%) and K3PO4 (21.2 mg, 99.8 µmol, 3.0 eq.) were suspended in 
EtOH (400 µL) and H2O (200 µL). The mixture was stirred at 50°C for 1 h after which UPLC-MS analysis showed complete 
conversion to the desired product. The black mixture was filtered and purified by reversed-phase preparative HPLC (Method A). 
Product-containing fractions were combined and lyophilized to yield the impure methyl ester of the product (12.0 mg, 53%). The 
material was dissolved in MeCN (0.5 mL) and a solution of LiOH monohydrate (7.4 mg, 177.0 µmol, 10.0 eq.) in H2O (590 µL) was 
added. The solution was stirred at RT for 2 h after which UPLC-MS analysis showed full conversion to the desired product. The 
reaction mixture was purified by reversed-phase preparative HPLC (Method A). Product-containing fractions were combined and 
lyophilized to yield the desired product as white solid (8.0 mg, 68%). 
1H NMR (500 MHz, DMSO-d6) δ/ppm: 13.62 (s, 1H), 8.72 (t, J = 5.7 Hz, 1H), 8.51 (t, J = 5.9 Hz, 1H), 8.24 – 8.20 (m, 1H), 8.17 (t, J = 
6.0 Hz, 1H), 8.14 – 8.10 (m, 1H), 8.00 – 7.96 (m, 1H), 7.96 – 7.90 (m, 4H), 7.90 – 7.84 (m, 2H), 7.60 (d, J = 7.9 Hz, 1H), 3.42 (t, J = 
6.7 Hz, 2H), 3.35 (td, J = 6.9, 5.6 Hz, 2H), 3.14 (dt, J = 8.0, 6.1 Hz, 2H), 2.81 (dt, J = 8.4, 6.0 Hz, 2H), 1.80 (p, J = 6.8 Hz, 2H). 
13C NMR (500 MHz, HMBC/HMQC, DMSO-d6) δ/ppm: 167.87, 165.38, 164.91, 147.22, 140.92, 138.64, 136.23, 135.33, 133.85, 
132.77, 132.44, 129.00, 128.97, 128.47, 128.05, 127.79, 126.97, 124.30, 124.27, 122.17, 120.00, 48.23, 41.00, 38.61, 36.44, 28.02. 
HRMS (ESI): C27H24F3N7NaO8S+ calcd: 686.1251, found: 686.1262. 
9.13 Synthesis of NP09 
 
XZ47 (20.0 mg, 33.3 µmol, 1.0 eq.), 3-carboxy-4-fluorophenylboronic acid (12.2 mg, 66.5 µmol, 2.0 eq.), Pd (π-cinnamyl) chloride 
dimer (3.5 mg, 6.7 µmol, 20 mol%) and K3PO4 (21.2 mg, 99.8 µmol, 3.0 eq.) were suspended in EtOH (400 µL) and H2O (200 µL). 
The mixture was stirred at 50°C for 1 h after which UPLC-MS analysis showed complete conversion to the desired product. The black 
mixture was filtered and purified by reversed-phase preparative HPLC (Method A). Product-containing fractions were combined and 
lyophilized to yield the desired product as brownish solid (18.0 mg, 88%).  
1H NMR (500 MHz, DMSO-d6) δ/ppm: 13.32 (s, 1H), 8.70 (t, J = 5.6 Hz, 1H), 8.44 (t, J = 5.8 Hz, 1H), 8.15 (t, J = 6.0 Hz, 1H), 8.01 – 
7.95 (m, 2H), 7.92 – 7.83 (m, 5H), 7.61 (ddd, J = 8.5, 4.5, 2.5 Hz, 1H), 7.54 (d, J = 7.9 Hz, 1H), 7.30 (dd, J = 10.7, 8.5 Hz, 1H), 3.41 
(t, J = 6.7 Hz, 2H), 3.34 (q, J = 6.6 Hz, 2H), 3.16 (dt, J = 7.5, 6.0 Hz, 2H), 2.88 (dt, J = 8.1, 6.1 Hz, 2H), 1.79 (p, J = 6.8 Hz, 2H). 
13C NMR (126 MHz, DMSO) δ/ppm: 168.44, 165.38, 164.84, 159.62, 147.66, 138.93, 137.17, 135.84, 135.41, 134.50, 134.11, 
132.73, 132.60, 131.72, 129.37, 128.33, 127.94, 126.50, 124.54, 119.07, 116.94, 116.76, 48.54, 41.61, 38.89, 36.75, 28.34. 
HRMS (ESI): C26H24FN7NaO8S+ calcd: 636.1283, found: 636.1291. 
9.14 Synthesis of Ethyl 2-bromoethoxyacetate XZ48 
 
Under an inert atmosphere 2-bromoethanol (709.0 µL, 10.0 mmol, 1.0 eq.) was dissolved in DCM (17 mL) and cooled in an ice bath. 
Rh2(OAc)4 (44.2 mg, 100 µmol, 1.0 mol%) was added and the mixture was stirred for 5 min. The ice bath was removed and a solution 
of ethyl 2-diazoacetate (1.2 mL, 9.6 mmol, 0.96 eq.) in DCM (8 mL) was added dropwise while gas evolution occurred. The green 
mixture was stirred at RT for 2 h. The mixture was filtered over Celite and concentrated in vacuo. The crude product was purified by 
bulb-to-bulb distillation (80°C, 3.6 x 10-1 mbar) to yield the desired product as a colorless liquid (1.3 g, 61%). Analytical data was in 
agreement with reported data.[14] 
1H NMR (400 MHz, Chloroform-d) δ/ppm: 4.23 (q, J = 7.2 Hz, 2H), 4.15 (s, 2H), 3.89 (t, J = 6.2 Hz, 2H), 3.51 (t, J = 6.2 Hz, 2H), 1.29 
(t, J = 7.1 Hz, 3H). 
9.15 Synthesis of 3-Ethyloxycarbonylmethoxyethoxyphenylboronic acid pinacol ester XZ49 
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Under an inert atmosphere 3-hydroxyphenylboronic acid pinacol ester (47.0 mg, 214.0 µmol, 1.0 eq.), XZ48 (54.1 mg, 256.0 µmol, 
1.2 eq.) and potassium carbonate (88.5 mg, 641.0 µmol, 3.0 eq.) were mixed in MeCN (1 mL). The suspension was stirred at 65°C 
for 39 h after which UPLC-MS analysis showed 78% conversion to the desired product. Potassium carbonate (29.5 mg, 213.4 µmol, 
1.0 eq.) and XZ48 (10.8 mg, 51.2 µmol, 0.2 eq.) were added and the mixture was continued stirring at 65°C for another 24 h. UPLC-
MS analysis showed >95% conversion to the desired product. The solvent was removed by rotary evaporation and the residue was 
taken up in DCM (5 mL) and H2O (5 mL). The organic layer was separated and the aqueous layer was extracted with DCM (2 x 
5 mL). The combined organic layers were washed with brine (10 mL), dried over Na2SO4 and concentrated in vacuo. The residue 
was purified by flash column chromatography (Silica, 9 g, 10:1→5:1 cyclohexane: EtOAc, Rf= 0.29, KMnO4) to yield the desired 
product as acolourless oil (53 mg, 71%).  
1H NMR (400 MHz, Chloroform-d) δ/ppm: 7.40 (dt, J = 7.2, 1.0 Hz, 1H), 7.33 (dd, J = 2.8, 0.9 Hz, 1H), 7.28 (dd, J = 8.3, 7.3 Hz, 1H), 
7.03 (ddd, J = 8.2, 2.8, 1.1 Hz, 1H), 4.24 – 4.18 (m, 6H), 3.97 – 3.91 (m, 2H), 1.34 (s, 12H), 1.28 (t, J = 7.1 Hz, 3H). 
13C NMR (101 MHz, CDCl3) δ/ppm: 170.57, 158.18, 129.11, 127.62, 119.72, 118.53, 83.98, 70.27, 69.09, 67.66, 61.04, 25.01, 14.35. 
HRMS (ESI): C18H27BNaO6+ calcd: 373.1793, found: 373.1793. 
9.16 Synthesis of NP10 
 
XZ47 (20.0 mg, 33.3 µmol, 1.0 eq.), XZ49 (23.3 mg, 66.5 µmol, 2.0 eq.), Pd (π-cinnamyl) chloride dimer (3.5 mg, 6.7 µmol, 20 mol%) 
and K3PO4 (21.2 mg, 99.8 µmol, 3.0 eq.) were suspended in EtOH (400 µL) and H2O (200 µL). The mixture was stirred at 50°C for 
1 h after which UPLC-MS analysis showed complete conversion to the desired product. The black mixture was filtered and purified by 
reversed-phase preparative HPLC (Method A). Product-containing fractions were combined and lyophilized to yield the product as an 
ester/acid mixture (12.0 mg, 52%). The material was dissolved in MeCN (0.5 mL) and a solution of LiOH monohydrate (7.2 mg, 177.0 
µmol, 10.0 eq.) in H2O (573 µL) was added. The solution was stirred at RT for 2 h after which UPLC-MS analysis showed full 
conversion to the desired product. The reaction mixture was purified by reversed-phase preparative HPLC (Method A). Product-
containing fractions were combined and lyophilized to yield the desired product as white solid (8.0 mg, 70%). 
1H NMR (500 MHz, DMSO-d6) δ/ppm: 8.66 (t, J = 5.7 Hz, 1H), 8.24 (t, J = 5.9 Hz, 1H), 8.13 (t, J = 6.0 Hz, 1H), 8.03 – 7.98 (m, 1H), 
7.98 – 7.94 (m, 1H), 7.93 – 7.87 (m, 2H), 7.86 – 7.82 (m, 2H), 7.49 (d, J = 8.4 Hz, 1H), 7.20 (t, J = 7.9 Hz, 1H), 6.98 (dd, J = 2.6, 1.6 
Hz, 1H), 6.95 – 6.91 (m, 1H), 6.86 (ddd, J = 8.3, 2.6, 0.9 Hz, 1H), 4.12 – 4.06 (m, 4H), 3.82 – 3.79 (m, 2H), 3.41 (t, J = 6.7 Hz, 2H), 
3.34 (q, J = 6.5 Hz, 2H), 3.15 (dt, J = 8.0, 6.1 Hz, 2H), 2.79 (dt, J = 8.3, 6.1 Hz, 2H), 1.79 (p, J = 6.8 Hz, 2H). 
13C NMR (500 MHz, HMBC/HMQC, DMSO-d6) δ/ppm: 171.35, 168.53, 165.26, 157.94, 147.49, 140.71, 138.87, 138.56, 134.89, 
133.95, 132.60, 132.28, 129.20, 128.99, 128.06, 127.52, 125.95, 124.37, 120.64, 114.61, 113.04, 68.76, 67.38, 66.83, 48.29, 41.25, 
38.50, 36.48, 28.06. 
HRMS (ESI): C29H31N7NaO10S+ calcd: 692.1745, found: 692.1751. 
9.17 Synthesis of N5-(3-azidopropyl)-3'-formyl-N2-(2-NOSYL-ethyl)-[1,1'-biphenyl]-2,5-dicarboxamide XZ50 
 
XZ47 (53.0 mg, 88.1 µmol, 1.0 eq.), 3-formylphenylboronic acid (26.4 mg, 176.0 µmol, 2.0 eq.), Pd (π-cinnamyl) chloride dimer 
(9.1 mg, 17.6 µmol, 20 mol%) and K3PO4 (56.1 mg, 264.0 µmol, 3.0 eq.) were suspended in EtOH (1 mL) and H2O (500 µL). The 
mixture was stirred at 50°C for 1 h after which UPLC-MS analysis showed complete conversion to the desired product. The black 
mixture was filtered and purified by reversed-phase preparative HPLC (Method A). Product-containing fractions were combined and 
lyophilized to yield the desired product as white solid (34.0 mg, 67%).  
1H NMR (400 MHz, Chloroform-d) δ/ppm: 9.89 (s, 1H), 8.13 – 7.98 (m, 1H), 7.88 – 7.81 (m, 1H), 7.80 – 7.66 (m, 4H), 7.58 (d, J = 1.6 
Hz, 1H), 7.55 – 7.39 (m, 3H), 7.38 – 7.27 (m, 3H), 6.08 (t, J = 5.9 Hz, 1H), 3.50 (q, J = 6.4 Hz, 2H), 3.43 (t, J = 6.5 Hz, 2H), 3.33 (q, J 
= 5.5 Hz, 2H), 3.06 (t, J = 5.6 Hz, 2H), 1.89 (p, J = 6.7 Hz, 2H). 
13C NMR (101 MHz, CDCl3) δ/ppm: 192.55, 169.98, 167.53, 148.08, 140.04, 138.72, 137.89, 136.48, 136.01, 134.64, 133.92, 133.36, 
132.97, 131.06, 130.20, 129.50, 128.86, 128.79, 128.41, 126.34, 125.44, 49.52, 42.97, 39.97, 38.15, 28.64. 
HRMS (ESI): C26H25N7NaO7S+ calcd: 602.1428, found: 602.1438. 
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9.18 Synthesis of NP11 
 
Under an inert atmosphere 18-crown-6 ether (3.0 mg, 11.2 µmol, 1.3 eq.) was dissolved in THF (500 µL) and KHMDS (2.1 mg, 10.4 
µmol, 1.2 eq.) was added. The mixture was cooled to -78°C in a dry ice/acetone bath. Methyl 2-[bis(2,2,2-
trifluoroethoxy)phosphoryl]acetate (2.0 µL, 9.5 µmol, 1.1 eq.) was added and the mixture was stirred at -78°C for 5 min. XZ50 
(5.0 mg, 8.6 µmol, 1.0 eq.) was added and the mixture was stirred at -78°C for 3 h. The cooling bath was removed and the solution 
was slowly warmed to RT. After in total 6 h reaction time UPLC-MS analysis showed full conversion to the methyl ester product. A 
solution of LiOH monohydrate (3.6 mg, 86.3 µmol, 10.0 eq.) in H2O (288 µL) was added and the mixture was continued stirring 
overnight. UPLC-MS analysis showed full conversion to the acid in a 3:1 isomeric ratio. The mixture was filtered and purified by 
reversed-phase preparative HPLC (Method A). Product-containing fractions were combined and lyophilized to yield the desired 
product as a white solid (2.5 mg, 47%, 24:1 cis:trans mixture).  
1H NMR (500 MHz, DMSO-d6) δ/ppm: 12.51 (s, 1H), 8.66 (t, J = 5.6 Hz, 1H), 8.32 (t, J = 5.9 Hz, 1H), 8.15 (t, J = 6.0 Hz, 1H), 8.03 – 
7.99 (m, 1H), 7.98 – 7.94 (m, 1H), 7.92 – 7.88 (m, 2H), 7.87 – 7.83 (m, 2H), 7.59 – 7.55 (m, 2H), 7.51 (d, J = 7.8 Hz, 1H), 7.37 – 7.27 
(m, 2H), 6.85 (d, J = 12.7 Hz, 1H), 5.94 (d, J = 12.7 Hz, 1H), 3.45 – 3.41 (m, 2H), 3.34 (q, J = 6.2 Hz, 2H), 3.16 (dt, J = 7.9, 6.0 Hz, 
2H), 2.81 (dt, J = 8.2, 6.1 Hz, 2H), 1.79 (p, J = 6.8 Hz, 2H). 
13C NMR (500 MHz, HMBC/HMQC, DMSO-d6) δ/ppm: 168.31, 167.00, 165.26, 147.32, 139.93, 139.23, 138.75, 138.51, 135.11, 
134.55, 133.96, 132.59, 130.73, 129.51, 129.19, 128.61, 128.28, 128.18, 127.64, 127.62, 125.90, 124.37, 121.19, 48.30, 41.28, 
38.58, 36.50, 28.06. 
HRMS (ESI): C28H27N7NaO8S+ calcd: 644.1534, found: 644.1540. 
9.19 Synthesis of NP12 
 
XZ47 (20.0 mg, 33.3 µmol, 1.0 eq.) and Pd (π-cinnamyl) chloride dimer (1.7 mg, 3.3 µmol, 10 mol%) were placed in a dry 5 mL 
Schlenk tube, which was evacuated and backfilled with N2 three times. THF (400 µL) was added and the yellow solution was cooled 
to 0°C. A solution of (S)-(3-methoxy-2-methyl-3-oxopropyl)zinc(II) bromide (99.8 µL, 49.9 µmol, 500 mM in THF, 1.5 eq.) was slowly 
added and the yellow solution was stirred at 0°C for 15 min. The solution was warmed to RT and stirred for another 45 min. UPLC-
MS analysis showed full conversion to the methyl ester product. A solution of LiOH monohydrate (7.0 mg, 166.0 µmol, 5.0 eq.) in H2O 
(333 µL) was added and the mixture was stirred overnight. UPLC-MS analysis showed complete conversion to the desired product. 
The mixture was filtered and purified by reversed-phase preparative HPLC (Method A). Product-containing fractions were combined 
and lyophilized to yield the desired product as a white solid (15 mg, 80%).  
1H NMR (500 MHz, DMSO-d6) δ/ppm: 8.55 (t, J = 5.7 Hz, 1H), 8.44 (t, J = 5.7 Hz, 1H), 8.20 (t, J = 5.9 Hz, 1H), 8.04 – 8.00 (m, 1H), 
8.00 – 7.96 (m, 1H), 7.90 – 7.85 (m, 2H), 7.73 – 7.68 (m, 2H), 7.44 – 7.40 (m, 1H), 3.41 (t, J = 6.7 Hz, 2H), 3.32 (qd, J = 6.2, 3.0 Hz, 
4H), 3.11 – 3.01 (m, 3H), 2.76 (dd, J = 13.5, 7.8 Hz, 1H), 2.65 (h, J = 7.1 Hz, 1H), 1.79 (p, J = 6.8 Hz, 2H), 0.97 (d, J = 7.0 Hz, 3H). 
13C NMR (500 MHz, HMBC/HMQC, DMSO-d6) δ/ppm: 176.50, 168.42, 165.38, 147.43, 138.92, 137.58, 137.34, 134.63, 133.88, 
132.52, 129.23, 128.87, 127.14, 124.57, 124.28, 48.26, 41.67, 39.92, 38.74, 36.41, 35.68, 28.05, 16.50. 
HRMS (ESI): C23H27N7NaO8S+ calcd: 584.1534, found: 584.1542. 
9.20 Synthesis of NP13 
 
XZ47 (20.0 mg, 33.3 µmol, 1.0 eq.) and Pd (π-cinnamyl) chloride dimer (1.7 mg, 3.3 µmol, 10 mol%) were placed in a dry 5 mL 
Schlenk tube, which was evacuated and backfilled with N2 three times. THF (400 µL) was added and the yellow solution was cooled 
to 0°C. A solution of (3-ethoxy-3-oxopropyl)zinc(II) bromide (99.8 µL, 49.9 µmol, 500 mM in THF, 1.5 eq.) was slowly added and the 
yellow solution was stirred at 0°C for 15 min. The solution was warmed to RT and stirred for another 45 min. UPLC-MS analysis 
showed full conversion to the ethyl ester product. A solution of LiOH monohydrate (14.0 mg, 333.0 µmol, 10.0 eq.) in H2O (665 µL) 
was added and the mixture was stirred at RT for 2 h. UPLC-MS analysis showed complete conversion to the desired product. The 
mixture was filtered and purified by reversed-phase preparative HPLC (Method A). Product-containing fractions were combined and 
lyophilized to yield the desired product as a white solid (16 mg, 88%).  
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1H NMR (500 MHz, DMSO-d6) δ/ppm: 8.55 (t, J = 5.7 Hz, 1H), 8.44 (t, J = 5.7 Hz, 1H), 8.22 (t, J = 6.0 Hz, 1H), 8.05 – 8.00 (m, 1H), 
8.00 – 7.96 (m, 1H), 7.90 – 7.84 (m, 2H), 7.75 (d, J = 1.7 Hz, 1H), 7.69 (dd, J = 7.9, 1.8 Hz, 1H), 7.41 (d, J = 7.9 Hz, 1H), 3.41 (t, J = 
6.8 Hz, 2H), 3.35 – 3.29 (m, 4H), 3.09 (q, J = 6.5 Hz, 2H), 2.91 (dd, J = 8.7, 7.1 Hz, 2H), 2.53 (dd, J = 8.7, 7.2 Hz, 2H), 1.79 (p, J = 
6.8 Hz, 2H). 
13C NMR (500 MHz, HMBC/HMQC, DMSO-d6) δ/ppm: 173.51, 168.47, 165.50, 147.47, 138.64, 138.57, 135.03, 133.96, 132.63, 
129.31, 128.31, 127.17, 126.62, 124.53, 124.38, 48.35, 41.79, 38.86, 36.48, 34.97, 28.15, 27.89. 
HRMS (ESI): C22H25N7NaO8S+ calcd: 570.1378, found: 570.1385. 
9.21 Synthesis of NP14 
 
XZ47 (20.0 mg, 33.3 µmol, 1.0 eq.) and Pd (π-cinnamyl) chloride dimer (1.7 mg, 3.3 µmol, 10 mol%) were placed in a dry 5 mL 
Schlenk tube, which was evacuated and backfilled with N2 three times. THF (400 µL) was added and the yellow solution was cooled 
to 0°C. A solution of (4-ethoxy-4-oxobutyl)zinc(II) bromide (99.8 µL, 49.9 µmol, 500 mM in THF, 1.5 eq.) was slowly added and the 
yellow solution was stirred at 0°C for 15 min. The solution was warmed to RT and stirred for another 45 min. UPLC-MS analysis 
showed full conversion to the ethyl ester product. A solution of LiOH monohydrate (14.0 mg, 333.0 µmol, 10.0 eq.) in H2O (665 µL) 
was added and the mixture was stirred at RT for 2 h. UPLC-MS analysis showed complete conversion to the desired product. The 
mixture was filtered and purified by reversed-phase preparative HPLC (Method A). Product-containing fractions were combined and 
lyophilized to yield the desired product as a white solid (7 mg, 38%).  
1H NMR (500 MHz, DMSO-d6) δ/ppm: 8.57 (t, J = 5.7 Hz, 1H), 8.40 (t, J = 5.7 Hz, 1H), 8.20 (t, J = 5.9 Hz, 1H), 8.06 – 8.00 (m, 1H), 
8.01 – 7.96 (m, 1H), 7.90 – 7.84 (m, 2H), 7.71 (d, J = 1.7 Hz, 1H), 7.69 (dd, J = 7.9, 1.7 Hz, 1H), 7.38 (d, J = 7.9 Hz, 1H), 3.41 (t, J = 
6.7 Hz, 2H), 3.32 (p, J = 6.3 Hz, 4H), 3.08 (q, J = 6.4 Hz, 2H), 2.73 – 2.67 (m, 2H), 2.19 (t, J = 7.5 Hz, 2H), 1.78 (dt, J = 10.2, 7.1 Hz, 
4H). 
13C NMR (500 MHz, HMBC/HMQC, DMSO-d6) δ/ppm: 173.93, 168.52, 165.48, 147.44, 139.23, 139.02, 138.80, 134.82, 133.91, 
132.56, 129.27, 128.17, 127.01, 124.34, 124.30, 48.31, 41.77, 38.75, 36.44, 33.13, 31.63, 28.11, 25.95. 
HRMS (ESI): C23H27N7NaO8S+ calcd: 584.1534, found: 584.1533. 
9.22 Synthesis of NP15 
 
XZ47 (20.0 mg, 33.3 µmol, 1.0 eq.) and Pd (π-cinnamyl) chloride dimer (6.7 mg, 13.3 µmol, 40 mol%) were placed in a dry 5 mL 
Schlenk tube, which was evacuated and backfilled with N2 three times. THF (400 µL) was added and the yellow solution was cooled 
to 0°C. A solution of (5-ethoxycarbonyl-2-furyl)zinc(II) bromide (99.8 µL, 49.9 µmol, 500 mM in THF, 1.5 eq.) was slowly added and 
the yellow solution was stirred at 0°C for 15 min. The solution was warmed to RT and stirred for another 45 min. UPLC-MS analysis 
showed 50% conversion to the ethyl ester product. The mixture was filtered and purified by reversed-phase preparative HPLC 
(Method A). Product-containing fractions were combined and lyophilized to yield the desired product as a yellow-brown solid (6 mg, 
29%). The material was dissolved in MeCN (300 µL) and a solution of LiOH monohydrate (4.1 mg, 97.8 µmol, 10.0 eq.) in H2O 
(196 µL) was added and the mixture was stirred at RT for 2 h. UPLC-MS analysis showed complete conversion to the desired 
product. The mixture was filtered and purified by reversed-phase preparative HPLC (Method A). Product-containing fractions were 
combined and lyophilized to yield the desired product as a white solid (3 mg, 52%).  
1H NMR (500 MHz, DMSO-d6) δ/ppm: 8.74 (t, J = 5.6 Hz, 1H), 8.60 (t, J = 5.7 Hz, 1H), 8.23 – 8.18 (m, 2H), 8.04 – 8.01 (m, 1H), 8.01 
– 7.97 (m, 1H), 7.91 – 7.85 (m, 3H), 7.50 (d, J = 7.9 Hz, 1H), 7.25 (d, J = 3.6 Hz, 1H), 6.85 (d, J = 3.6 Hz, 1H), 3.43 (t, J = 6.7 Hz, 
2H), 3.34 (dq, J = 19.1, 6.6 Hz, 4H), 3.08 (dt, J = 7.6, 6.2 Hz, 2H), 1.81 (p, J = 6.8 Hz, 2H). 
13C NMR (500 MHz, HMBC/HMQC, DMSO-d6) δ/ppm: 168.20, 164.92, 153.68, 147.43, 144.15, 137.36, 135.03, 133.89, 132.57, 
129.22, 127.92, 126.99, 126.00, 125.59, 124.30, 119.27, 110.50, 99.05, 48.27, 41.54, 38.86, 36.52, 28.03. 
HRMS (ESI): C24H23N7NaO9S+ calcd: 608.1170, found: 608.1167. 
9.23 Synthesis of NP16 
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XZ47 (20.0 mg, 33.3 µmol, 1.0 eq.) and Pd (π-cinnamyl) chloride dimer (1.7 mg, 3.3 µmol, 10 mol%) were placed in a dry 5 mL 
Schlenk tube, which was evacuated and backfilled with N2 three times. THF (400 µL) was added and the yellow solution was cooled 
to 0°C. A solution of (6-ethoxy-6-oxohexyl)zinc(II) bromide (99.8 µL, 49.9 µmol, 500 mM in THF, 1.5 eq.) was slowly added and the 
yellow solution was stirred at 0°C for 15 min. The solution was warmed to RT and stirred for another 45 min. UPLC-MS analysis 
showed 16% conversion to the ethyl ester product plus a lot of byproduct. A solution of LiOH monohydrate (14.0 mg, 333.0 µmol, 
10.0 eq.) in H2O (665 µL) was added and the mixture was stirred at RT for 2 h. UPLC-MS analysis showed complete conversion to 
the desired product. The mixture was filtered and purified by reversed-phase preparative HPLC (Method A). Product-containing 
fractions were combined and lyophilized to yield the desired product as a brownish solid (3 mg, 15%).  
1H NMR (500 MHz, DMSO-d6) δ/ppm: 11.96 (s, 1H), 8.54 (t, J = 5.7 Hz, 1H), 8.38 (t, J = 5.7 Hz, 1H), 8.20 (t, J = 6.0 Hz, 1H), 8.04 – 
8.00 (m, 1H), 8.00 – 7.96 (m, 1H), 7.91 – 7.85 (m, 2H), 7.70 (d, J = 1.7 Hz, 1H), 7.67 (dd, J = 7.9, 1.8 Hz, 1H), 7.37 (d, J = 7.9 Hz, 
1H), 3.41 (t, J = 6.7 Hz, 2H), 3.33 – 3.28 (m, 4H), 3.10 – 3.03 (m, 2H), 2.72 – 2.64 (m, 2H), 2.16 (t, J = 7.4 Hz, 2H), 1.78 (p, J = 6.8 
Hz, 2H), 1.56 – 1.42 (m, 4H), 1.32 – 1.20 (m, 2H). 
13C NMR (500 MHz, HMBC/HMQC, DMSO-d6) δ/ppm: 174.21, 168.64, 165.59, 147.46, 139.96, 138.83, 138.74, 134.79, 133.92, 
132.55, 129.16, 128.17, 126.95, 124.31, 124.16, 48.32, 41.76, 38.70, 36.44, 33.29, 32.21, 30.45, 28.25, 28.11, 23.99. 
HRMS (ESI): C25H31N7NaO8S+ calcd: 612.1847, found: 612.1846. 
9.24 Synthesis of NP17 
 
In a dry Schlenk tube triethyl-4-phosphonocrotonate (5.0 µL, 22.4 µmol, 1.3 eq.) was dissolved in THF (400 µL) and cooled to 0°C. n-
BuLi (16.2 µL, 25.9 µmol, 1.5 eq. 1.6 M in hexanes) was added and the yellow solution was stirred for 15 min at 0°C. XZ50 (10.0 mg, 
17.3 µmol, 1.0 eq.) was added and the yellow solution was stirred at 0°C for 15 min. The ice bath was removed and the solution was 
stirred at RT overnight, after which UPLC- MS analysis showed complete conversion of the starting material. The mixture was filtered 
and purified by reversed-phase preparative HPLC (Method A). Product-containing fractions were combined and lyophilized to yield 
the ethyl ester product as a white solid (5 mg, 43%). The material was dissolved in MeCN (500 µL) and a solution of LiOH 
monohydrate (6.2 mg, 148.0 µmol, 20.0 eq.) in H2O (493 µL) was added and the mixture was stirred at RT for 2 h. UPLC-MS analysis 
showed complete conversion to the desired product. The mixture was filtered and purified by reversed-phase preparative HPLC 
(Method A). Product-containing fractions were combined and lyophilized to yield the desired product as a white solid (2 mg, 42%). 
1H NMR (500 MHz, DMSO-d6) δ/ppm: 12.29 (brs, 1 H), 8.66 (t, J = 5.7 Hz, 1H), 8.31 (t, J = 5.9 Hz, 1H), 8.14 (t, J = 6.0 Hz, 1H), 8.02 
– 7.97 (m, 1H), 7.96 – 7.92 (m, Hz, 1H), 7.91 – 7.88 (m, 2H), 7.88 – 7.85 (m, 2H), 7.57 – 7.51 (m, 2H), 7.48 (dt, J = 7.2, 1.8 Hz, 1H), 
7.38 – 7.28 (m, 3H), 7.14 – 7.00 (m, 2H), 6.01 (d, J = 15.2 Hz, 1H), 3.41 (t, J = 6.8 Hz, 2H), 3.34 – 3.31 (m, 2 H), 3.15 (dt, J = 8.0, 6.1 
Hz, 2H), 2.76 (dt, J = 8.4, 6.2 Hz, 2H), 1.79 (p, J = 6.8 Hz, 2H). 
13C NMR (500 MHz, HMBC/HMQC, DMSO-d6) δ/ppm: 168.31, 167.23, 165.19, 147.47, 144.03, 143.89, 139.95, 139.31, 138.81, 
138.39, 135.71, 135.00, 133.95, 132.56, 129.17, 128.63, 128.36, 128.19, 127.54, 126.95, 126.79, 126.04, 125.97, 124.38, 122.26, 
48.30, 41.24, 38.53, 36.50, 28.07. 
HRMS (ESI): C30H29N7NaO8S+ calcd: 670.1691, found: 670.1694. 
9.25 Synthesis of 6-Bromo methyl sorbate XZ51 
 
Methyl sorbate (517.0 µL, 3.96 mmol, 1.0 eq.) and NBS (733.0 mg, 4.12 mmol, 1.0 eq.) were suspended in chlorobenzene (3.37 mL) 
and stirred at 100°C for 1 h. Benzoylperoxide (86.6 mg, 359 µmol, 9 mol%) was added and the mixture was refluxed for 5 h. The 
reaction was concentrated in vacuo and the residue was dissolved in Et2O (8 mL). The organic layer was washed with aqueous 
NaOH (5%, 2 mL per wash) until the aqueous layer remained colorless. The organic layer was dried over Na2SO4, concentrated by 
rotary evaporation and the crude was purified by flash column chromatography (Silica, 60 g, cyclohexane:EtOAc, 30:1→25:1 →20:1, 
Rf = 0.31, UV) to yield the desired product as yellow oil (254 mg, 31%). Analytical data was in agreement with reported data.
[15] 
1H NMR (400 MHz, CDCl3) δ/ppm: 7.29 – 7.23 (m, 1H), 6.42 – 6.35 (m, 1H), 6.28 – 6.20 (m, 1H), 5.94 (d, J = 15.2 Hz, 1H), 4.03 (d, 
J = 7.7 Hz, 2H), 3.75 (s, 3H). 
9.26 Synthesis of Methyl (2E,4E)-6-(diethoxyphosphoryl)hexa-2,4-dienoate XZ52 
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XZ51 (100.0 mg, 488.0 µmol, 1.0 eq.) was dissolved in toluene (935 µL) and P(OEt)3 (1.04 mL, 5.9 mmol, 12 eq.) was dropwise 
added. The mixture was refluxed for 2 h after which the solvent was removed by rotary evaporation. The crude residue was purified 
by flash column chromatography (Silica, 15 g, petrol ether:EtOAc, 1:1→1:4→100% EtOAc, Rf = 0.25, UV) to yield the desired product 
as a colorless oil (104 mg, 81%). Analytical data was in agreement with reported data.[16] 
1H NMR (400 MHz, CDCl3) δ/ppm: 7.29 – 7.22 (m, 1H), 6.34 – 6.26 (m, 1H), 6.10 – 6.00 (m, 1H), 5.85 (dd, J = 15.4, 2.4 Hz, 1H), 4.14 
– 4.06 (m, 4H), 3.74 (s, 3H), 2.71 (dd, J = 23, 7.6 Hz, 2H), 1.31 (t, J = 7.1 Hz, 3H). 
9.27 Synthesis of NP18 
 
XZ52 (10.9 mg, 41.4 µmol, 1.2 eq.) was dissolved in THF (600 µL) and cooled to -78°C. n-BuLi (32.4 µL, 51.8 µmol, 1.5 eq. 1.6 M in 
hexanes) was added and stirred at -78°C for 15 min. A solution of XZ50 (20.0 mg, 34.5 µmol, 1.0 eq.) in THF (400 µL) was added 
and the mixture was stirred at -78°C for 2 h. The mixture was slowly warmed to RT and continued stirring for 5.5 h after which HMPA 
(14.4 µL, 82.8 µmol, 2.4 eq.) was added. The mixture was stirred at RT overnight, filtered and purified by reversed-phase preparative 
HPLC (Method A). Product-containing fractions were combined and lyophilized to yield the desired product as a yellowish solid 
(14 mg, 59%). The material was dissolved in MeCN (400 µL) and a solution of LiOH monohydrate (8.5 mg, 203.7 µmol, 10 eq.) in 
H2O (310µL) was added. The mixture was agitated at RT for 1 h, after which UPLC-MS analysis showed complete conversion to the 
desired product. The solution was acidified to pH 3 with aqueous HCl. The crude was purified by reversed-phase preparative HPLC 
(Method A). Product-containing fractions were combined and lyophilized to yield the desired product as a yellowish solid (2.6 mg, 
24%). 
1H NMR (500 MHz, DMSO-d6) δ/ppm: 12.26 (s, 1H), 8.70 – 8.61 (m, 1H), 8.30 (td, J = 5.8, 3.3 Hz, 1H), 8.17 – 8.09 (m, 1H), 8.03 – 
7.97 (m, 1H), 7.96 – 7.92 (m, 1H), 7.92 – 7.81 (m, 4H), 7.67 – 7.43 (m, 3H), 7.42 – 7.24 (m, 3H), 7.23 – 6.99 (m, 1H), 6.90 – 6.72 (m, 
1H), 6.62 – 6.45 (m, 1H), 6.40 – 6.13 (m, 1H), 5.95 (dd, J = 17.3, 15.1 Hz, 1H), 3.41 (t, J = 6.7 Hz, 2H), 3.34 – 3.31 (m, 2H), 3.15 (q, 
J = 6.7 Hz, 2H), 2.83 – 2.71 (m, 2H), 1.79 (p, J = 6.8 Hz, 2H). 
13C NMR (500 MHz, HMBC/HMQC, DMSO-d6) δ/ppm: 168.42, 167.36, 165.25, 147.44, 139.95, 138.88, 138.53, 136.81, 136.26, 
135.83, 135.01, 133.94, 132.58, 130.62, 129.19, 128.61, 128.22, 128.20, 127.53, 127.08, 127.00, 126.51, 125.99, 125.95, 125.73, 
124.38, 121.67, 48.31, 41.27, 38.55, 36.51, 28.07. 
HRMS (ESI): C32H31N7NaO8S+ calcd: 696.1847, found: 696.1855. 
9.28 Synthesis of NP19 
  
In a dry Schlenk tube triethyl 3-methyl-4-phosphono-2-butenoate (24.2 µL, 89.8 µmol, 1.3 eq.) was dissolved in THF (1.6 mL) and 
cooled to 0°C. n-BuLi (64.8 µL, 103.6 µmol, 1.5 eq. 1.6 M in hexanes) was added and the yellow solution was stirred at 0°C for 15 
min. XZ50 (40.0 mg, 69.0 µmol, 1.0 eq.) was added and the yellow solution was stirred at 0°C for 15 min. The ice bath was removed 
and the solution was stirred at RT for 38 h after which UPLC-MS analysis showed about 60% conversion to the product. The mixture 
was filtered and purified by reversed-phase preparative HPLC (Method A). Product-containing fractions were combined and 
lyophilized to yield the two isomeric ethyl ester products as white solids (major isomer, 26 mg, 54%)/(minor isomer, 6 mg, 13%). The 
major isomer was dissolved in MeCN (1 mL) and a solution of LiOH monohydrate (22.8 mg, 544.0 µmol, 15.0 eq.) in H2O (1.1 mL) 
was added and the mixture was stirred at RT for 22 h. UPLC-MS analysis showed complete conversion to the desired product. The 
mixture was acidified with conc. HCl, filtered and purified by reversed-phase preparative HPLC (Method A). Product-containing 
fractions were combined and lyophilized to yield the desired product as a white solid (15 mg, 63%). NOE analysis confirmed the 
correct structure of the product. 
1H NMR (500 MHz, DMSO-d6) δ/ppm: 12.15 (s, 1H), 8.67 (t, J = 5.6 Hz, 1H), 8.30 (t, J = 5.8 Hz, 1H), 8.14 (t, J = 6.0 Hz, 1H), 8.02 – 
7.97 (m, 1H), 7.96 – 7.92 (m, 1H), 7.91 – 7.86 (m, 4H), 7.60 (d, J = 1.6 Hz, 1H), 7.54 – 7.50 (m, 2H), 7.34 – 7.27 (m, 2H), 7.08 – 6.98 
(m, 2H), 5.96 (d, J = 1.4 Hz, 1H), 3.45 – 3.40 (m, 2H), 3.34 (q, J = 6.6 Hz, 2H), 3.15 (dt, J = 7.9, 6.0 Hz, 2H), 2.78 (dt, J = 8.4, 6.1 Hz, 
2H), 2.31 (d, J = 1.2 Hz, 3H), 1.79 (p, J = 6.8 Hz, 2H). 
13C NMR (500 MHz, HMBC/HMQC, DMSO-d6) δ/ppm: 168.36, 167.51, 165.23, 150.72, 147.47, 139.95, 138.82, 138.51, 135.96, 
134.99, 133.95, 133.22, 132.55, 132.08, 129.18, 128.35, 128.34, 128.24, 127.55, 127.00, 126.79, 126.01, 125.87, 124.39, 120.66, 
48.32, 41.28, 38.56, 36.53, 28.09, 13.03. 
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HRMS (ESI): C31H31N7NaO8S+ calcd: 684.1847, found: 684.1859. 
9.29 Synthesis of NP20 
 
The isolated minor isomer from NP19 synthesis (5.0 mg, 7.3 µmol, 1.0 eq.) was dissolved in MeCN (200 µL) and a solution of LiOH 
monohydrate (4.6 mg, 109.0 µmol, 15 eq.) in H2O (217 µL) was added. The solution was stirred at RT for 22 h after which UPLC-MS 
analysis showed full conversion. The solution was acidified with HCl (2 M) and purified by reversed-phase preparative HPLC 
(Method A). Product-containing fractions were combined and lyophilized to yield the desired product as a white solid (3 mg, 63%). 
NOE analysis confirmed the correct structure of the product. 
1H NMR (500 MHz, DMSO-d6) δ/ppm: 12.15 (s, 1H), 8.67 (t, J = 5.4 Hz, 1H), 8.33 – 8.25 (m, 2H), 8.13 (dt, J = 9.9, 5.8 Hz, 1H), 8.03 
– 7.97 (m, 1H), 7.93 (dd, J = 6.2, 3.2 Hz, 1H), 7.90 – 7.86 (m, 4H), 7.56 – 7.48 (m, 2H), 7.44 (dt, J = 7.6, 1.5 Hz, 1H), 7.35 – 7.28 (m, 
2H), 7.02 (d, J = 16.1 Hz, 1H), 5.76 (s, 1H), 3.44 – 3.39 (m, 3H), 3.36 – 3.33 (m, 2H), 3.17 – 3.12 (m, 2H), 2.74 (dt, J = 8.3, 6.1 Hz, 
2H), 2.08 (d, J = 1.3 Hz, 3H), 1.79 (td, J = 6.7, 1.3 Hz, 2H). 
13C NMR (500 MHz, HMBC/HMQC, DMSO-d6) δ/ppm: 168.28, 166.77, 165.23, 149.53, 147.30, 140.01, 138.82, 138.56, 136.23, 
135.02, 134.40, 133.92, 132.52, 129.16, 128.46, 128.43, 128.11, 127.50, 127.34, 127.10, 126.00, 125.69, 125.54, 124.34, 118.65, 
48.28, 41.22, 38.50, 36.48, 28.04, 20.18. 
HRMS (ESI): C31H31N7NaO8S+ calcd: 684.1847, found: 684.1857. 
9.30 Synthesis of NP21 
 
In a dry Schlenk tube 2-methyl-triethyl-4-phosphonocrotonate (44.5 mg, 135.0 µmol, 1.3 eq.) was dissolved in THF (1 mL) and cooled 
to 0°C. n-BuLi (97.1 µL, 155.3 µmol, 1.5 eq. 1.6 M in hexanes) was added and the yellow solution was stirred at 0°C for 15 min. XZ50 
(60.0 mg, 104.0 µmol, 1.0 eq.) was added and the yellow solution was stirred at 0°C for 15 min. The ice bath was removed and the 
solution was stirred at RT for 25 h after which UPLC-MS analysis showed about 66% conversion to the product. The solvent was 
removed by rotary evaporation and purified by reversed-phase preparative HPLC (Method A). Product-containing fractions were 
combined and lyophilized to yield the ethyl ester product as a white solid (41 mg, 57%). The material was dissolved in MeCN 
(1.5 mL) and a solution of LiOH monohydrate (24.9 mg, 594.0 µmol, 10.0 eq.) in H2O (743 µL) was added and the mixture was stirred 
at RT for 23 h. UPLC-MS analysis showed complete conversion to the desired product. The mixture was acidified with conc. HCl, 
filtered and purified by reversed-phase preparative HPLC (Method A). Product-containing fractions were combined and lyophilized to 
yield the desired product as a white solid (30 mg, 76%). 
1H NMR (500 MHz, DMSO-d6) δ/ppm: 8.67 (t, J = 5.7 Hz, 1H), 8.34 (t, J = 5.9 Hz, 1H), 8.14 (t, J = 6.0 Hz, 1H), 8.01 – 7.97 (m, 1H), 
7.96 – 7.92 (m, 1H), 7.91 – 7.85 (m, 4H), 7.62 (s, 1H), 7.57 – 7.49 (m, 2H), 7.33 (t, J = 7.5 Hz, 1H), 7.30 (dt, J = 7.6, 1.6 Hz, 1H), 
7.27 – 7.18 (m, 2H), 6.97 (d, J = 13.4 Hz, 1H), 3.41 (t, J = 6.7 Hz, 2H), 3.37 – 3.32 (m, 2H), 3.16 (dt, J = 7.9, 6.0 Hz, 2H), 2.79 (dt, J = 
8.4, 6.1 Hz, 2H), 1.98 (d, J = 1.2 Hz, 3H), 1.79 (p, J = 6.8 Hz, 2H). 
13C NMR (126 MHz, DMSO) δ/ppm: 169.11, 168.68, 165.50, 147.70, 140.20, 139.17, 138.78, 138.28, 137.63, 136.38, 135.22, 
134.10, 132.72, 132.57, 129.37, 128.64, 128.57, 128.43, 128.06, 127.71, 126.98, 126.36, 126.19, 124.64, 124.57, 48.57, 41.52, 
38.85, 36.78, 28.33, 12.86. 
HRMS (ESI): C31H31N7NaO8S+ calcd: 684.1847, found: 684.1854. 
9.31 Synthesis of AA008 
 
Under an inert atmosphere rac-H-β,β-Dicyclohexyl-Ala-OH (100 .0 mg, 395.0 µmol, 1.0 eq.) was suspended in MeOH (3 mL) and 
cooled to 0°C. SOCl2 (288 µL, 4.0 mmol, 10.0 eq.) was slowly added whereby a clear solution formed. The solution was stirred in the 
ice bath for 10 min and was then warmed to RT. After 20 h another portion of SOCl2 (288 µL, 4.0 mmol, 10.0 eq.) was added and the 
solution continued stirring. After 72 h more SOCl2 (144 µL, 2.0 mmol, 5.0 eq.) was added. After total 7 d UPLC-MS analysis showed 
>98% conversion to the product. The volatiles were removed by rotary evaporation and the residue was dissolved in DCM (20 mL) 
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and washed with half-saturated NaHCO3 solution (3 x 20 ml). The combined aqueous layers were extracted with DCM (2 x 20 mL) 
and the combined organic layers were washed with brine (20 mL), dried over Na2SO4 and concentrated in vacuo to yield the desired 
product as a yellowish oil (94 mg, 89%).  
1H NMR (400 MHz, Methylene Chloride-d2) δ/ppm: 3.66 (s, 3H), 3.61 (d, J = 2.6 Hz, 1H), 1.74 – 1.54 (m, 11H), 1.41 – 1.37 (m, 1H), 
1.28 – 1.03 (m, 11H). 
13C NMR (101 MHz, CD2Cl2) δ/ppm: 178.61, 54.59, 52.37, 52.14, 38.83, 36.88, 32.89, 32.43, 32.42, 30.61, 27.66, 27.65, 27.60, 
27.51, 27.32, 27.20. 
HRMS (ESI): C16H30NO2+ calcd: 268.2271, found: 268.2272. 
9.32 Synthesis of Benzyl (E)-penta-2,4-dienoate XZ53 
  
Pentadienoic acid (200.0 mg, 2.0 mmol, 1.0 eq.) was suspended in DCM (3 mL) and benzylic alcohol (422.0 µL, 4.1 mmol, 2.0 eq.) 
was added. The mixture was cooled in an ice bath and EDC hydrochloride (782.0 mg, 4.1 mmol, 2.0 eq.) and DMAP (167.0 mg, 
1.4 mmol, 0.7 eq.) were added. The mixture was warmed to RT and stirred for 5.5 h. HCl solution (1 M) was added to acidify the 
mixture and the phases were separated. The aqueous phase was extracted with DCM (2 x 8 mL) and the combined organic layers 
were washed with saturated NaHCO3 solution, dried over Na2SO4 and concentrated by rotary evaporation. The crude was purified by 
column chromatography (Silica, 50 g, cyclohexane:EtOAc 1:1) to yield the desired product as a colorless liquid (271 mg, 71%). 
Analytical data was in agreement with reported data.[17] 
1H NMR (400 MHz, CDCl3) δ/ppm: 7.41 – 7.27 (m, 6H), 6.46 (dt, J = 17.1, 10.1 Hz, 1H), 5.96 (d, J = 15.6 Hz 1H), 5.62 (d, J = 17.1 Hz, 
1H), 5.50 (d, J = 10.1 Hz, 1H), 5.20 (s, 2H). 
9.33 Synthesis of Benzyl (2E, 4E)-6-(bis-(Boc)aminohexa-2,4-dienoate XZ54 
 
XZ53 (100.0 mg, 531.0 µmol, 1.0 eq.) and bis-Boc allylamine (342.0 mg, 1.3 mmol, 2.5 eq.) were dissolved in DCM (1.5 mL). A 
solution of the Hoveyda-Grubbs catalyst (23.3 mg, 37.2 µmol, 7.0 mol%) in DCM (1.2 mL) was added and the reaction mixture was 
stirred at 40°C for 16 h. The reaction mixture was concentrated by rotary evaporation and purified by preparative reversed phase 
HPLC (Method A, no TFA) to yield the desired product as a greenish solid (70 mg, 32%). 
1H NMR (400 MHz, CD3CN) δ/ppm: 7.45 – 7.62 (m, 6H), 6.33 – 6.625 (m, 1H), 6.23 – 6.14 (m, 1H), 5.97 (d, J = 15.4 Hz, 1H), 5.16 (s, 
2H), 4.25 (d, J = 5.5 Hz, 2H), 1.46 (s, 18H). 
13C NMR (101MHz, CD3CN) δ/ppm: 167.2, 153.1, 145.0, 139.8, 137.6, 129.7, 129.5, 129.0, 129.0, 121.8, 83.2, 66.7, 48.3, 28.2. 
HRMS (ESI): C23H31NNaO6+ calcd: 440.2044, found: 440.2051. 
9.34 Synthesis of (2E, 4E)-6-(bis-(Boc)aminohexa-2,4-dienoic acid XZ55 
 
XZ54 (60.0 mg, 144.0 µmol, 1.0 eq.) was dissolved in H2O (1.2 mL) and MeCN (1.2 mL) and LiOH monohydrate (90.5 mg, 2.2 mmol, 
15 eq.) was added. The mixture was stirred at RT for 18 h. The mixture was purified by preparative reversed phase HPLC (Method A, 
no TFA) to yield the desired product as a brownish solid (32 mg, 68%). 
1H NMR (500 MHz, DMSO-d6) δ/ppm: 6.71 – 6.63 (m, 1H), 6.18 – 6.10 (m, 1H), 5.78 – 5.70 (m, 2H), 4.11 (d, J = 6.4 Hz, 2H), 1.43 (s, 
18H). 
13C NMR (126 MHz, DMSO-d6) δ/ppm: 169.4, 151.8, 134.7, 134.4, 131.8, 130.1, 81.8, 47.4, 27.6. 
HRMS (ESI): C16H25NNaO6+ calcd: 350.1574, found: 350.1576. 
9.35 Synthesis of AA076 
 
XZ55 (32.0 mg, 97.7 µmol, 1.0 eq.) was suspended in MeOH (5.3 mL) and cooled in an ice bath. SOCl2 (71.3 µL, 97.7 µmol, 10 eq.) 
was added and the mixture was stirred for 15 min at 0°C. The cooling bath was removed and the mixture was stirred at RT for 3 h. 
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The volatiles were removed by rotary evaporation and the crude was recrystallized from MeOH/Et2O to yield methyl the desired 
product as a brown solid (10 mg, 58%). 
1H NMR (400 MHz, MeOD-d4) δ/ppm: 7.31 (dd, J = 15.4, 10.9 Hz, 1H), 6.59 (dd, J = 15.4, 11.0 Hz, 1H), 6.19 (dt, J = 15.4, 6.4 Hz, 
1H), 6.06 (d, J = 15.4 Hz, 1H), 3.75 (s, 3H), 3.69 (d, J = 6.4 Hz, 2H). 
13C NMR (126 MHz, MeOD-d4) δ/ppm:169.5, 144.0, 134.5, 133.5, 124.2, 52.2, 41.8. 
HRMS (ESI): C7H12NO2+ calcd: 142.0863, found: 142.0863. 
9.36 Synthesis of AA077 
 
Aminooxyacetic acid (1.0 g, 11.0 mmol, 1.0 eq.) was suspended in MeOH (25 mL) and cooled to 0°C. SOCl2 (4.0 mL, 54.9 mmol, 5.0 
eq.) was slowly added and the solution was stirred at 0°C for 10 min. The cooling bath was removed and the solution was stirred at 
RT for 20 h. The solvent was removed by rotary evaporation and the residue was dissolved in half-saturated NaHCO3 solution (25 
mL). The mixture was extracted with EtOAc (3 x 25 mL) and the combined organic layers were washed with brine (25 mL), dried over 
Na2SO4 and concentrated. The crude material was purified by bulb-to-bulb distillation (100°C, 90 mbar). The desired product was 
isolated as colorless liquid (300 mg, 26%). Analytical data was in agreement with reported data.[18] 
1H NMR (400 MHz, Chloroform-d) δ/ppm: 4.48 (s, 2H), 3.80 (s, 3H). 
9.37 Synthesis of AA078 
 
3-[2-[2-(2-aminoethoxy)ethoxy]ethoxy]propanoic acid (118.0 mg, 533.0 µmol, 1.0 eq.) was dissolved in MeOH (3 mL) and cooled in 
an ice bath. SOCl2 (389.0 µL, 5.3 mmol, 10.0 eq.) was dropwise added and the mixture was stirred at 0°C for 10 min. The ice bath 
was removed and the mixture was stirred at RT for 14 h after which UPLC-MS analysis showed full conversion to the desired 
product. The volatiles were removed by rotary evaporation and the residue was dissolved in MeOH (5 mL), filtered and concentrated 
to yield the desired product as yellow oil (121 mg, 84%).  
1H NMR (500 MHz, Methanol-d4) δ/ppm: 3.75 (t, J = 6.1 Hz, 2H), 3.73 – 3.70 (m, 2H), 3.69 – 3.67 (m, 3H), 3.67 – 3.65 (m, 3H), 3.66 
– 3.59 (m, 5H), 3.15 – 3.11 (m, 2H), 2.60 (t, J = 6.1 Hz, 2H). 
13C NMR (126 MHz, MeOD) δ/ppm: 173.91, 71.52, 71.34, 71.20, 71.18, 67.83, 67.60, 52.18, 40.68, 35.62. 
HRMS (ESI): C10H22NO5+ calcd: 236.1492, found: 236.1494. 
9.38 Synthesis of AA087 
 
NaH in mineral oil (38.5 mg, 1.0 mmol, 1.6 eq. 60%) was suspended in THF (3 mL) and the mixture was cooled to 0°C. Methyl 2-
diethoxyphosphorylacetate (173.0 µL, 942.0 µmol, 1.5 eq.) was added and the solution was stirred at 0°C for 15 min. 2-(N-
Boc)acetaldehyde (100.0 mg, 628.0 µmol, 1.0 eq.) was added and the mixture was stirred at this temperature for 15 min. The cooling 
bath was removed and the solution was stirred at RT for 3.5 h after which TLC showed full conversion of the starting material. The 
reaction was quenched by the addition of EtOH (3 mL). The solvent was removed by rotary evaporation and the crude was purified 
by flash column chromatography (Silica, 37 g, 4:1 cyclohexane:EtOAc, Rf = 0.28, KMnO4). Product-containing fractions were 
combined and concentrated to yield the Boc protected intermediate as a colorless oil (77 mg, 57%). The material was dissolved in 
DCM (2 mL) and cooled in an ice bath. HCl in dioxane (895.0 µL, 3.6 mmol, 10.0 eq. 4 M) was slowly added and the solution was 
stirred at 0°C for 10 min. The cooling bath was removed and the mixture was stirred at RT for 16 h. The volatiles were removed by 
rotary evaporation and the residue was co-evaporated with DCM (5 mL) to yield the desired product as beige solid (47 mg, 86%). 
1H NMR (500 MHz, DMSO-d6) δ/ppm: 8.28 (brs, 3H), 6.87 (dt, J = 16.0, 5.6 Hz, 1H), 6.18 (dt, J = 16.0, 1.8 Hz, 1H), 3.71 (s, 3H), 3.70 
– 3.66 (m, 2H). 
13C NMR (126 MHz, DMSO) δ/ppm: 165.36, 140.61, 123.35, 51.71, 40.11. 
HRMS (ESI): C5H10NO2+ calcd: 116.0706, found: 116.0707. 
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18-crown-6 ether (216.0 mg, 817.0 µmol, 1.3 eq.) was dissolved in THF (3 mL) and KHMDS (150.0 mg, 754.0 µmol, 1.2 eq.) was 
added. The yellow solution was cooled to -78°C and methyl 2-[bis(2,2,2-trifluoroethoxy)phosphoryl]acetate (147.0 µL, 691.0 µmol, 
1.1 eq.) was added and the solution was stirred at 0°C for 5 min. 2-(N-Boc)acetaldehyde (100.0 mg, 628.0 µmol, 1.0 eq.) was added 
and the solution was stirred at -78°C for 1 h. The cooling bath was removed and the solution was stirred at RT for 1 h after which TLC 
showed full conversion of the starting material. The reaction was quenched by the addition of EtOH (3 mL). The solvent was removed 
by rotary evaporation and the crude was purified by flash column chromatography (Silica, 37 g, 5:1 cyclohexane:EtOAc, Rf = 0.23, 
KMnO4). Product-containing fractions were combined and concentrated to yield the Boc protected intermediate as a beige solid 
(60 mg, 44%). The material was dissolved in DCM (2 mL) and cooled in an ice bath. HCl in dioxane (696.0 µL, 2.8 mmol, 10.0 eq. 
4 M) was slowly added and the solution was stirred at 0°C for 10 min. The cooling bath was removed and the mixture was stirred at 
RT for 15 h. The volatiles were removed by rotary evaporation and the residue was co-evaporated with DCM (5 mL) to yield the 
desired product as beige solid (41 mg, 96%). 
1H NMR (500 MHz, DMSO-d6) δ/ppm: 8.21 (brs, 3H), 6.37 (dt, J = 11.7, 5.9 Hz, 1H), 6.08 (dt, J = 11.5, 2.2 Hz, 1H), 4.00 (s, 2H), 3.69 
(s, 3H). 
13C NMR (126 MHz, DMSO) δ 165.51, 141.74, 121.89, 51.50, 37.58. 
HRMS (ESI): C5H10NO2+ calcd: 116.0706, found: 116.0708. 
9.40 Synthesis of AA088 
 
Under an inert atmosphere in a Schlenk tube methyl (E)-3-bromo-2-methylprop-2-enoate (250.0 mg, 1.4 mmol, 1.0 eq.), bis-(Boc)-
allylamine (719.0 mg, 2.8 mmol, 2.0 eq.), Pd(OAc)2 (9.4 mg, 41.9 µmol, 3 mol%), tris(o-tolyl)phosphine (25.5 mg, 83.8 µmol, 6 mol%) 
and triethylamine (389.0 µL, 2.8 mmol, 2.0 eq.) were mixed and heated to 100°C and stirred at this temperature for 19 h after which 
UPLC-MS analysis showed complete conversion. The black mixture was quenched with NaOH (10%, 10 mL) and extracted with 
MtBE (3 x 10 ml). The combined organic layers were washed with brine (10 mL), dried over Na2SO4 and concentrated by rotary 
evaporation. The crude material was purified by flash column chromatography (Silica, 95g, cyclohexane:EtOAc 20:1→10:1, Rf= 0.20, 
UV/KMnO4) to yield the desired product as yellow oil (341 mg, 69%). The material (287.0 mg, 807 µmol, 1.0 eq.) was dissolved in 
DCM (4 mL) and cooled in an ice bath. HCl in dioxane (4.0 mL, 16.1 mmol, 20.0 eq 4 M in dioxane) was added and the solution was 
stirred at 0°C for 15 min. The mixture was warmed to RT and stirred for 19 h after which UPLC-MS analysis showed full conversion to 
the desired product. The volatiles were removed by rotary evaporation and the residue was dissolved in MeOH (3 mL). The mixture 
was filtered by syringe filter, cooled in an ice bath to 0°C and Et2O (5 x 3 mL) was added portionwise. The formed suspension was 
continued stirring at 0°C for 30 min and the precipitate was filtered off, washed with cold Et2O (10 mL), dried in vacuo to yield the 
desired product as a white solid (100 mg, 65%). 
1H NMR (400 MHz, Methanol-d4) δ/ppm: 7.19 (d, J = 11.3 Hz, 1H), 6.82 (ddd, J = 15.2, 11.3, 1.7 Hz, 1H), 6.11 (dt, J = 15.2, 6.7 Hz, 
1H), 3.76 (d, J = 1.7 Hz, 3H), 3.71 (d, J = 6.7 Hz, 2H), 1.99 (s, 3H). 
13C NMR (101 MHz, MeOD) δ/ppm: 169.88, 137.43, 132.10, 131.96, 130.75, 52.52, 42.03, 12.93. 
HRMS (ESI): C8H14NO2+ calcd: 156.1019, found: 156.1018. 
9.41 Synthesis of AA106 
 
(Trans-racemic) 1-tert-butyl-3-methyl-4-(5,6-dimethoxypyridin-3-yl)pyrrolidine-1,3-dicarboxylate (250 mg, 682 µmol, 1.0 eq.) and 
triethylsilane (1.1 mL, 6.8 mmol, 10.0 eq.) were dissolved in DCM (3 mL) and cooled in an ice bath. HCl in dioxane (1.7 mL, 6.8 
mmool, 10.0 eq. 4 M in dioxane) was added dropwise over 5 min and the solution was stirred in the ice bath for 10 min. The cooling 
bath was removed and the solution was stirred at RT for 50 min after which UPLC-MS analysis showed full conversion to the desired 
product. The volatiles were removed by rotary evaporation and the crude was purified by reversed phase column chromatography on 
the ISOLERA (RP- Silica, 100 g, H2O:MeCN, UV). Product-containing fractions were combined and lyophilized to yield the desired 
product as a white, hygroscopic solid (38 mg, 16%).  
1H NMR (500 MHz, Deuterium Oxide) δ/ppm: 7.65 (d, J = 1.9 Hz, 1H), 7.37 (d, J = 2.1 Hz, 1H), 3.97 (s, 3H), 3.91 (s, 3H), 3.87 (ddd, J 
= 11.7, 8.5, 5.0 Hz, 2H), 3.80 – 3.73 (m, 2H), 3.69 (s, 3H), 3.61 – 3.55 (m, 1H), 3.46 (t, J = 11.4 Hz, 1H). 
13C NMR (126 MHz, D2O) δ/ppm: 172.81, 153.96, 144.19, 135.21, 126.19, 117.38, 55.71, 53.91, 52.95, 50.82, 48.60, 47.05, 44.36. 
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HRMS (ESI): C13H19N2O4+ calcd: 267.1339, found: 267.1338. 
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